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Abstract 
Modern theories of emotion emphasise the role of homeostatic requirements in motivating and 
shaping behaviour and link emotions with motor and autonomic responses to define 
physiological, behavioural and neurobiological phenomena initiated by the emotional 
valence and relevance of a stimulus. Intermittent dysautonomia is a transient but recurrent 
dysregulation of autonomic nervous system function, such as orthostatic intolerance (postural 
tachycardia syndrome, vasovagal syncope) or thermoregulatory dysfunction (essential 
hyperhidrosis). The sympathetic and parasympathetic nervous systems often work 
antagonistically and with organ specificity, producing definable patterns of activity, yet 
despite the coupling of emotion with autonomic function, the evidence for robust emotion-
specific patterns remains elusive. Although psychiatric patients may report symptoms akin to 
intermittent dysautonomia, such as sweating, faintness or palpitations, autonomic diagnostic 
criteria are rarely met. However, comorbid psychological symptoms, such as subclinical 
anxiety and depression, are often reported in intermittent dysautonomia. Recent 
neuroimaging techniques have elucidated the interrelationship of autonomic and 
neurobiological pathophysiology and the perturbation of autonomic neuroanatomy by 
peripheral autonomic function and dysfunction. This thesis will investigate the complex 
interplay between brain and body in intermittent dysautonomia and healthy controls in order 
to improve our understanding of the common cognitive-affective symptomatology in 
vasovagal syncope (VVS), the postural tachycardia syndrome (PoTS) and essential 
hyperhidrosis (EH) that can complicate diagnosis and treatment. Moreover, organic conditions 
that provide such an overrepresentation of comorbid psychological symptoms may provide 
insight into cognitive-affective processes beyond autonomic medicine.	
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Chapter 1. Introduction with aims 
‘Homeostasis’ refers to the maintenance of a bodily steady-state for optimal health and 
functionality. Homeostatic feedback and feedforward systems operate across central and 
visceral mechanisms in response to physiological requirements, generating corrective 
metabolic, cardiovascular or behavioural actions. Homeostatic regulation is facilitated via the 
autonomic nervous system (ANS) and its unique ability to mediate activity of bodily organs, 
glands and blood vessels via peripheral efferent neurons (see figure 1). The sympathetic 
nervous system (SNS) acts to increase effector organ activity predominantly via the 
catecholamines, noradrenaline (NA) and adrenaline at the neruoeffector junction. The 
parasympathetic nervous system (PNS) promotes vegetative activity mainly via acetylcholine 
(Ach), such as the slowing of heart rate (HR) or facilitation of food digestion by increasing gut 
motility.  
 
Figure	1.	Autonomic innervation of human organs. Sweat glands (not shown) are supplied by cholinergic fibres. From 
Jänig (1995). 
 
To counteract venous pooling and maintain cerebral perfusion during orthostasis (standing), 
cardiopulmonary mechanoreceptors and arterial baroreceptors in the aortic arch and carotid 
sinus detect changes in vascular contraction and send afferent signals to the brainstem, 
upregulating peripheral sympathetic nerve activity (SNA), thereby, increasing peripheral 
vascular resistance, venous tone and HR so that the necessary arterial pressure to adequately 
perfuse neural tissue is reached (Smit et al., 1999). Behaviour-dependent increases in blood 
pressure (BP) are both enabled and moderated by the baroreflex (Janig and Habler, 2003, 
Dampney et al., 2013, Dampney et al., 2002). Failure of these autonomic reflexes can lead to 
transient loss of consciousness (TLoC) due to cerebral hypoperfusion.  
 
Human consciousness and cognition is dependent on sympathetic, parasympathetic and 
sensory innervation of the cerebral vasculature to mediate cerebral perfusion, however, the 
complexity of neurovascular coupling allows for the breakdown of cerebral perfusion. 
Intracranial pressure and local arterial pressure maintain cerebral perfusion pressure 
(difference between intracranial pressure and mean arterial pressure (Van Lieshout et al., 
2003)) at 80 mmHg and excessive increases or decreases (<50 mmHg) are prevented by 
autoregulation of cerebral blood flow (CBF), regardless of peripheral variations in BP (Van 
Lieshout et al., 2003). However, cerebral perfusion pressure is dependent on system arterial 
pressure, itself dependent on cardiac output and peripheral vascular resistance, therefore a 
reduction in either of these peripheral factors can cause reductions in cerebral perfusion 
pressure. Should cerebral perfusion pressure drop below 70 mmHg, the brain becomes 
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inadequately perfused with oxygen and other metabolites, predisposing to a transient loss of 
consciousness (TLoC) (Rosner et al., 1995).  
 
To ensure biochemical reactions are efficient, the human body’s’ optimum core temperature 
is 37°C. Some cerebral activities, such as stress, shock or sleep also effect thermoregulation 
(Collins, 2013). Following the perception of thermal discomfort, thermoregulatory behaviour 
can be initiated to maintain thermostasis. Perceived changes in skin temperature and thermal 
discomfort induce behavioural modifications (Schlader et al., 2009). The spinothalamic tract 
and other afferents provide feedback to the thalamus and posterior hypothalamus, which 
assumes the role of a central ‘thermostat’. Cutaneous thermoception is relayed to second-
order thermal sensory neurons in the dorsal horn via dorsal root ganglia and glutaminergic 
third-order cool-sensitive neurons of the lateral parabrachial nucleus and lateral subnucleus. 
Conscious thermoception is relayed to the cortex and thalamus via dorsal horn neurons. 
 
The body’s main defence against hyperthermia is heat loss via evaporation from the skin and 
respiratory passages, thus transferring heat from the body to the environment. Cholinergic 
sympathetic sudomotor neurons innervate 2-4 million eccrine glands that secrete a hypotonic 
saline solution during heat stress. Sweat evaporation cools the surrounding skin, which then 
cools the local cutaneous blood flow. Body temperature can also be regulated via skin blood 
flow (see figure 2).  
	
Figure	2.	Diagram	of	thermoregulatory	skin	blood	flow.	NE	=	noradrenaline,	NPY	=	neuropeptide	Y,	NO	=	nitric	oxide,	
CGRP	=	calcitonin	gene–related	peptide,	SP	=	substance	P,	NKA	=	neurokinin	A.	From	Charkoudian,	2003	
	
Vasoconstriction during cold stress conserves heat and lessens peripheral blood flow. 
Hypothermia is defined as a core temperature of <35°C. Cold responsive neurons in the caudal 
portion of the raphe pallidus and dorsomedial nucleus of the hypothalamus that initiate cold-
defence behaviours are inhibited by hypothalamic warm sensitive neurons. Preoptic warm-
sensitive neurons also synapse with shiver-promoting dorsomedial hypothalamic neurons 
which, via shivering premotor neurons in the rostral raphe pallidus and ventral horn, provide 
efferents to skeletal muscle α and γ motor neurons to invoke shivering. Cutaneous 
vasoconstriction sympathetic tone is modulated by noradrenaline (NA) and neuropeptide Y 
(NPY) (both post-ganglionic), serotonin and glutamate.  
 
Central autonomic networks within the spinal cord, brainstem and hypothalamus mediate 
cardiovascular and thermoregulatory autonomic outflows (Benarroch, 1993). The 
ventromedial prefrontal cortex (vmPFC) is involved with PNS and antisympathetic activity 
(Gianaros et al., 2004; Matthews et al., 2004) and supragenual areas of the mid and anterior 
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cingulate are associated with SNS activity. Haemodynamic changes are global autonomic 
responses requiring input from the cortex, limbic forebrain and midbrain (Saper, 2002) 
(Morrison, 2001). Dorsal anterior cingulate cortex (Critchley et al., 2003) and insula cortex 
(Critchley et al., 2000a, Critchley et al., 2000b) activity reflects engagement of sympathetic 
activity coupled to mental and physical behaviours. Increased activity in the medial prefrontal 
cortex (mPFC), anterior and posterior insula and ventroposterior thalamus occurs during 
respiration, isometric exercise and valsalva manoeuvre (King et al., 1999).  
 
Activity in the anterior cingulate cortex (Acc), insula, medial temporal lobe (MTL), ventral PFC 
(vPFC) and mPFC, medial thalamus, cerebellum, midbrain and pons increases during cold 
pressor and valsalva manoeuvres (Harper et al., 2000) and increases in BP are positively 
correlated with right dorsal Acc activity. These findings indicate sympathetic responses are 
lateralized to the right hemisphere (Oppenheimer et al., 1992) and the left insular cortex is 
involved in parasympathetic cardiovascular regulation.  
 
Hypothalamic, pontine and medullary sympathetic and parasympathetic nuclei interact with 
homeostatic representations to generate physically or behaviourally-induced organ-specific 
autonomic responses (Saper, 2002). HR changes are predicted by amygdala and dorsal Acc 
activity (Janig and Habler, 2003) and during threat/stress induction, amygdala function 
predicts cardiac contractility (Dalton et al., 2005). The amygdala and other limbic structures 
supply a descending efferent drive to the hypothalamus and brainstem for congruent 
autonomic responses to emotion-related behaviour (Saper, 2002).  
 
The nucleus of the solitary tract (NTS) receives baroreceptor afferents that synapse with the 
rostral ventrolateral medulla to set efferent pressor tone (see figure 3). Reduced baroreceptor 
tone has been associated with Acc, amygdala and anterior insula (AI) function, whereas 
initiation of baroreflexes increases activity in lateral PFC (lPFC) and posterior insula (Kimmerly 
et al., 2005).  
	
Figure	3.	Brainstem	nucleai,	including	the	nucleus	tractus	solitarius	(NTS),	involved	with	baroreflex	and	pressor	function.		
Nucleus	tractus	solitarius	=	NTS,	caudal	ventrolateral	medulla	=	CVLM,	rostral	ventrolateral	medulla	RVLM,	dorsal	motor	
nucleus	of	the	vagus	=	DMNX,	circumventricular	organs	=CVO,	paraventricular	nucleus	=	PVN),	supraoptic	nucleus	SON.	
From	Albaghdadi,	2007	
 
Autonomic disease and dysfunction (dysautonomia) can be classified as either fixed or 
intermittent (Mathias and Bannister, 2013). Fixed ANS disorders cause autonomic failure (AF) as 
the lesion is fixed and usually irreversible, such as in spinal cord injury (SCI) or pure autonomic 
failure (PAF). The lesion may also be progressive, as in Parkinson’s disease with AF or multiple 
system atrophy (MSA). AF is characterised by a postural fall in BP which is defined as orthostatic 
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hypotension (OH) when the fall is over 20 mmHg systolic BP (SBP) and/or 10 mmHg DBP. Fixed 
ANS disorders commonly present in patients of >40 years, whereas intermittent ANS disorders 
can present in all ages. 
 
Intermittent dysautonomia is a temporary but recurrent dysregulation of normative autonomic 
function attributable to a specific factor, such as orthostatic intolerance (OI) or 
thermoregulatory dysfunction. Thermoregulatory dysautonomia may occur due to a systemic 
(malignancy, shock), metabolic (diabetes mellitus, menopause) or febrile illness (infection), as 
well as neurological disorders (stroke, Parkinsons disease) and can be focal or generalised in 
nature. Cardiovascular intermittent dysautonomia relates to orthostatic intolerance (OI), 
though factors such as food digestion, dehydration and exercise can also exacerbate 
symptoms. Sudomotor and cardiovascular intermittent dysautonomia often present in 
adolescence/early adulthood and with strong positive family histories (Kaufmann et al., 2003, 
Iodice et al., 2010).  
 
The postural tachycardia syndrome (PoTS) is the most common form of OI (170 cases per 
100,000) (Schondorf et al., 1999) and is characterised by an excessive HR increase of +30 bpm 
or HR >120 bpm without OH within 10 mins of orthostasis or head up tilt (HUT) (Freeman et al., 
2011a). PoTS can be broadly divided into hyperadrenergic or neuropathic phenotypes 
(Benarroch, 2012), however, dysfunction of the noradrenaline transporter gene promoter 
region (Esler et al., 2006), infection (Schondorf and Low, 1993), deconditioning (Parsaik et al., 
2012), hypovolemia and/or poor orthostatic cerebral autoregulation (Ocon et al., 2009b) have 
also been implicated in PoTS pathophysiology. Around 70% of PoTS patients are diagnosed 
with the heritable rheumatological condition, Ehlers-Danlos Syndrome iii/joint hypermobility 
type (Mathias et al., 2012), which also leads to vascular abnormalities that exacerbate 
orthostatic-related symptoms (Benarroch, 2012, Mathias et al., 2012).  
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Figure	4.	Supine	and	head	up	tilt	blood	pressure	and	heart	rate	profiles	of		a	(a)	healthy	individual	and	(b)	a	patient	with	
PoTS.	The	vertical	dashed	line	indicates	the	onset	of	postural	change	(head-up	tilt).	Excessive	tachycardia	is	observed	
after	the	onset	of	head-up	tilt	in	the	PoTS	patient.	PoTS,	=	postural	tachycardia	syndrome.	From	Mathias	et	al.,	2012 
 
Autonomic (neurally) mediated syncope (AMS) is a group of syncopal (fainting) phenotypes 
that are caused by the breakdown of autonomic reflexes. The three forms of AMS are; 
I. Carotid sinus hypersensitivity (CSH) 
II. Situational syncope (SS) 
III. Vasovagal syncope (VVS) 
 
VVS is caused by vasodilatation and/or bradycardia and predominantly occurs in females 
under 40 years, as opposed to CSH typically occurs in those >50 years of age due to 
exaggerated baroreceptor activation (Humm and Mathias, 2010). VVS typically first presents 
in late adolescence/early adulthood, whereas syncope in the elderly is predominately 
cardiogenic or due to OH (Vaddadi et al., 2007). VVS constitutes around 40% of syncopal 
events, making it the most common cause of syncope (Fenton et al., 2000). VVS is a 
paroxysmal malfunction of baroreflexes and the autonomic instability of a vasovagal episode 
is defined by prodromal sympathoexcitation that precedes parasympathetoexciation 
(vasodilatation, reduced cardiac output) (Medow et al., 2008, Barcroft and Edholm, 1945).  
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Despite the wealth of laboratory and ambulatory equipment available, the cause of 10-26% 
of syncope cases remains unexplainable (Brignole et al., 2005, Krahn et al., 1995, Krahn et al., 
1998) and psychiatric illness is more prevalent in these patients with unexplained syncope, 
particularly if syncopal episodes are recurrent and/or include multiple somatic symptomology 
(Kapoor et al., 1995). ‘Psychogenic pseudosyncope’ (PSS) is the occurrence of apparent 
syncope (unresponsiveness and loss of postural tone) during normal physiological indices that 
would not result in cerebral hypoperfusion. There is currently a paucity of literature on PSS (van 
Dijk and Wieling, 2013) and direct observation of pseudosyncope in a clinical setting is rare 
(Luzza et al., 2004). Moreover, symptoms of OI, particularly pre-syncope, are commonly 
reported in functional somatic disorders (Kroenke and Rosmalen, 2006). During a PSS episode, 
the vast majority of patients close their eyes and resist eyelid opening (Tannemaat et al., 2013), 
periods of apparent unconscious are also significantly longer than AMS patients and occur 
more frequently than in AMS.  
  
Conversion or medically unexplainable symptoms during autonomic testing remains under-
researched and inadequately understood. One may also question the clarity, objectivity and 
accuracy of the term ‘psychogenic pseudosyncope’ due to the fact that actual episodes of 
VVS can be psychogenic, such as the site of blood, frustration or humiliation. Therefore, the 
term ‘functional syncope’ (FS) will be used in this thesis, rather than the less objective, 
inaccurate and repetitive term of psychogenic pseudosyncope.   
 
FS appears to be a conversion disorder yet it is often reported or described with little attempt 
to try and unpick the psychophysiological mechanisms that may be involved in its 
presentation, therefore, specific aim # 1 of this thesis will; 
(i) review the historical profiles of FS patients to better understand the condition,  
(ii) investigate any underlying autonomic or dysatuonomic aspects to FS, 
(iii) describe the presentation and incidence of FS during autonomic testing 
 
Essential hyperhidrosis (EH) is diagnosed when an individual’s excreted sweat exceeds that 
required to normalise body temperature and causes significant functional impairment (see 
figure 5). The aetiology of EH remains unknown but the condition is defined by excessive local 
or generalised sweating, typically on the palms of the hands, soles of feet and axillary. The 
prevalence of the condition has been estimated to be 2-3% (Lai et al., 2014, Moraites et al., 
2014). Eccrine glands are primarily implicated in EH, with the exception of axillary EH, which 
appears to have a more diffuse pathophysiology (Lonsdale-Eccles et al., 2003, Bovell et al., 
2001). 
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Figure	5.	(Left	panel)	Palmar	hyperhidrosis	and	(right	panel)	generalised	hyperhidrosis	
 
Although psychiatric patients may report symptoms akin to intermittent dysautonomia, e.g., 
sweating, faintness or palpitations, autonomic diagnostic criteria are rarely met (Ruchinskas et 
al., 2002, Lkhagvasuren et al., 2011). However, attentional and secondary psychological 
symptoms are often reported in AMS, EH and PoTS (Giada et al., 2005, Gracie et al., 2006, 
Ruchinskas, 2007, D'Antono et al., 2009, Raj et al., 2009, Vazquez et al., 2011, Rios-Martinez et 
al., 2009). 
 
Like PoTS, comorbid EDSiii/JHT and anxiety is significantly more common in young females 
(Martin-Santos et al., 1998). Investigations of functional disability in PoTS have found day-to-
day limitations closely related to catastrophising thoughts, which also mediate anxiety and 
somatic hypervigilance (Benrud-Larson et al., 2003), another common anxiety trait in PoTS (Raj 
et al., 2009, Masuki et al., 2007, Raj, 2006). Cognitive function can be impaired in PoTS 
(Anderson et al., 2014, Raj et al., 2009). Inattention has been found to decrease with illness 
duration, likely due to adaptive or treatment responses. Furthermore, hyperactive traits were 
absent in childhood, suggestive of a causal role in these cognitive symptoms that often present 
in PoTS. that poor quality sleep, daytime sleepiness and fatigue have also common in PoTS 
(Bagai et al., 2011) is noteworthy. 
 
Cohen et al (Cohen et al., 2000a) found that anxiety scores were positively correlated with 
positive (symptomatic hypotension and/or bradycardia) HUT. Anxiety has also been 
associated with greater syncope burden (Lerma et al., 2013). Though emotional stress may 
increase BP and HR, vascular resistance is not typically influenced by psychological factors, 
however, in an episode of emotionally-induced VVS, BP, HR and peripheral resistance fall 
profoundly (Mosqueda-Garcia et al., 2000). Abnormally high levels of depression, anxiety and 
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blood/injury phobia are common in VVS (Graham, 1961, McGrady et al., 2001, Luborsky et al., 
1973, Karaca et al., 2007), with syncopal episodes often proceeding anticipation of real or 
fantasised physical harm in a social context, where fight/flight was perceived as 
unacceptable. Psychosocial threats, such as humiliation and mortification, to which the fainter 
feels they cannot escape can also provoke vasovagal episodes (Sledge, 1978). VVS patients 
who do not respond to treatment are more anxious and depressed than VVS treatment 
responders, report more negative thoughts regarding threats to physical harm or death, as 
well as higher levels of avoidance/protection coping and rumination (Gracie et al., 2006). VVS 
predisposition relates to differences in brainstem neuroanatomy that regulate baroreflex BP 
control and cardiovascular homeostasis (Beacher et al., 2009).  
 
EH remains a neglected area of study. Although the aetiology of the condition remains 
uncertain, patients commonly report anxiety (Karaca et al., 2007), though it remains unclear 
whether anxiety is a prodromal symptom of EH or vice versa (Noppen et al., 1997, Ruchinskas, 
2007). Anxiety in moderate rather than severe cases of axillary and craniofacial hyperhidrosis 
cases to be the most anxious (Braganca et al., 2014) and surgical interventions for EH typically 
involve thoracic sympathectomy, which often causes compensatory sweating yet still 
apparently improves psychosocial distress (Ramos et al., 2006). Such convoluted findings make 
delineating emotional and sudomotor factors in EH challenging. Therefore, specific aim # 2 of 
this thesis will  
(i) thoroughly and systematically investigate cognitive-affective symptoms in EH, AMS 
and PoTS to  
(ii) decipher if these psychological symptoms are related to dysautonomia symptoms 
that functionally overlap with physical manifestations of anxiety and panic  
(iii) or are trait-like phenomena independent of dysautonomia. 
 
Theories of emotion connect affect with motor, neurobiological and autonomic responses to 
define a spectrum and time course (used to define emotions from moods) of phenomena 
initiated by the valence and arousal of a stimulus, which can be internal or located in the 
environment (LeDoux, 1992, McTeague et al., 2012). Emotional processing and decision-
making are now not only seen as interrelated but complimentary (Bechara and Damasio, 
2005). The ANS provides a key role in cognitive-affective processes as central processing of 
autonomic feedback influences behaviour in order to both avoid punishment and maximize 
reward, as evidenced by autonomic arousal reflecting behavioural learning (Bechara et al., 
1997b, Damasio et al., 1991, Critchley et al., 2001a, Coricelli et al., 2005).  
 
Regardless of whether a stimulus evokes a defensive or appetitive response, the two primary 
reflexes of increased sensory processing and preparation for mobilisation remain the same 
(Lang and Davis, 2006) across valances. This overlap, along with methodological 
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inconsistencies (e.g., experimental protocols, knowledge of the ANS, length of time responses 
were monitored), may explain the lack of validated emotion-specific autonomic signatures to 
date (Lang, 1994, Kreibig, 2010). Much of this research was influenced by the James-Lange 
theory, which proposes that physiological responses differentiate emotion from non-emotion 
(Lange and James, 1922) and that certain emotions are attached to the central interpretation 
(interoception) of bodily states, which are primarily defined by varying patterns of autonomic 
activity. The ‘Somatic Marker Hypothesis’ (Damasio, 1999) emphasises how homeostatic 
requirements motivate and shape behaviour, for example, individuals are more mindful of 
palatable sensory signals when hungry. Such theories of brain-body integration posit that the 
sensitivity of the brain to bodily responses governs the intensity of emotional experience 
(Paulus, 2013).  
 
‘Interoception’ is the processing of afferent visceral nerve activity, which informs autonomic 
mediation of homeostasis and contributes to emotion, behaviour and cognition at varying 
levels of consciousness, from baroreceptors modulating cardiac responses to fluctuations in BP 
to maintain cerebral perfusion, to discarding an item of clothing as an act of behavioural 
thermoregulation. An individual’s interoceptive accuracy (IA) moderates the degree to which 
somatic events are linked to cognitive-affective processes (Damasio, 1999, Gray et al., 2012) 
and individuals with greater IA experience emotions more deeply, particularly anxiety 
(Schandry, 1981). Interoception is therefore a fundamental process of central and visceral 
homeostatic and allostatic integration, as evidenced by the recent finding that interoceptor 
(arterial baroreceptors) activity influences cognitive-affective processes on a preconscious 
level (Garfinkel et al., 2014) or that the sight or smell of food causes the release of insulin (Teff, 
2011). In hypochondriasis, anxiety disorders and somatisation disorders, patients report somatic 
hypervigilance and somatosensory amplification (Barsky, 1992, Rief et al., 1998, Ludewig et al., 
2005, Anderson and Hope, 2009), indicating anxiety shifts attention to interoceptive events. 
	
Figure	6.	Schematic	of	afferent	interoceptive	pathways	in	the	human	central	nervous	system.	 
 
Predictions of experienced versus expected interoceptive error signals of bodily events can be 
a ‘bottom up’ source of anxiety (Paulus and Stein, 2006). Therefore, if one were to feel dizzy, 
tachycardic or too hot or sweaty whilst being aware that the situation did not require these 
aberrant allostatic adaptions, the processing of these interoceptive error signals would create 
anxiety at the discordant bodily states. This hypothesis is supported by evidence that the insula 
detect discrepancies in predictions of one’s physical state rather than actual changes in 
physical state (Gray et al., 2007), and that these error code predictions then influence 
behaviour and mood. Therefore, to investigate the potential influences of intermittent 
cardiovascular (PoTS, AMS) and sudomotor (EH) autonomic overactivity on brain-body 
integration processes, such as interoception, specific aim # 3 of this thesis will; 
23	
	
I. assess somatic hypervigilance in AMS, EH and PoTS in comparison to controls. 
II. assess empathy (an emotion influenced by interoception (Grynberg and Pollatos, 2015) 
that predicts autonomic arousal during emotional stimulation (Bogdanov et al., 2013) in 
AMS, EH and PoTS in comparison to controls. 
III. define the subjective measure of interoceptive sensibility, objective measure of 
interoceptive accuracy (IA) and metacognitive measure of interoceptive awareness in 
AMS, EH and PoTS in comparison to healthy controls.   
IV. assess heart rate variability (HRV) to examine autonomic variability and how this relates to 
brain-body integration in AMS, EH and PoTS in comparison to healthy controls. 
 
The ANS is the primary mediator of efferent and afferent nerve traffic between the brain and 
the periphery and provides a potential framework to explore the associations between 
autonomic activity and affective disorders (Thayer et al., 1996, Thayer et al., 2000). It also leads 
one to consider what happens to cognitive-affective processes in conditions of exaggerated 
autonomic responsivity (Eccles et al., 2015). Phylogenetic defence responses have evolved to 
protect from physical harm, e.g., eye blink to air puff or limb shock withdrawal (Darwin, 
1872/1998). These innate defence responses, particularly fight/flight, share many autonomic 
characteristics with intermittent forms of dysautonomia. 
v Freezing/hypervigilance – All movement except oculomotor and respiratory is suspended 
(Blanchar and Blanchar, 1969). This response makes it more difficult to localise prey for 
movement-dependent predators. 
v Fight or flight – a heightened defence response to threat. The SNS enables physiological 
responses to escape or repel the heightened danger, including: 
o Increased heart rate (PoTS) 
o Bladder relaxation (VVS) 
o Face flushing (EH) 
o Xerostomia (PoTS) 
o Shaking (PoTS, VVS)  
o Sudomotor activation (EH) 
v Tonic immobility (TI) – has been well-documented in animals as ‘sham death’ and is an 
end-stage strategy (Monassi et al., 1999). In humans, TI typically occurs during sexual 
assault and is often preceded by peritraumatic fear and perceived inescapability (Bovin 
et al., 2008).  
 
Despite the inconsistencies in defining emotion-specific autonomic signatures (Hodgson and 
Rachman, 1974, Rachman and Hodgson, 1974), a reliable and robust early response to a novel 
stimulus, especially unpleasant, is cardiac deceleration (Fanselow, 1994). Cardiac 
deceleration is a peripheral component of the ‘orienting response’ (OR), which is a series of 
involuntary sensory, motor and autonomic adjustments in response to an emotionally salient 
stimulus (see figure 7). These adjustments of SNS and PNS activity ensure optimal perception of 
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the stimulus, including inhibition of conditioned and unconditioned reflexes (Pavlov, 1953, 
Hedger et al., 2015) to ‘increase analyser sensitivity’ (Sokolov, 1963a). The OR is the first 
response provoked by any novel stimulus and its magnitude depends on the evocative 
potential of the stimulus. 
	
Figure	7.	Diagram	of	the	cardiac	deceleration	orienting	response	(left	panel)	and	the	skin	conductance	orienting	
response	(right	panel).	From	Bach	et	al.,	2007 
 
Electroencephalogram (EEG) and respiratory components of the OR represent novelty, 
peripheral vasoconstriction ORs reflect stimulus intensity and cardiac deceleration indicates 
stimulus detection (Barry, 2009). Moreover, the degree of cardiac deceleration predicts 
subsequent memory performance (Buchanan et al., 2006). Greater ORs are proposed to 
represent greater emotional significance of the stimulus and greater interoceptive accuracy 
(IA) is associated with increased subjective emotional experience, therefore, it is possible that 
a relationship may exist between IA and ORs and could provide an insight into holistic brain-
body integration. However, this has not been investigated. 
 
The non-muscular visceral components of the OR are autonomically mediated but there have 
been no investigations into whether dysautonomia affects ORs or related processes. This is 
worthy of investigation because the functional and organ-specific autonomic patterns that 
maintain homeostasis are permanently compromised in autonomic failure (AF) and 
intermittently compromised in conditions of OI, such as PoTS and AMS. In addition, many of 
these patients report comorbid affective, functional and cognitive symptoms not attributable 
to autonomic pathophysiology or neuropathophysiology (Heims et al., 2006a, Guaraldi et al., 
2014, Ross et al., 2013, Ocon et al., 2009b, Stewart et al., 2012). From a clinical autonomic 
perspective, some unanswered questions remain, such as, (i) how do ORs compare at supine 
rest and during orthostasis, (ii) and between healthy controls and patients with compromised 
baroreflex function, particularly as PoTS and AMS have an over-representation of comorbid 
cognitive-affective symptoms? (iii) Would investigating the possible relationship between IA 
and ORs provide an insight into brain-body integration or these patients’ common comorbid 
psychological symptoms, as greater ORs are proposed to represent greater emotional 
significance of the stimulus and greater IA is associated with increased emotional experience? 
Therefore, specific aim # 4 of this thesis will investigate; 
(i) the effects of orthostatic stress on ORs in PoTS and AMS in comparison to controls  
(ii) explore any interactions between ORs and IA.  
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Chapter 2. Literature review & specific 
aims  
2. Homeostasis 
Although homo sapiens have developed rich and complex emotional lives, we exist within 
environments that place stresses on our bodies. In 1865, French physiologist, Claude Bernard 
defined the term ‘homeostasis’ to describe the maintenance of an internal steady-state 
environment within the body for optimal health and functionality. Homeostatic feedback and 
feedforward systems operate across central and visceral mechanisms in response to 
physiological requirements, generating corrective metabolic, cardiovascular or behavioural 
actions.  
 
2.1. The autonomic nervous system 
Homeostatic regulation is facilitated via the autonomic nervous system (ANS) and its unique 
ability to mediate activity of bodily organs, glands and blood vessels via peripheral efferent 
neurons. The term ‘autonomic’ derives from the fact that, with the exception of the sexual 
glands, autonomic nerve function is beyond conscious control. Autonomic neurons from the 
central (CNS) and peripheral nervous systems can be subdivided into the sympathetic nervous 
system (SNS) and the parasympathetic nervous system (PNS). The SNS acts to increase effector 
organ activity predominantly via the catecholamines, noradrenaline (NA) and adrenaline at 
the neruoeffector junction. The PNS promotes vegetative activity mainly via acetylcholine 
(Ach), such as the slowing of heart rate (HR) or facilitation of food digestion by increasing gut 
motility.  
 
 
 
2.1.1. The sympathetic nervous system 
The SNS is essential for maintaining blood pressure (BP) and cerebral perfusion (see figure 9), 
which is vital for cognition and consciousness. Central SNS neurons synapse with peripheral 
sympathetic neurons via sympathetic ganglia (see Figure 1). Sympathetic preganglionic 
neurons are situated in the intermediolateral cell column of the spinal cord (Guyton, 1991). 
Preganglionic sympathetic neurons are cholinergic, secreting ACh to affect postganglionic 
neurons, most of which are adrenergic. 
 
Figure	8.	Schematic	of	the	main	autonomic	ganglia	neurotransmitters.	The	acetylcholine	receptor	at	all	ganglia	is	
the	nicotinic	subtype	but	postganglionic	sympathetic	and	parasympathetic	cholinergic	receptors	sites	are	of	the	
muscarinic	subtype.	Ach	=	acetylcholine,	NA	=	noradrenaline,	Adr	=	adrenaline 
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2.1.2. The parasympathetic nervous system  
The PNS acts to conserve energy and facilitate recuperation and digestion by reducing 
effector organ function. Parasympathetic fibres predominantly exit the CNS via sacral spinal 
nerves and cranial nerves (Guyton, 1991). Three quarters of parasympathetic nerve fibres are 
located in the vagus nerve, where they innervate thoracic and gastrointestinal (GI) tissue. Pre-
and-postganglionic parasympathetic nerve terminals are cholinergic.  
 
2.1.3. Cardiovascular autonomic function  
A homeostatic challenge to our bodies’ equilibrium occurs whenever we stand upright 
(orthostasis). During the first 10-15 seconds of orthostasis, gravity attracts approximately 750ml 
of blood flow to the leg, pelvic and abdominal capacitance veins, known as venous pooling. 
To counteract venous pooling and maintain cerebral perfusion, cardiopulmonary 
mechanoreceptors and arterial baroreceptors in the aortic arch and carotid sinus detect 
changes in vascular contraction and send afferent signals to the brainstem, upregulating 
peripheral sympathetic nerve activity (SNA), which increases peripheral vascular resistance, 
venous tone and HR so that the necessary arterial pressure to adequately perfuse neural tissue 
is reached (see figure 9) (Smit et al., 1999).  
 
 
	
Figure	9.	Central	and	peripheral	responses	to	orthostasis.	From	Mosqueda-Garcia	et	al,	2000. 
 
Behaviour-dependent increases in BP are both enabled and moderated by the baroreflex 
(Janig and Habler, 2003, Dampney et al., 2013, Dampney et al., 2002). Failure of these 
autonomic reflexes can lead to transient loss of consciousness (TLoC) due to cerebral 
hypoperfusion. BP is an amalgamation of vascular resistance and cardiac output and is 
centrally mediated by three main groups of sympathetic efferent neurons that innervate blood 
vessels, cardiac tissue and the adrenal cortex and medulla;  
Ø Barosensitive neurons; 
⇒ are activated by mental stress, 
⇒ responsible for short-term BP fluctuations (Janig and Habler, 2003) 
⇒ are under the control of arterial baroreceptors,  
⇒ have a dominant role in both short and long-term BP regulation, 
⇒ reside in and are regulated by the rostroventral lateral medulla (RVLM) (Dampney 
et al., 2002), spinal cord, hypothalamus and the nucleus of the solitary tract (NTS)  
⇒ innervate the kidney  
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⇒ are downregulated during arterial stretch or volume expansion  
⇒ increase HR and noradrenaline (NA) release from adrenal chromaffin cells, which 
constricts non-dermal resistance arterioles 
⇒ are activated by cutaneous nociceptors (Janig and Habler, 2003, Coote, 2005). 
 
Ø Glucosensitive cardiovascular neurons;  
⇒ control adrenaline release from the adrenal medulla  
⇒ are activated by physical exertion and hypoglycaemia. 
 
Ø Thermosensitive neurons:  
⇒ consist primarily of cutaneous vasoconstrictor neurons  
⇒ are activated by hyperventilation, hypothermia and emotional arousal (Janig and 
Habler, 2003, Vallbo et al., 2004, Dampney et al., 2002) 
 
BP control also involves a number of neurohormones, such as antidiuretic hormone (ADH), 
noradrenaline (NA), adrenaline and the renin-angiotensin system (RAS). These neurohormones 
bring about vasoconstriction and water retention. During orthostasis, NA and to a lesser extent, 
adrenaline release increases, inducing vasoconstriction and increasing peripheral resistance 
(Mathias et al., 2013). Peripheral vasoconstriction is also influenced by renin, which is converted 
from angiotensin released from renal arterioles and promotes the release of aldosterone from 
the adrenal cortex. Plasma volume is maintained by water and sodium re-absorption within 
the kidney, which is promoted by aldosterone. As with adrenergic neurotransmitters, orthostasis 
also encourages the release of renin (Laszlo et al., 2001). The pituitary gland releases ADH, also 
known as vasopressin, which is involved in a feedback arc with variation of baroreflex 
responses and blood osmolarity (Robertson, 2001).  
 
2.1.3.1. Cerebral perfusion & autoregulation 
As bipeds with evolved neocortices, human consciousness and cognition is dependent on 
sympathetic, parasympathetic and sensory innervation of the cerebral vasculature to mediate 
cerebral perfusion, however, the complexity of this neurovascular coupling allows for the 
breakdown of cerebral perfusion. Intracranial pressure and local arterial pressure maintain 
cerebral perfusion pressure (difference between intracranial pressure and mean arterial 
pressure (Van Lieshout et al., 2003)) at 80 mmHg and excessive increases or decreases (<50 
mmHg) are prevented by autoregulation of cerebral blood flow (CBF), regardless of peripheral 
variations in BP (Van Lieshout et al., 2003). However, cerebral perfusion pressure is dependent 
on system arterial pressure, itself dependent on cardiac output and peripheral vascular 
resistance, therefore a reduction in either of these peripheral factors can cause reductions in 
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cerebral perfusion pressure. Should cerebral perfusion pressure drop below 70 mmHg, the brain 
becomes inadequately perfused with oxygen and other metabolites, predisposing to a 
transient loss of consciousness (TLoC) (Rosner et al., 1995).  
 
2.1.3.2. Cutaneous blood flow 
In the periphery, vasodilation of blood vessels in non-glabrous skin occurs when cutaneous and 
core temperatures increase, such as during exercise or stress (Kellogg, 2006). Cutaneous 
vasodilation is mediated at the effector junction by nitric oxide, neuropeptide P (NPY), 
histamine, vasoactive intestinal peptide (VIP) and prostanoids (McCord et al., 2006). This 
increase in skin blood flow is biphasic (Nicotra et al., 2006); 
I. Neurogenic phase (fast responding, peaking after a few minutes) – axon-reflex 
mediated skin blood flow increase peaks, initiated by activity of sensory nerves and 
modulated by sympathetic nerves (Hornyak et al., 1990) 
II. Phase Two (peaking around 30mins) - mediated by endothelial nitric oxide and other 
endogenous mediators 
 
2.1.4. Thermoregulatory autonomic function 
To ensure biochemical reactions are efficient, the human body’s’ optimum core temperature 
is 37°C. A number of peripheral, central and behavioural mechanisms aid thermoregulation, 
however, some cerebral activities, such as stress, shock or sleep also effect thermoregulation 
(Collins, 2013).  
  
2.1.4.1. Thermoception 
Following the perception of thermal discomfort, thermoregulatory behaviour can be initiated 
to maintain thermostasis, increase temperature (e.g., voluntary locomotor activity, involuntary 
locomotor activity) or decrease temperature (e.g., removing clothing, adjusting ambient 
temperature, cessation of locomotor activity, water consumption) to negate the intervention 
of autonomically-mediated thermoregulatory mechanisms (Benzinger, 1969, Flouris and 
Cheung, 2009). Perceived changes in skin temperature and thermal discomfort induce 
behavioural modifications (Schlader et al., 2009) at rest (Nakamura et al., 2008) and during 
exercise (Tucker et al., 2006, Tatterson et al., 2000). Initiation of thermoregulatory behaviour is 
uniform in terms of skin, rectal temperature and thermal comfort, when exposed to hot (45 °C) 
(Schlader et al., 2009) and cold environments (Flouris and Cheung, 2009). Behavioural 
thermoregulation generally precedes endocrine and autonomic thermostatic mechanisms 
(Mundel et al., 2007).  
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Brain thermoregulatory centres include, the dorsalmedial hypothalamus (Dimicco and 
Zaretsky, 2007), amygdala (Kanosue et al., 2002), insula (Verhagen et al., 2004), cingulate, 
primary and secondary somatosensory cortex and orbitofrontal cortex (Craig et al., 1994). 
Within the preoptic-anterior hypothalamus (POAH), skin, viscera, and spinal cord reside cool 
and warm-sensitive thermoreceptor neurons. The spinothalamic tract and other afferents 
provide feedback to the thalamus and posterior hypothalamus, which assumes the role of a 
central ‘thermostat’. Cutaneous thermoception is relayed to second-order thermal sensory 
neurons in the dorsal horn via dorsal root ganglia and glutaminergic third-order cool-sensitive 
neurons of the lateral parabrachial nucleus and lateral subnucleus. Warm-sensitive neurons 
located in the dorsal horn, project to third-order neurons in the lateral parabrachial nucleus in 
the lateral reticular formation, where cranial nerve efferents include the vagus nerve (Morrison 
and Nakamura, 2011).  
 
Conscious thermoception is relayed to the cortex and thalamus via dorsal horn neurons. 
Glutamatergic cool-sensitive neurons of the external lateral subnucleus of the lateral 
parabrachial nucleus (LPBel) synapse with GABAergic interneurons in the median preoptic 
(MnPO) area to inhibit action potentials in warm-sensitive neurons of the medial preoptic 
(MPO) subnucleus, mediating control of cutaneous vasoconstriction (CVC), shivering and 
thermogenic brown adipose tissue (BAT). BAT sympathoexcitatory neurons in the dorsomedial 
hypothalamus are inhibited by preoptic warm-sensitive neurons. Glutamate, serotonin (5-HT) 
and vesicular glutamate transporter 3 (VGLUT3) act as BAT neuromodulators to control BAT 
sympathetic outflow and thermogenesis.  
 
Preoptic warm-sensitive neurons also synapse with shiver-promoting dorsomedial 
hypothalamus neurons. Warm-sensitive MPO neurons are activated by glutaminergic 
interneurons of the MnPO. These MPO warm-sensitive neurons supress CVC sympathetic 
premotor neurons in the rostral ventromedial medulla and intermediolateral nucleus (IML), in 
which CVC sympathetic tone is modulated by serotonin and glutamate.  
 
2.1.4.2. Hyperthermia 
The body’s main defence against hyperthermia is heat loss via evaporation from the skin and 
respiratory passages, thus transferring heat from the body to the environment. The human 
body has three types of sweat gland, eccrine, apo-eccrine and apocrine. Eccrine glands are 
particularly densely populated in the forehead, palms, soles and axillae. Hypothalamic 
efferents descend via the lateral reticular formation and tegmentum of the pons to the 
intermediolateral column of the spinal cord where cholinergic neurons synapse with 
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paravertebral sympathetic ganglia. Post-ganglionic sympathetic cholinergic sudomotor axons 
then effect eccrine glands (Morrison and Nakamura, 2011). Sudomotor innervation of eccrine 
glands can be represented dermatonally; 
⇒ T1-T4 sympathetic sudomotor neurons innervate the face 
⇒ T2-T9 sympathetic sudomotor neurons innervate the upper limbs 
⇒ T4-T12 sympathetic sudomotor neurons innervate the trunk  
⇒ T10-L2 sympathetic sudomotor neurons innervate the lower limbs (Kirshblum et al., 
2014, Nicotra et al., 2006).  
 
These cholinergic sympathetic sudomotor neurons innervate 2-4 million eccrine glands that 
secrete a hypotonic saline solution during heat stress. Sweat evaporation cools the surrounding 
skin, which then cools the local cutaneous blood flow. Body temperature can also be 
regulated via skin blood flow (see 2.1.3.2. Cutaneous blood flow).  
 
2.1.4.3 Hypothermia 
Vasoconstriction during cold stress conserves heat and lessens peripheral blood flow. 
Hypothermia is defined as a core temperature of <35°C. The neural pathways modulating cold 
stress thermoregulations are better described than heat stress responses. Sympathetic 
preganglionic neurons are activated by the caudal portion of the raphe pallidus via 
descending neural pathways (Nagashima et al., 2000) (McAllen, 2007). Cold responsive 
neurons in the caudal portion of the raphe pallidus and dorsomedial nucleus of the 
hypothalamus that initiate cold-defence behaviours are inhibited by hypothalamic warm 
sensitive neurons. Glutamatergic cool-sensitive neurons of the external lateral subnucleus of 
the lateral parabrachial nucleus (LPBel) synapse with GABAergic interneurons in the MnPO 
area to inhibit warm-sensitive neurons of the MPO subnucleus and mediate cutaneous 
vasoconstriction, shivering and BAT. Preoptic warm-sensitive neurons also synapse with shiver-
promoting dorsomedial hypothalamic neurons which, via shivering premotor neurons in the 
rostral raphe pallidus and ventral horn, provide efferents to skeletal muscle α and γ motor 
neurons to invoke shivering (see Figure 10). Cutaneous vasoconstriction sympathetic tone is 
modulated by NA and NPY (both post-ganglionic), serotonin and glutamate.  
	
Figure	10.	Thermoregulatory	pathways.	From	Morrison	and	Nakamura	(2011) 
 
2.2. Autonomic neuroanatomy 
Central autonomic networks within the spinal cord, brainstem and hypothalamus mediate 
cardiovascular and thermoregulatory autonomic outflows (see figures 11a and 11b) 
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(Benarroch, 1993). The ventromedial prefrontal cortex (vmPFC) is involved with PNS and 
antisympathetic activity (Gianaros et al., 2004; Matthews et al., 2004) and supragenual areas 
of the mid and anterior cingulate are associated with SNS activity. Haemodynamic changes 
are global autonomic responses requiring input from the cortex, limbic forebrain and midbrain 
(Saper, 2002) (Morrison, 2001). Magnetic resonance imaging (MRI) and functional MRI (fMRI) 
report activity within the dorsal anterior cingulate cortex (Critchley et al., 2003) and insula 
cortex (Critchley et al., 2000a, Critchley et al., 2000b) reflects engagement of sympathetic 
activity coupled to mental and physical behaviours (see figure 11b). Increased activity in the 
medial prefrontal cortex (mPFC), anterior and posterior insula and ventroposterior thalamus 
occurs during respiration, isometric hand-grip exercise and the valsalva manoeuvre (King et 
al., 1999), a clinical assessment of autonomic integrity in which the subject breathes against a 
closed glottis (Mathias et al., 2013).  
 
Activity in the anterior cingulate cortex (Acc), insula, medial temporal lobe (MTL), ventral PFC 
(vPFC) and mPFC, medial thalamus, cerebellum, midbrain and pons increases during cold 
pressor and valsalva manoeuvres (Harper et al., 2000). Using positron emission tomography 
(PET) to assess brain activity during isometric hand-grip exercise and mental arithmetic (both 
well-validated pressor exercises (Mathias et al., 2013)) in healthy controls, Critchley and 
colleagues (Critchley et al., 2000a) found increases in BP were positively correlated with right 
dorsal Acc activity, supporting findings that sympathetic responses are lateralized to the right 
hemisphere (Oppenheimer et al., 1992) and the left insular cortex is involved in 
parasympathetic cardiovascular regulation, e.g., acute left insular stroke disrupts the 
correlation between HR and BP (Oppenheimer et al., 1996).  
4a.       4b.		
Figure	11.	Left panel (11a) displays the key central autonomic structures related to autonomic function. Right panel 
(11b) displays amygdala and central nucleus areas involved with emotion-related autonomic and behavioural 
responses. From Benarroch (1993).	
	
Hypothalamic, pontine and medullary sympathetic and parasympathetic nuclei interact with 
homeostatic representations to generate physically or behaviourally-induced organ-specific 
autonomic responses (Saper, 2002). HR changes are predicted by amygdala and dorsal Acc 
activity (Janig and Habler, 2003) and during threat/stress induction, amygdala function 
predicts cardiac contractility (Dalton et al., 2005). The amygdala and other limbic structures 
supply a descending efferent drive to the hypothalamus and brainstem for congruent 
autonomic responses to emotion-related behaviour (see figure 11b) (Saper, 2002).  
 
The nucleus of the solitary tract (NTS) receives baroreceptor afferents that synapse with the 
rostral ventrolateral medulla to set efferent pressor tone (see figure 12). Reduced baroreceptor 
tone has been associated with Acc, amygdala and anterior insula (AI) function, whereas 
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initiation of baroreflexes increases activity in lateral PFC (lPFC) and posterior insula (Kimmerly 
et al., 2005).  
	
Figure	12.	Spinal	(sympathetic)	and	brainstem	(parasympathetic)	visceral	sensory	pathways	to	the	thalamus	and	cortex.	
NTS	=	nucleus	of	the	solitary	tract.	Adapted	from	Saper	(2002) 
 
2.3. Dysautonomia  
Autonomic disease and dysfunction (dysautonomia) can be classified as either fixed or 
intermittent (Mathias and Bannister, 2013). Fixed ANS disorders cause autonomic failure (AF) as 
the lesion is fixed and usually irreversible, as in spinal cord injury (SCI) or pure autonomic failure 
(PAF). The lesion may also be progressive, as in Parkinson’s disease with AF or multiple system 
atrophy (MSA). AF is characterised by a postural fall in BP which is defined as orthostatic 
hypotension (OH) when the fall is > 20 mmHg systolic BP (SBP) or > 10mmHg diastolic BP (DBP). 
Fixed ANS disorders commonly present in patients of >40 years, whereas intermittent ANS 
disorders can present in all ages. 
 
Intermittent dysautonomia is a temporary dysregulation of normative autonomic function 
attributable to a specific factor, such as orthostatic intolerance (OI) or thermoregulatory 
dysfunction. Thermoregulatory dysautonomia may occur due to a systemic (malignancy, 
shock), metabolic (diabetes mellitus, menopause) or febrile illness (infection), as well as 
neurological disorders (stroke, Parkinsons disease) and can be focal or generalised in nature. 
Cardiovascular intermittent dysautonomia relates to orthostatic intolerance (OI), though 
factors such as food digestion, dehydration and exercise can also exacerbate symptoms. 
Sudomotor and cardiovascular intermittent dysautonomia often present in adolescence/early 
adulthood and with strong positive family histories (Kaufmann et al., 2003, Iodice et al., 2010).  
 
2.3.1. Postural tachycardia syndrome 
Postural tachycardia syndrome (PoTS) is the most common form of OI, with prevalence 
accounting for at least 170 cases per 100,000 individuals in the general population (Schondorf 
et al., 1999). PoTS is characterised by an excessive HR increase of +30 bpm or HR >120 bpm 
without OH within 10 mins of orthostasis or head up tilt (HUT) (Freeman et al., 2011a). PoTS has 
only relatively recently (1993) been clearly described (Schondorf and Low, 1993) and as 
understanding has increased, other factors, such as prolonged standing, heat or eating can 
provoke symptoms and presentation (Mathias et al., 2012).  
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PoTS can be broadly divided into hyperadrenergic or neuropathic phenotypes (see Table 1) 
(Benarroch, 2012), however, dysfunction of the noradrenaline transporter gene promoter 
region (Esler et al., 2006), infection (Schondorf and Low, 1993), deconditioning (Parsaik et al., 
2012), hypovolemia and/or poor orthostatic cerebral autoregulation (Ocon et al., 2009b) have 
also been implicated in PoTS pathophysiology.  
 
PoTS patients may also present with pre-syncope, syncope, dizziness, palpations, headache, 
fatigue, bladder and gastrointestinal (GI) symptoms and around 70% also have the heritable 
rheumatological condition, Ehlers-Danlos Syndrome iii/joint hypermobility type (Mathias et al., 
2012), which also leads to vascular abnormalities that exacerbate orthostatic-related 
symptoms (Benarroch, 2012, Mathias et al., 2012).  
 
Mechanism of PoTS subtype Markers Examples 
Neuropathic PoTS: Impaired 
sympathetically mediated 
vasoconstriction in the lower 
limbs 
Impaired distal sweating, blunted late phase 
ii in Valsalva maneuver, low supine BP, 
reduced NA spillover in leg veins, reduced 
cardiac meta-iodobenzylguanidine uptake, 
High leg blood flow 
Restricted post-viral or 
autoimmune neuropathies 
Hyperadrenergic PoTS: 
exaggerated cardiac 
sympathoexcitatory 
responses 
Standing plasma NA >600 pg/mL, 
fluctuating BP or hypertension during HUT 
Anxiety, Pheochromocytoma, 
Mast cell activation disorders, 
voltage-gated potassium 
channel autoimmunity 
Volume dysregulation 
Elevated plasma angiotensin II, Impairment 
of renin-angiotensin-aldosterone system, 
impaired renal control of fluid secretion 
Conditions associated with 
hypovolemia 
Physical deconditioning 
V˙O2max <85% on exercise testing, reduced 
left ventricular mass 
Prolonged bed rest, Chronic 
fatigue syndrome 
Table 1 Overview of PoTS phenotypes, adapted from Benarroch (2012). 
 
2.3.2. Autonomic (neurally) mediated syncope  
Although intrinsically autoregulated (see 2.1.3.1. Cerebral perfusion & autoregulation), 
neurovascular coupling allows for potential breakdown in cerebral perfusion. Orthostasis 
should normally provoke an intricate integration of central and peripheral autonomic reflexes 
and feedback mechanisms to ensure cerebral perfusion, which is dependent on systemic 
vascular resistance, cardiac output, arterial pressure, local metabolic control and 
cerebrovascular resistance. Transient loss of consciousness (TLoC) can be induced by a variety 
of physiological phenomena that lead to either inadequate cerebral perfusion pressure or 
abnormally high cerebral vascular resistance (see Table 2). Autonomic (neurally) mediated 
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syncope (AMS) is a group of syncopal (fainting) phenotypes that are caused by the 
breakdown of autonomic reflexes. The three forms of AMS are; 
I. Carotid sinus hypersensitivity (CSH) 
II. Situational syncope (SS) 
III. Vasovagal syncope (VVS) 
 
VVS is caused by vasodilatation and/or bradycardia and predominantly occurs in females 
under 40 years, as opposed to CSH typically occurs in those >50 years of age due to 
exaggerated baroreceptor activation (Humm and Mathias, 2010). The lifetime incidence of 
syncope is approximately 39% (Lipsitz et al., 1985, Ganzeboom et al., 2006) and accounts for 
3-5% of emergency room admissions (Kapoor et al., 1995, Linzer et al., 1991, Linzer et al., 1994). 
70% of patients with recurrent syncope suffer impairment of daily activities, 39% have to 
change occupation, 64% are unable to drive and 6% suffer fractures (Linzer et al., 1991, Linzer 
et al., 1994). UK ambulance services respond to between 300,000–400,000 emergency calls for 
falls and syncopal episodes annually, with up to 50% being taken to hospital (Close et al., 2002, 
Marks et al., 2002). Once admitted, the diagnostic yield of standard investigations such as 
electroencephalography (EEG) and brain imaging in syncope, particularly in non-convulsive 
blackouts, can be less than 5% (Eagle and Black, 1983, Kapoor et al., 1983). In addition to 
paramedic costs, the average cost of admittance for a patient who has fallen/fainted is 
approximately £2000–£3000 (Scuffham et al., 2003). If the patient has no cardiac structural 
abnormalities, electrophysiological and electrocardiogram (ECG) can have a very low yield 
(Hess et al., 1982, Krahn et al., 1999) in defining the cause of the fall, moreover, due to the 
episodic nature of attacks, only 2-4% of ECG investigations obtain relevant data 
 
VVS typically first presents in late adolescence/early adulthood, whereas syncope in the 
elderly is predominately cardiogenic or due to OH (Vaddadi et al., 2007). VVS constitutes 
around 40% of syncopal events, making it the most common cause of syncope (Fenton et al., 
2000). VVS is a paroxysmal malfunction of baroreflexes and the autonomic instability of a 
vasovagal episode, wherein sympathoexcitation is a prodromal phenomenon that precedes 
parasympathetoexciation (vasodilatation, reduced cardiac output) has long been reported 
(Medow et al., 2008, Barcroft and Edholm, 1945).  
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Low arterial blood pressure 
Increased resistance to 
cerebral blood flow 
Other causes of cerebral 
dysfunction 
Low cardiac output Cerebral vasoconstriction 
Epilepsy may be confused with 
simple faints 
Inadequate venous return due to excessive venous pooling or 
low blood volume 
Low Paco2, due to 
hyperventilation 
Metabolic and endocrine 
disorders—hypoglycaemia, 
Addison’s disease, hypopituitarism 
Cardiac causes - tachyarrhythmias, bradyarrhythmias, 
valvular disease, bradycardia 
Cerebral vasospasm 
Electrolyte disorders—may be 
associated with hypovolaemia or 
predispose to cardiac arrhythmias 
Low total peripheral vascular resistance 
Vascular disease—either 
extracranial of intracranial 
areteries. 
Vasovagal attacks 
Widespread cutaneous vasodilatation in thermal stress 
Reflex causes — vasovagal attacks, ‘carotid sinus syndrome’, 
visceral pain reflexes (may cause vasodilatation or 
vasoconstriction), decreased stimulation of visceral stretch 
receptors (e.g. voiding distended bladder) 
Vasodilator drugs 
Autonomic neuropathies 
Table 2 Classification and causes of syncope. Hainsworth and Claydon, 2012.  
 
2.3.2.1. Updating ‘psychogenic pseudosyncope’ 
Despite the wealth of laboratory and ambulatory equipment available, the cause of 10-26% 
of syncope cases remains unexplainable (Brignole et al., 2005, Krahn et al., 1995, Krahn et al., 
1998) and psychiatric illness is more prevalent in these patients with unexplained syncope, 
particularly if syncopal episodes are recurrent and/or include multiple somatic symptomology 
(Kapoor et al., 1995). Directed treatment focused on psychiatric symptoms can result in 
syncope remission in up to 90% of these cases (Linzer et al., 1990). 
 
‘Psychogenic pseudosyncope’ (PSS) is the occurrence of apparent syncope 
(unresponsiveness and loss of postural tone) during normal physiological indices that would 
not result in cerebral hypoperfusion, as measured by HR, BP, ECG, electroencephalogram 
(EEG) or transcranial Doppler. PSS would appear to be a form of conversion disorder but there 
is currently a paucity of literature on PSS (van Dijk and Wieling, 2013) and direct observation of 
pseudosyncope in a clinical setting is rare (Luzza et al., 2004). Moreover, symptoms of OI, 
particularly pre-syncope, are commonly reported in functional somatic disorders (Kroenke and 
Rosmalen, 2006). In comparison to other types of syncope, PPS patients often report a greater 
number of prodromal symptoms, such as chest pains, palpitations, paraesthesia, dyspnea, 
dizziness (Luzza et al., 2004), however, during a PSS episode, the vast majority of patients close 
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their eyes and resist eyelid opening (Tannemaat et al., 2013). PSS patients’ periods of apparent 
unconscious are also significantly longer than syncope patients and occur with greater 
frequency.  
   
Conversion or medically unexplainable symptoms during autonomic testing remains under-
researched and inadequately understood. One may also question the clarity, objectivity and 
accuracy of the term ‘psychogenic pseudosyncope’ due to the fact that actual episodes of 
VVS can be psychogenic, such as the site of blood, frustration or humiliation. Some have 
proposed that diagnoses of this nature can be ‘a disguise for ignorance and a fertile source 
of clinical error’ (Slater, 1965). Syncope of unknown aetiology significantly impairs the patient’s 
quality of life (QoL) (Raj et al., 2014) and contributes to ~£18 billion per annum spent treating 
and supporting patients with somatization disorders (Bermingham et al., 2010). Trimble (Trimble, 
1982) proposes the use of the term ‘functional’ in such cases as, in its original usage, 
‘functional’ referred to aberrant function of the nervous system, the cause of which was under 
investigation. Therefore, the term ‘functional syncope’ (FS) will be used in this thesis, rather than 
the less objective, inaccurate and repetitive term of psychogenic pseudosyncope.   
 
FS appears to be a conversion disorder yet it is often reported or described with little attempt 
to try and unpick the psychophysiological mechanisms that may be involved in its 
presentation. Other functional disorders, such as fibromyalgia, irritable bowel syndrome and 
chronic fatigue syndrome have been reported in PoTS (the most common form of OI), 
therefore, specific aim # 1 of this thesis will; 
(iv) review the historical case notes of FS patients to ascertain whether FS is a typical 
conversion disorder 
(v) investigate any underlying autonomic or dysautonomic contributions to FS, 
(vi) describe the presentation and incidence of FS during autonomic testing 
 
2.3.3. Essential hyperhidrosis  
Essential hyperhidrosis (EH) is diagnosed when an individual’s excreted sweat exceeds that 
required to normalise body temperature and causes significant functional impairment. The 
aetiology of EH remains unknown but the condition is defined by excessive local or generalised 
sweating, typically on the palms of the hands, soles of feet and axillary. The prevalence of the 
condition has been estimated to be 2-3% (Lai et al., 2014, Moraites et al., 2014). Eccrine glands 
are primarily implicated in EH, with the exception of axillary EH, which appears to have a more 
diffuse pathophysiology (Lonsdale-Eccles et al., 2003, Bovell et al., 2001). Once a secondary 
cause of hyperhidrosis has been eliminated (see Table 3), sudomotor activity can be examined 
with moisture-sensitive indicator dyes during a thermoregulatory sweat test (Low and Fealey, 
2013). EH can be provoked by everyday factors, such as mild exertion or food ingestion.  
38	
	
GENERALISED CAUSES OF HYPERHIDROSIS 
Environment Heat, humidity, exercise 
Febrile disease, 
systemic disease 
Acute and chronic infections, malignancy, cardiovascular disorders, shock and 
syncope, respiratory failure, intense pain, alcohol, drug withdrawal 
Metabolic 
Thyrotoxicosis, diabetes mellitus, hypoglycaemia, gout, pheochromocytoma, 
hyperpituitarism, acromegaly, carcinoid tumor, menopause 
Neurologic Riley-Day syndrome, hypothalamic lesions, Parkinson´s disease 
Drugs Propranolol, physostigmine, pilocarpine, tricyclic antidepressants, venlafaxine 
FOCAL CAUSES OF HYPERHIDROSIS 
Extrinsic Heat, olfactory 
Gustatory Citric acid, coffee, chocolate, peanut butter, spicy food 
Neurological 
Central or peripheral nervous system lesions causing localized anhidrosis can cause 
compensatory sweating in other areas (stroke, spinal cord lesion, neuropathy, Ross 
Syndrome), Frey Syndrome (gustatory sweating); eccrine nevus, social anxiety 
disorder 
Idiopathic Primary or essential hyperhidrosis 
Table 3. Examples of causes of secondary and essential hyperhidrosis. Adapted from Naumann, 2012. 
 
2.4. Postural tachycardia syndrome, vasovagal syncope & 
essential hyperhidrosis: autonomic endophenotypes of 
anxiety 
Although psychiatric patients may report symptoms akin to intermittent dysautonomia, e.g., 
sweating, faintness or palpitations, autonomic diagnostic criteria are rarely met (Ruchinskas et 
al., 2002, Lkhagvasuren et al., 2011). However, comorbid psychological symptoms are often 
reported in AMS, EH and PoTS (Giada et al., 2005, Gracie et al., 2006, Ruchinskas, 2007, 
D'Antono et al., 2009, Raj et al., 2009, Vazquez et al., 2011, Rios-Martinez et al., 2009), with 
recent evidence suggesting these co-morbid psychological factors may be, to some extent, 
resultant rather than causative of autonomic dysfunction in PoTS (Khurana, 2006, Masuki et al., 
2007, Raj et al., 2009).  
 
2.4.1. Palpations, dizziness, tremulousness: the postural 
tachycardia syndrome endophenotype of anxiety  
In the United Kingdom, approximately 70% of PoTS patients meet the diagnostic criteria for the 
heritable rheumatological condition Ehlers-Danlos Syndrome III/Joint Hypermobility Type 
(Mathias et al., 2012) which has been associated with anxiety disorders (60%–68% prevalence), 
particularly panic disorder (Bulbena et al., 2004, Eccles et al., 2011, Eccles et al., 2012). Like 
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PoTS, comorbid EDSiii/JHT and anxiety is significantly more common in young females (Martin-
Santos et al., 1998). Investigations of functional disability in PoTS have found day-to-day 
limitations closely related to catastrophising thoughts, which also mediate anxiety and somatic 
hypervigilance (Benrud-Larson et al., 2003), another common anxiety trait in PoTS (Raj et al., 
2009, Masuki et al., 2007, Raj, 2006). Although PoTS and panic disorder may share psychological 
(e.g., tremulousness, health anxiety, impaired concentration) and physiological (e.g., 
palpitations, tachycardia, chest pain, dyspnea) symptomatology and can co-exist (Esler et al., 
2004), a differentiating factor is that PoTS can be provoked by physiological challenges alone 
(Masuki et al., 2007).  
 
Umeda and colleagues used simultaneous fMRI and physiological recording during emotional 
stimuli showing that, regardless of emotional valence, PoTS patients produced exaggerated 
supine cardiac responses to visual emotional stimuli in comparison to healthy controls. 
Activation of the ventromedial PFC, which has an ‘anti-sympathetic’ role (see Autonomic 
neuroanatomy), and the right dorsolateral PFC was significantly reduced in PoTS patients 
during stimulus presentation across all valences. Functional connectivity between PoTS 
patients’ dorsolateral PFCs, orbital PFCs and basal ganglia were positively correlated with the 
magnitude of emotional supine cardiac response and state anxiety (Umeda et al., 2009). 
These data may help elucidate the interrelationship of autonomic and neurobiological 
pathophysiology that drives the diffuse secondary psychological symptoms reported in PoTS 
and the potential perturbation of autonomic-sensitive neuroanatomy by the syndrome.   
 
In addition to affective symptoms, cognitive function can be impaired in PoTS (Anderson et 
al., 2014, Raj et al., 2009), e.g., patients’ short term memory (Anderson et al., 2014) and 
attentional and recall abilities are significantly poorer than controls and PoTS patients score 
significantly higher on attention deficit hyperactivity disorder indexes (Raj et al., 2009). 
Inattention has been found to decrease with illness duration, likely due to adaptive or 
treatment responses. Furthermore, hyperactive traits were absent in childhood, suggestive of 
a causal role in these cognitive symptoms that often present in PoTS. Masuki and colleagues’ 
(Masuki et al., 2007) disproved PoTS as being psychogenic by comparing orthostatic and 
psychological stress responses in PoTS patients and healthy controls. It may be noteworthy that 
catastrophic cognitions of visceral feedback are more commonly applied to cardiac signals 
in anxiety disorders (Willem Van der Does et al., 2000, Domschke et al., 2010). 
 
It may be relevant that poor quality sleep, daytime sleepiness and fatigue are also common 
in PoTS (Bagai et al., 2011). In PoTS patients with comorbid chronic fatigue syndrome (CFS), 
working memory, accuracy and information processing are impaired during orthostasis, yet 
the cause of this ‘brain fog’ that is commonly reported by many PoTS patients, remains elusive, 
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despite investigations into cerebral blood velocity, sleep quality or neurotransmitter function 
(Ocon, 2013, Ross et al., 2013). In a related study, PoTS patients performed worse in tests of 
current verbal and non-verbal IQ intellectual functioning and in measures of focused attention 
and short term memory. Cognitive data was influenced by years of education and underlying 
levels of anxiety and depression (Anderson et al., 2014). 
 
2.4.2. Dizziness, nausea, dissociation: the vasovagal syncope 
endophenotype of anxiety  
The occurrence of the vasovagal reflex (sympathetic inhibition and vagal activation) during 
haemorrhagic shock, such as blood donation or physical injury, causes bradycardia and 
decreases myocardial oxygen consumption which prevents exsanguination during major 
bleeding. A phenomenon comparable to the sham death or tonic immobility seen in many 
invertebrates when caught by a predator (Alboni et al., 2008, Diehl, 2005). In a study of 66 VVS 
patients, Cohen et al (Cohen et al., 2000a) found that anxiety scores were positively correlated 
with positive (symptomatic hypotension and/or bradycardia) HUT. Anxiety has also been 
associated with greater syncope burden (Lerma et al., 2013). Though emotional stress may 
increase BP and HR, vascular resistance is not typically influenced by psychological factors, 
however, in an episode of emotionally-induced VVS, BP, HR and peripheral resistance fall 
profoundly (Mosqueda-Garcia et al., 2000).  
 
Abnormally high levels of depression, anxiety and blood/injury phobia are common in VVS 
(Graham, 1961, McGrady et al., 2001, Luborsky et al., 1973, Karaca et al., 2007), with syncopal 
episodes often proceeding anticipation of real or fantasised physical harm in a social context, 
where fight/flight was perceived as unacceptable, i.e., “…when an individual experiences 
fear he must deny” (Engel, 1962).  Depression, anxiety, frustration and helplessness have been 
identified as VVS antecedents (Luborsky et al., 1973) and  psychosocial threats, such as 
humiliation and mortification, to which the fainter feels they cannot escape can also provoke 
vasovagal episodes (Sledge, 1978).  
 
Psychiatry, neurology and cardiology research groups have found psychiatric conditions are 
over-represented in patients with VVS, particularly anxiety, depression and somatization 
disorders (Giada et al., 2005). Leftheriotis (Leftheriotis et al., 2008) and co-workers surveyed 67 
patients with ‘minor psychiatric disorder’ for VVS. 58% had a vasovagal episode during HUT 
and 45% had a history of syncope. VVS patients who do not respond to treatment are more 
anxious and depressed than VVS treatment responders, report more negative thoughts 
regarding threats to physical harm or death, as well as higher levels of avoidance/protection 
coping and rumination (Gracie et al., 2006). 
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Imaging studies have provided evidence of reduced medulla and midbrain grey matter 
volume in VVS. Moreover, left caudate nucleus volumes were negatively correlated with 
cardiac vagal tone (as measured by HF-HRV), syncopal episodes and anxiety (see Figure 13), 
suggesting that VVS predisposition relates to differences in brainstem neuroanatomy that 
regulate baroreflex BP control and cardiovascular homeostasis (Beacher et al., 2009).  
	
Figure 13. Figure 5. (A) Caudate regions showing significant negative correlations between regional gray matter 
volumes and anxiety levels, within VVS participants. (B) Within VVS participants, left caudate regions showing 
significant negative correlations between regional gray matter volumes and anxiety levels (red), fainting frequency 
(yellow) and HF-HRV (green). From Beacher et al., (2009) 
 
Anticipatory processing has a perceptual role in the assessment of a sensory stimulus by 
coordinating a series of preparatory physiological adjustments that allow the subject to 
respond and potentially interact with the stimulus (Van Boxtel and Böcker, 2004). Studies have 
shown that when faced with a threat stimulus, the decision to avoid the threat stimulus follows 
an increase in SBP which does not occur when the subject is powerless to avoid the noxious 
stimulus (Manuck et al., 1978) (Light and Obrist, 1980). A recent study using Stimulus Preceding 
Negativity (SPN) during emotional stressors in AMS patients has provided a central measure of 
reduced emotional variation, anticipation and regulation in this cohort (Buodo et al., 2012).    
 
 
2.4.3. Sweating, clamminess & flushing: the essential 
hyperhidrosis endophenotype of anxiety  
EH remains a neglected area of study. Although the aetiology of the condition remains 
uncertain, patients commonly report anxiety (Karaca et al., 2007), though it remains unclear 
whether anxiety is a prodromal symptom of EH or vice versa (Noppen et al., 1997, Ruchinskas, 
2007). Explanations of EH as simple basal sympathetic hyperactivity are complicated by most 
patients’ accompanying affective distress and HRV findings of increased parasympathetic 
cardiac activity (HF-HRV) (Birner et al., 2000, Kaya et al., 2005). In a study by De Marinis and co-
workers (Kaya et al., 2005), 34% of EH patients also had ‘OH’, furthermore, this sub-group had 
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greater total body sweat rates and larger orthostatic BP and HR changes than the remaining 
EH patients and normal controls. However, in consideration of the subjects’ age range (28 ± 6 
years); these were more likely to be vasovagal episodes rather than autonomic failure-induced 
hypotensive episodes.  
 
In a survey of ‘treatment-seeking’ patients referred to a dermatology clinic, patients receiving 
a diagnosis of EH were typically younger (mean age 34 years), unmarried, employed, more 
educated, and received a higher annual salary than non-EH patients. Moreover, 
hyperhidrotics were also more greatly disabled by their symptoms, had poorer QoL as well as 
having higher levels of social anxiety (Lessa Lda et al., 2014). Interestingly, a recent survey 
found the greatest levels of anxiety in moderate rather than severe cases of axillary and 
craniofacial hyperhidrosis cases to be the most anxious (Braganca et al., 2014). Surgical 
interventions for EH typically involve thoracic sympathectomy, which often causes 
compensatory sweating yet still apparently improves psychosocial distress (Ramos et al., 2006). 
Such convoluted findings make delineating emotional and sudomotor factors in EH 
challenging. 
 
In studies examining emotion in autonomic failure (AF) patients, i.e., endophenotypes of fixed 
or progressive autonomic hypoarousal, complex higher order emotional responses, such as 
empathy are diminished (Chauhan et al., 2008, Heims et al., 2006b), indicating the emotional 
impairment of insufficient reciprocal autonomic arousal. Therefore, specific aim # 2 of this 
thesis will  
(iv) thoroughly and systematically investigate cognitive-affective symptoms in EH, AMS 
and PoTS to  
(v) decipher if these psychological symptoms are related to dysautonomia symptoms 
that functionally overlap with physical manifestations of anxiety and panic  
(vi) or are trait-like or trauma-related affective phenomena independent of 
dysautonomia. 
 
2.5. Brain, body & emotion: the autonomic common thread 
Facial expressions have been used to define cross-cultural ‘basic emotions’, such as disgust, 
happiness, sadness, fear, surprise and anger (Ekman, 1993). Cross-species studies suggest that 
basic emotions most likely have a phylogenetic basis, as even basic life forms display defined 
aggressive behaviours (Aaltonen et al., 2013) and many mammals exhibit facial expressions of 
disgust (Berridge and Robinson, 2003) (see figure 14a and 14b). 
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Figure	14.	Top: dog and cat defence behaviours. From Darwin (1872). (A) Bottom left panel: (right) Male drosophila 
raises it wings as a display of aggression. (A) Bottom right panel: decapitated female drosophila provokes the males 
to attack each other. From Chen et al (2002). (B) Top: cross-species (infant homo sapien, infant orang-utan, rat) 
facial expressions associated with palatable tastents and (bottom right) unpalatable tastents. From Berridge and 
Robinson (2003). 
 
To study emotion, it has been necessary to define emotions in terms of arousal and valence. 
Theories of emotion connect affect with motor, neurobiological and autonomic responses to 
define a spectrum and time course (used to define emotions from moods) of phenomena 
initiated by the valence and arousal of a stimulus, which can be internal or located in the 
environment (LeDoux, 1992, McTeague et al., 2012). 
	
From a psychological construction perspective, emotions are influenced by afferent signals 
evoked by the stimulus that are represented within the CNS. These representations interact 
with perceptions of the surroundings and previous emotional experience during emotion 
formation. This ‘top-down’ perspective has evidenced much heterogeneity of emotion 
(Barrett, 2006), which is explained by classifying emotions as cognitive categories comprised 
of a spectrum of unique ‘instances’ that reflect the relevant psychosocial factors of a given 
situation (Clore and Ortony, 2013). The psychological constructionist perspective posits that 
physiological afferent feedback only becomes relevant when caused by or related to a 
defined situation.  
 
‘Dual process’ theories have attributed cognition with a corrective role on emotion in adults. 
Emotional processing and decision-making are now not only seen as interrelated but 
complimentary (Bechara and Damasio, 2005). The Acc and anterior insula are involved in the 
processing of visceral afferent feedback (see figure 5), as well as the mediation of responses 
to somatosensory and sensory information (Medford and Critchley, 2010). The ANS provides a 
key role in cognitive-affective processes as central processing of autonomic feedback 
influences behaviour in order to both avoid punishment and maximize reward, as evidenced 
by autonomic arousal reflecting behavioural learning (Bechara et al., 1997b, Damasio et al., 
1991, Critchley et al., 2001a, Coricelli et al., 2005).  
 
2.5.1. Insights from affective neuroscience 
Functional neuroimaging has seen a sea change away from functional localization of brain 
structures to viewing brain function in terms of networks and regional interactions that are 
defined as much by their connections as local functional architecture. Key emotional 
neuroanatomy are the insula, Acc, orbitofrontal cortex and amygdala (LeDoux, 1992) (see 
A	 B	
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figure 15). Brain imaging has allowed the definition of four emotional neural substrates; fear, 
panic, seeking and rage (Panksepp, 2010), that have been utilised to develop therapeutic 
applications (Harrison and Critchley, 2007). 
 
The orbital and ventromedial PFC (vmPFC) are vital social and higher function centres. The 
medial PFC (mPFC) is known to mediate and assess emotions (Damasio, 1994) and, together 
with the amygdala and Acc, are important centres in emotional processing as well as 
autonomic reactivity (LeDoux, 1995, Devinsky et al., 1995), underlining how affect and 
autonomic function are coupled. Vulnerabilities to anxiety disorders has been linked to Acc 
morphology (Mayberg, 2003, Pujol et al., 2002) and depression susceptibility with vmPFC 
morphology (Mayberg, 2003). Both the insula and cingulofrontal areas are important for 
emotional perception (Critchley et al., 2001b, Katkin et al., 2001).  
	
Figure	15. Fundamental neuroanatomical emotional centres: insula (purple), orbitofrontal cortex (red), anterior 
cingulate cortex (yellow) and amygdala (orange). Adapted from LeDoux, 2005. 
 
 
2.5.1.1. Emotion & the autonomic nervous system 
The interaction and contribution of brain, body and environment in emotion was aptly 
demonstrated by Schachter and Singer (Schachter and Singer, 1962) in 1962. Participants were 
injected with adrenaline or saline before entering a room inhabited by actors portraying angry 
or happy behaviour. The recipients of the adrenaline infusion reported feeling happier or 
angrier in parallel with the emotion portrayed by the study confederates, whereas recipients 
of the saline infusion experienced no significant change in affect. Interpretation of 
environmental factors determined the emotional valence that was experienced but 
autonomic arousal (via sympathomimetic) heightened emotion.  
 
Regardless of whether a stimulus evokes a defensive or appetitive response, the two primary 
reflexes of increased sensory processing and preparation for mobilisation remain the same 
(Lang and Davis, 2006) across valances. This overlap, along with methodological 
inconsistencies (e.g., experimental protocols, knowledge of the ANS, length of time responses 
were monitored), may explain the lack of validated emotion-specific autonomic signatures to 
date (Lang, 1994, Kreibig, 2010). For example, Ekman and colleagues (Ekman et al., 1983) 
trained subjects to facially express various emotions whilst simultaneously trying to subjectively 
experience the corresponding emotion. Autonomic (skin temperature and heart rate) 
recording during testing found that;  
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⇒ ANGER = High heart rate + high skin temperature  
⇒ SADNESS, FEAR = High heart rate + low skin temperature 
⇒ DISGUST, HAPPINESS, SURPRISE = low heart rate 
 
Rainville and co-workers (Rainville et al., 2006) recorded heart rate, cardiac vagal tone (HF-
HRV) and respiration during emotion provocation, concluding that;  
⇒ ANGER = Increased heart rate  
⇒ FEAR = Increased heart rate + decreased HF-HRV + coupled respiration changes  
⇒ HAPPINESS = Increased heart rate + decreased HF-HRV + no respiration changes  
⇒ SADNESS = Increased heart rate + decreased HF-HRV + increased respiration 
variability 
 
Much of this research was influenced by the James-Lange theory, which proposes that 
physiological responses differentiate emotion from non-emotion (Lange and James, 1922) and 
that certain emotions are attached to the central interpretation (interoception) of bodily 
states, which are primarily defined by varying patterns of autonomic activity. The James-Lange 
theory provided the foundation for modern ‘peripheral’ theories of emotion, such as Antonio 
Damasio’s ‘Somatic Marker Hypothesis’ (Damasio, 1999), which emphasises how homeostatic 
requirements motivate and shape behaviour, for example, individuals are more mindful of 
palatable sensory signals when hungry. This view was supported by Damasio’s findings that 
lesions to brain centres that represent the internal visceral state impair social and emotional 
behaviour and can result in ‘acquired sociopathy’ (Damasio et al., 1990).  
 
Such theories of brain-body integration posit that the sensitivity of the brain to bodily responses 
governs the intensity of emotional experience (Paulus, 2013). This is supported by neuroimaging 
findings that somatovisceral information enters the CNS via brainstem nuclei from the spinal 
cord, is translated to the insula, amygdala and somatosensory cortex before reaching the PFC 
(Critchley et al., 2004). During this synaptic transmission, the original afferent autonomic and 
somatic information is integrated with other subjective information to inform the interpretive 
response (Paulus and Stein, 2006, Suzuki et al., 2013).  
 
2.5.1.2. Trauma & sympathoexcitation 
During emotional or physical trauma, SNA increases due to psychogenic or allostatic demand. 
If the defence response does not re-establish homeostasis, the subject becomes over-exposed 
to the perceived threat, or a stimulus becomes associated with trauma, then disorders of 
emotion may develop, which establish a new homeostatic baseline (Cohen et al., 1998) 
46	
	
and/or acute maladaptive responses to real or, in extreme cases, imagined stimulus exposure 
(Bale, 2006, de Kloet et al., 2005). This dysregulation causes intolerance to physiological and/or 
emotional stressors, predisposing to dysfunctional behaviours, such as self-harm, self-mutilation 
or substance abuse, which are seen as attempts to regulate a dysfunctional ANS (Ogden et 
al., 2006) that has become sensitised to markers of the original trauma (Van der Kolk, 1996).  
 
Post-traumatic stress disorder (PTSD) alters autonomic thresholds so that autonomic mediation 
of bodily systems, such as cardiovascular, sleep (Germain et al., 2008) or respiratory control, 
are sympathetically-dominated (Blechert et al., 2007, Buckley and Kaloupek, 2001). PTSD 
subjects report greater distress to unpredictable and uncontrollable anxiety-related somatic 
symptoms in comparison to individuals with panic disorder (Pfaltz et al., 2010). PTSD also effects 
noradrenergic function, as evidenced by supressed growth hormone (GH) responses to 
intravenous clonidine challenge (though BP was not measured) (Morris et al., 2004). Clonidine 
is a peripheral α2-agonist, therefore, these findings result from desensitization of post-synaptic 
α2-receptors in PTSD subjects.  
	
2.5.1.3. Dissociation & sympathetic inhibition  
Despite marked anxiety, distress and functional impairment, dissociation and dissociative 
disorders tend to downregulate sympathetic activity, unlike most anxiety disorders. 
Depersonalization disorder (DPD) is a dissociative disorder defined by derealization (one’s 
surroundings feel unreal), emotional numbing, feelings of disembodiment and memory recall 
deficits relating to the personalization but not retrieval of memory (Lee et al., 2012). DPD is a 
defensive, emotionally-disengaging response that is implemented to accommodate threat 
deemed as beyond ones’ control (Lee et al., 2012). It has a lifetime prevalence of 74% for mild 
episodes and 1%-2% for chronic DPD (Sierra and David, 2011).  
 
Skin conductance responses (SCRs) are both more quickly manifested and yet abnormally 
weakened in DPD during aversive stimuli exposure (Sierra et al., 2002), indicating hypervigilant 
attentional appraisal and rapid suppression of psychogenic autonomic arousal. NA levels 
have also been found to be negatively correlated with DPD severity (Simeon et al., 2003). 
Models of DPD predict hypervigilance of environmental and emotional stimuli and the 
engagement of an emotionally dampening mechanism during aversion, evidenced by 
reduced skin conductance responses (SCRs) to disagreeable images compared to both 
healthy controls and anxiety disorder patients, despite depersonalized subjects being equally 
as anxious as anxiety participants (Sierra et al., 2002). Inverse correlations between SCRs and 
dorsal PFC responses (Lemche et al., 2008, Lemche et al., 2007) indicate a central correlate 
for the blunted autonomic arousal and brain-body dysregulation in DPD.  
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Peritraumatic dissociation shares some symptoms with depersonalization - emotional numbing, 
derealisation, self-observation, and dysmorphia - and occurs at a time of extreme inescapable 
threat (Mooren and van Minnen, 2014). In a survey of peritraumatic dissociation in 85 females 
who had recently (2 months) been the victim of sexual assault, those who had experienced 
high levels of peritraumatic dissociation recorded reduced post-traumatic sympathetic (SCRs 
and HR) arousal during trauma interviews, yet also perceived their attack as more life-
threatening (Griffin et al., 1997).  
 
2.5.1.4. Interoception in emotion, cognition & homeostasis 
‘Interoception’ is the term given to the processing of afferent visceral nerve activity, which 
informs autonomic mediation of homeostasis and contributes to emotion, behaviour and 
cognition at varying levels of consciousness (see figure 16), from baroreceptors modulating 
cardiac responses to fluctuations in BP to maintain cerebral perfusion, to discarding an item of 
clothing as an act of behavioural thermoregulation. An individual’s interoceptive accuracy 
(IA) moderates the degree to which somatic events are linked to cognitive-affective processes 
(Damasio, 1999, Gray et al., 2012) and individuals with greater IA experience emotions more 
deeply, particularly anxiety (Schandry, 1981). Conversely, depressed individuals have impaired 
interoception (Pollatos et al., 2009, Dunn et al., 2010). 
 
Interoception of sensory signals is therefore a fundamental process of central and visceral 
homeostatic and allostatic integration, as evidenced by the recent finding that interoceptor 
(arterial baroreceptors) activity influences cognitive-affective processes on a preconscious 
level (Garfinkel et al., 2014) or that the sight or smell of food causes the release of insulin (Teff, 
2011). Interoceptive signalling moderates the degree to which subjective awareness of 
physical events within one’s body are linked to emotional and cognitive processes (Dunn et 
al., 2010, James, 1894, Damasio, 1999, Gray et al., 2012), meaning that interoception not only 
binds the body and the self (Seth, 2013) but mediaties onself to others via affective empathy, 
cognitive empathy and shared emotion (Tajadura-Jimenez and Tsakiris, 2014, Grynberg and 
Pollatos, 2015).  
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Figure	16. Varying levels of interoception.	
 
It has been proposed that predictions of experienced versus expected interoceptive error 
signals of bodily events can be a ‘bottom up’ source of anxiety (Paulus and Stein, 2006). 
Therefore, if one were to feel dizzy, tachycardic or too hot or sweaty whilst being aware that 
the situation did not require these aberrant allostatic adaptions, the interoceptive processing 
of these error signals would create anxiety at the discordant bodily states. This hypothesis is 
supported by evidence that the insula detect discrepancies in predictions of one’s physical 
state rather than actual changes in physical state (Gray et al., 2007), and that these error code 
predictions then influence behaviour and mood.  
 
The anterior insula, dorsal Acc and VMPFC are vital for the integrative processing of 
interoceptive information. The Acc shares some functionality with the amygdala, such as 
attentional mechanisms, genesis of motivated behaviour and pain appraisal, assigning both 
structures vital roles in autonomic and emotional reactivity (LeDoux, 1992). Using fMRI, Critchley 
and co-workers (Critchley et al., 2004) found that activation of the insula cortex, particularly 
the right, highly correlated with interoceptive awareness and accuracy in healthy controls 
(n=17). The right insula was found to depict internal bodily state that could be consciously 
accessed and its activity was positively correlated with anxiety and interoceptive awareness. 
Moreover, anterior and mid insula cortices, Acc and somatomotor cortex were functionally 
associated with shifting one’s attention to interoceptive events. The role of the right insula in 
second-order conscious homeostatic representations has been further evidenced using false 
physiological feedback of HR during fMRI by Gray and colleagues (Gray et al., 2007), who 
examined emotional appraisal of neutral faces during baseline and isometric handgrip 
exercise. False feedback of increased HR during emotional stimuli caused appraisal levels of 
emotional intensity/salience to increase.  
 
Visceral 
interoceptive 
nerve activity
Homeostatic regulatory interoceptor processes, e.g., 
baroreceptor, chemoceptor function
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In hypochondriasis, anxiety disorders and somatisation disorders, patients report somatic 
hypervigilance and somatosensory amplification (Barsky, 1992, Rief et al., 1998, Ludewig et al., 
2005, Anderson and Hope, 2009), indicating anxiety shifts attention to interoceptive events. 
The only interoception study to date in dysautonomia concerned 11 PoTS patients and 10 
controls (Khurana, 2014). PoTS patients were not any better or worse at counting their 
heartbeats at supine rest, during head up tilt, drug (Atropine) induced vagal blockade or the 
Valsalva manoeuvre than controls, but were more able to describe varying types of 
palpitations during testing (Khurana, 2014), leading the author to conclude that palpitations 
were independent of tachycardia in PoTS patients’ subjective experience of cardiothoracic 
symptoms. Therefore, to investigate the potential influences of intermittent cardiovascular 
(PoTS, AMS) and sudomotor (EH) autonomic overactivity on brain-body integration processes, 
such as interoception, specific aim # 3 of this thesis will; 
Ø assess somatic hypervigilance (anxiety attributable to fear and worry of bodily symptoms 
that are common in EH, AMS and PoTS) in AMS, EH and PoTS in comparison to controls. 
Ø assess empathy (an emotion influenced by interoception (Grynberg and Pollatos, 2015) 
that predicts autonomic arousal during emotional stimulation (Bogdanov et al., 2013) in 
AMS, EH and PoTS in comparison to controls to examine the potential influence of ‘bottom-
up’ somatic perturbation on higher order affect. 
Ø define the subjective measure of interoceptive sensibility, objective measure of 
interoceptive accuracy and metacognitive measure of interoceptive awareness in AMS, 
EH and PoTS in comparison to healthy controls.   
Ø assess HRV to examine autonomic variability and how this relates to brain-body integration 
in AMS, EH and PoTS in comparison to healthy controls from the perspective of 
‘neurovisceral phenotypes’, which emphasises the importance of autonomic variability in 
emotion regulation.  
 
These areas will be sequentially and systematically examined to attempt to construct a 
framework of neurovisceral architecture and how this may inform emotion and behaviour 
through homeostatic drives, in an attempt to elucidate the comorbid psychological symptoms 
that commonly present in EH, AMS and PoTS.  
 
2.5.1.5. The shared somatic markers of intermittent dysautonomia & 
phylogenetic defence responses 
The ANS is the primary mediator of efferent and afferent nerve traffic between the brain and 
the periphery and provides a potential framework to explore the associations between 
autonomic activity and affective disorders (Thayer et al., 1996, Thayer et al., 2000). It also leads 
one to consider what happens to cognitive-affective processes in conditions of exaggerated 
autonomic responsivity (Eccles et al., 2015). 
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Phylogenetic defence responses have evolved to protect from physical harm, e.g., eye blink 
to air puff or limb shock withdrawal (Darwin, 1872/1998). These innate defence responses, 
particularly fight/flight, share many autonomic characteristics with intermittent forms of 
dysautonomia. In the 1920’s Ivan Pavlov (Pavlov, 1927b) and Walter Cannon (Cannon, 1929) 
defined a number of somatomotor and autonomic responses to noxious or threatening stimuli 
that rely on sympathoexcitation and share many autonomic manifestation with PoTS, EH and 
VVS (in fact, it has been argued that VVS is a phylogenetic relic for the (further) prevention of 
injury and blood loss); 
v Freezing/hypervigilance – All movement except oculomotor and respiratory is suspended 
(Blanchar and Blanchar, 1969). This response makes it more difficult to localise prey for 
movement-dependent predators. 
v Fight or flight – a heightened defence response to threat. The SNS enables physiological 
responses to escape or repel the heightened danger, including: 
o Increased heart rate (PoTS) 
o Bladder relaxation (VVS) 
o Face flushing (EH) 
o Xerostomia (PoTS) 
o Shaking (PoTS, VVS)  
o Sudomotor activation (EH) 
v Tonic immobility (TI) – has been well-documented in animals as ‘sham death’ and is an 
end-stage strategy (Monassi et al., 1999). In humans, TI typically occurs during sexual 
assault and is often preceded by peritraumatic fear and perceived inescapability (Bovin 
et al., 2008).  
 
During heightened threat, information is processed and integrated with contextual information 
from the hippocampus, before being conveyed to the amygdala. If one’s well-being is 
threatened, processing of both the insula and amygdala are sensitive to changes in 
autonomic activity (Critchley et al., 2002). The locus coeruleus (LC), located on the floor of the 
fourth ventricle of the pons, is important for sensory processing, as well as attention and arousal 
states, implicating it in the defence response process (Abercrombie and Jacobs, 1987). The LC 
has diffuse projections that regulate NA tone (Aston-Jones and Cohen, 2005) and, along with 
sympathetic nuclei in the medulla and pons, comprise the reticular activating system (RAS), 
which modulates intracortial synchronization of processes, such as, the startle response, sleep 
and BP (Bhaskaran and Freed, 1988, Aston-Jones, 1991). Hypervigilance is also facilitated by 
the LC filtering out unimportant information, leading to a centrally-driven increase in SNA, HPA 
axis stimulation (via corticotrophin-releasing hormone [CRH] release of adrenocorticotrophic 
releasing hormone [ACTH]) and immune system mobilization. The SNS is activated by the 
hypothalamic lateral nucleus (autonomic pathways) and the parabrachial nucleus 
(endocrine pathways) (see figure 17).  
	
Figure	17.	Schematic	of	main	neuroanatomy	of	the	fight/flight/freeze	response.	From	Gorman	et	al,	2000 
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The LC facilities behavioural arousal by NA release and activation of the PAG invokes 
defensive behaviours, including fight/flight and movement cessation. In cats, caudal 
stimulation of the dorsolateral PAG (dlPAG) and lateral PAG (lPAG) invoke flight behaviours, 
whereas rostral activation of the dlPAG and lPAG provokes fight and aggressive responses, 
such as confrontation. Venrolateral PAG (vlPAG) stimulation induces passivity and down-
regulation of HR and BP (Porges, 2003).  
 
2.5.1.6. The orienting response – is it compromised by orthostatic 
intolerance? 
Despite the inconsistencies in defining emotion-specific autonomic signatures (Hodgson and 
Rachman, 1974, Rachman and Hodgson, 1974), a reliable and robust early response to a novel 
stimulus, especially unpleasant, is cardiac deceleration (Fanselow, 1994). This response is 
centrally mediated by the ‘defence system’, particularly the amygdala (Hermans et al., 2013) 
and peripherally mediated by the vagus nerve (Mathias, 1976, May et al., 1989). Cardiac 
deceleration is a peripheral component of the ‘orienting response’ (OR), which is a series of 
involuntary sensory, motor and autonomic adjustments (see figure 18) that occur in response 
to an emotionally salient stimulus. These adjustments of sympathetic and parasympathetic 
activity ensure optimal perception of the stimulus including inhibition of conditioned and 
unconditioned reflexes (Pavlov, 1953, Hedger et al., 2015) to ‘increase analyser sensitivity’ 
(Sokolov, 1963a). The OR is the first response provoked by any novel stimulus and its magnitude 
depends on the evocative potential of the stimulus. 
 
The OR is differentiated from the cardiac defence response (CDR) by the cardiac deceleration 
during the OR to a moderate or novel stimulus facilitates attention and perception of the 
stimulus. In contrast, the defining cardiac acceleration during the CDR to an intense or aversive 
stimulus reduces attention and perception to protection against the stimulus (Pavlov, 1927a, 
Sokolov, 1963b, Fernandez and Vila, 1989). It is widely accepted from psychophysiological 
research that the OR is therefore the opposite of the CDR. The issue of stimulus has received 
empirical support (Turpin, 1986), however, there is no formal definition or criteria on the level of 
stimulus intensity that differentiates ORs from CDRs, neither have any studies investigated the 
effect of intensity in different sensory modalities. 
 
Originally believed to be a unitary reflex (Sokolov, 1963a), subsequent studies have evidenced 
that the electroencephalogram (EEG) and respiratory components of the OR represent 
novelty, peripheral vasoconstriction ORs reflect stimulus intensity and cardiac deceleration 
indicates stimulus detection (Barry, 2009). Moreover, the degree of cardiac deceleration 
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predicts subsequent memory performance (Buchanan et al., 2006). Greater ORs are proposed 
to represent greater emotional significance of the stimulus and greater interoceptive 
accuracy (IA) is associated with increased subjective emotional experience, therefore, it is 
possible that a relationship may exist between IA and ORs and could provide an insight into 
holistic brain-body integration. However, this has not been investigated. 
	
Figure	18. Central and visceral correlates of the orienting response (OR). Blue = autonomically mediated OR 
components. 
 
The non-muscular visceral components of the OR are autonomically mediated but there have 
been no investigations into whether autonomic disease or dysfunction effects ORs or related 
processes. This is worthy of investigation because the functional and organ-specific autonomic 
patterns that maintain homeostasis are permanently compromised in autonomic failure (AF) 
(e.g., spinal cord injury (SCI), pure autonomic failure (PAF)) and intermittently compromised in 
conditions of OI, such as PoTS and AMS. In addition, many of these patients report comorbid 
affective, functional and cognitive symptoms not attributable to autonomic pathophysiology 
or neuropathophysiology (Heims et al., 2006a, Guaraldi et al., 2014, Ross et al., 2013, Ocon et 
al., 2009b, Stewart et al., 2012) (see Postural tachycardia syndrome, vasovagal syncope & 
essential hyperhidrosis: autonomic endophenotypes of anxiety). From a clinical autonomic 
perspective, some unanswered questions remain, such as, (i) how do ORs compare at supine 
rest and during orthostasis, (ii) and between healthy controls and patients with compromised 
baroreflex function, particularly as PoTS and AMS have an over-representation of comorbid 
cognitive-affective symptoms? (iii) Would investigating the possible relationship between IA 
and ORs provide an insight into brain-body integration or these patients’ common comorbid 
psychological symptoms, as greater ORs are proposed to represent greater emotional 
significance of the stimulus and greater IA is associated with increased emotional experience? 
Therefore, specific aim # 4 of this thesis will investigate; 
Sense organs become more sensitive; 
pupils dilate, threshold to light reduced in 
retina (Wang and Munoz, 2015), auditory 
threshold lowered by 4-10 decibels 
(Gershundi, 1960). Skeletal muscles that direct sense 
organs are activated, e.g., head 
turns towards stimulus, or in canines 
as ‘pricking up of the ears’ 
Faster and lower electroencephalogram 
(EEG) activity indicating increased arousal 
(Nagai et al., 2004) 
General muscle tonus rises, as 
evidenced by increased 
electromyographic (EMG) activity 
Initial cessation of respiration 
followed by increased amplitude 
and decreased frequency (Davis, 
1955) 
Phasic heart rate deceleration 
(Abercrombie et al., 2008) (Turpin, 
1986) 
Galvanic skin response (GSR) 
occurs (Nagai et al., 2004) 
Peripheral vasoconstriction 
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(i) the effects of orthostatic stress on ORs in PoTS and AMS in comparison to controls to 
examine the influence (if any) of dysautonomia-related dysregulated ORs  
(ii) explore any interactions between ORs and IA in controls and OI.  
 
2.6. Specific aims 
Specific aim # 1 of this thesis will; 
I. review the historical casenote of FS patients to ascertain whether FS is a typical 
conversion disorder 
II. investigate any underlying autonomic or dysautonomic contributions to FS, 
III. describe the presentation and incidence of FS during autonomic testing 
 
Specific aim # 2 of this thesis will  
I. thoroughly and systematically investigate cognitive-affective symptoms in EH, AMS 
and PoTS to  
II. decipher if these psychological symptoms are related to dysautonomia symptoms that 
functionally overlap with physical manifestations of anxiety and panic  
III. or are trait-like or trauma-related affective phenomena independent of 
dysautonomia. 
 
Specific aim # 3 of this thesis will; 
I. assess somatic hypervigilance (anxiety attributable to fear and worry of bodily symptoms 
that are common in EH, AMS and PoTS) in AMS, EH and PoTS in comparison to controls. 
II. assess empathy (an emotion influenced by interoception (Grynberg and Pollatos, 2015) 
that predicts autonomic arousal during emotional stimulation (Bogdanov et al., 2013) in 
AMS, EH and PoTS in comparison to controls to examine the potential influence of ‘bottom-
up’ somatic perturbation on higher order affect. 
III. define the subjective measure of interoceptive sensibility, objective measure of 
interoceptive accuracy and metacognitive measure of interoceptive awareness in AMS, 
EH and PoTS in comparison to healthy controls.   
IV. assess HRV to examine autonomic variability and how this relates to brain-body integration 
in AMS, EH and PoTS in comparison to healthy controls from the perspective of 
‘neurovisceral phenotypes’, which emphasises the importance of autonomic variability in 
emotion regulation.  
 
Specific aim # 4 of this thesis will investigate; 
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I. the effects of orthostatic stress on ORs in PoTS and AMS in comparison to controls to 
examine the influence (if any) of dysautonomia-related dysregulated ORs  
II. explore any interactions between ORs and IA in controls and OI.  
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Chapter 3.  General Methods 
3. Introduction 
For the purposes of this PhD, it was necessary to use a battery of clinical and experimental 
methodologies. All experimental procedures received local ethical approval (NRES 
Committee London - Harrow, University College London Healthcare Trust Research and Design 
Office, Imperial AHSC Joint Research Compliance Office). The study was conducted in 
compliance with the Helsinki declaration (1968). 
 
3.1. Participants   
Clinical and healthy control participants were recruited from the Autonomic Units at St Mary's 
Hospital and The National Hospital for Neurology and Neurosurgery (NHNN) at Queen Square, 
London and included the following patient cohorts: Postural Tachycardia Syndrome (PoTS), 
essential hyperhidrosis (EH) and vasovagal syncope (VVS). Healthy control participants were 
recruited from the general population. Patients must have received a positive diagnosis from 
the London Autonomic Units and were recruited by mail from a database of patients at both 
London Autonomic Units. Diagnosis of hyperhidrosis (Benson et al., 2013, Cohen et al., 2007) 
was made after thermoregulatory sweat test (Low and Fealey, 2013) and of orthostatic 
intolerance (OI) (Freeman et al., 2011b) after cardiovascular autonomic function tests (see 
Clinical autonomic investigations) by consultant autonomic neurologists (CJM or VI). A 
detailed history was obtained in all cases, with an emphasis on information to help explain the 
cause of syncope, including potential symptom exacerbation in relation to orthostasis, 
postprandial hypotension or tachycardia and whether syncope was associated with blood-
injury phobia and/or emotional provocation. Information on familial syncope and the relation 
to neck movement was sought, particularly in elderly patients. 
 
Using established protocols, including, head up tilt (HUT), prolonged head up tilt (pHUT), supine 
exercise testing and liquid meal challenge, central and peripheral stimuli (Valsalva 
manoeuvre, pressor responses to mental arithmetic, isometric exercise, and cutaneous cold 
application) were used in the assessment of autonomic function, including, sympathetic and 
parasympathetic nerve function (Mathias et al., 2013, Mathias and Bannister, 2013). 
Parasympathetic cardiac function was tested using respiratory sinus arrhythmia (RSA) 
responses to deep breathing, hyperventilation and the Valsalva manoeuvre and pressor 
exercises investigated vasomotor integrity (Mathias et al., 2013). In those with suspected blood-
injury phobia relating to VVS, suitable observations and precautions were made during 
venepuncture on HUT and pHUT (45 min maximum). In patients >50 years in whom autonomic 
56	
	
failure (AF) was excluded, carotid sinus massage (CSM) was performed to exclude carotid 
sinus hypersensitivity (CSH) during supine baseline and HUT, unless contraindicated due to 
carotid artery disease. A symptomatic fall in systolic blood pressure (SBP) of 20 mmHg and/or 
diastolic blood pressure (DBP) of at least 10 mm Hg within 3 min of standing, and/or with HR 
below 40 beats per min (BPM) was regarded as abnormal (Mathias et al., 2013). 
 
Healthy controls were required to not have any previous or current autonomic disorders, 
cardiovascular disease or psychiatric conditions. Fully informed written and verbal and 
ethically approved consent was obtained from all clinical and control participants.  
 
3.2. Clinical autonomic investigations  
Participants were asked to discontinue any medications which could alter their autonomic 
function for 24 hours before participation and to also abstain from nicotine and caffeine 
consumption on the day of testing.  
3.2.1. Head up tilt (HUT) 
A variety of non-invasive tests can be used to investigate autonomic cardiovascular function. 
HUT is used to diagnose various forms of dysautonomia. In healthy subjects, the initial blood 
pressure fall induced by HUT should recover within 60 seconds because when decreased 
venous return to the heart causes reduced stroke volume and cardiac output, arterial 
baroreceptors and cardiopulmonary mechanoreceptors then signal autonomic brain centres 
to increases sympathetic nerve activity (SNA), raising HR and causing vasoconstriction of the 
blood vessels in various vascular beds to compensate for postural and gravitational demands 
(Imholz et al., 1990). In normal subjects where the baroreflex is intact, HUT of 45-90° should not 
provoke a prolonged fall in BP. HUT has proven an invaluable and relatively simple investigative 
tool(Mathias et al., 2013). Following a 10 minute unstimulated supine baseline period of 
recording, the tilt table is electrically-operated and raised to 60° for a period of 10 minutes 
(Mathias et al., 2013). HUT was terminated if syncopal, pre-syncopal or other OI-related 
symptoms were recorded or reported by the participant. 
 
3.2.2. Pressor exercises 
Pressor manoeuvres, including isometric (hand-grip) exercise, cutaneous cold application, 
deep breathing and mental arithmetic provide an index of SNA and induce autonomic 
cardiovascular changes, particularly BP, which is regulated via the SNS. Pressor stimuli have 
been well-validated and correlate with HUT (RK Khurana, 1996). Isometric and cutaneous cold 
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pressor stimuli raise BP via activation of sympathetic efferent nerve pathways and provide the 
most responsive data in comparison to mental arithmetic or other pressor tests. Peripheral 
receptors are activated but in both cutaneous cold or isometric exercise tests there is an 
important central command (isometric) or nociceptive (cold) role, which is more pronounced 
in isometric exercise study leading to a greater increase SNA in this test compared to the cold 
pressor.  
 
Pressor exercises were carried out in the supine position, so that orthostatic demand does not 
confound the pressor responses. Isometric exercise involved the participant using their right 
hand to partially inflate a sphygmomanometer cuff to sub-maximal pressure, i.e., one third of 
a previously obtained maximal voluntary contraction. The sub-maximal pressure was then 
maintained for 3 mins. A minimum of 4 mins baseline was then carried out to allow autonomic 
activity to return to baseline levels. The cold pressor uses a col compress to be applied to the 
right hand for 90 seconds. A minimum of 4 mins baseline was then carried out to allow 
autonomic activity to return to baseline levels. 
 
3.2.3. Heart rate variability (HRV) 
Much cardiac tissue has intrinsic pacemaker properties and the ANS regulates the 
myocardium’s contractile and electrical output via vagal (parasympathetic) and sympathetic 
outflows (Spyer, 1994). Pacemaker depolarisation is increased by activation of the SNS and 
parasympathetic vagal flow promotes the cardiac pacemaker cells to hyperpolarise and slow 
depolarisation speed (Spyer, 1994). Autonomic mediation of localized ion channel function is 
vital in depolarisation of all cardiac pacemaker cells. 
 
In normal populations, there is an increase in HR during inspiration and a decrease in HR during 
expiration, known as respiratory sinus arrhythmia (RSA), which is a measure of the functional 
endpoint of cardioinhibitory vagal fibres emanating from the nucleus ambiguus in the 
brainstem (Neff et al., 2003). Heart rate variability (HRV) records the beat-to-beat variations of 
HR and the intervals between QRS complexes (RR intervals) of sinus depolarisations (Stein et 
al., 1994). HRV describes sympathetic and vagal influence on the sinus node using non-invasive 
electrocardiographic markers. In a healthy individual with an unlesioned heart and intact ANS, 
continuous sinus cycles reflect a balanced and integrated sympthovagal state (van 
Ravenswaaij-Arts et al., 1993).  
 
The high frequency (HF) band of HRV is a measure of vagal efferent activity and is comparable 
to RSA. LF heart rate variability (HRV) was, until recently, believed to depict sympathetic 
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cardiac influences (Malliani et al., 1991) however, LF-HRV as a purely sympathetic measure 
has been called into question (Goldstein et al., 2011, Parati et al., 2006) as research has shown 
that endogenous fluctuations in LF-HRV provide information about sympathetic regulation of 
BP, such as vasomotor tone and baroreceptor activity. Moreover, recent studies have 
positively correlated LF-HRV and baroreceptor sensitivity (Goldstein et al., 2011, Moak et al., 
2007) as well as reduced LF-HRV and baroreflex-cardiovagal failure (Rahman et al., 2011). 
Therefore, LF-HRV may well provide information about sympathetic mechanisms but perhaps 
not cardiac sympathetic nerve activity specifically but rather of baroreflex function and 
dysfunction. In addition, very low frequency (VLF) can also be assessed, but VLF’s role is less 
clearly defied than that of LF and HF. Exercise-induced increases in LF-HRV has been linked 
with metabolic activity in insular, cingulate and somatomotor regions (Critchley et al., 2003) 
and HF-HRV with the basal ganglia and anterior temporal lobe (Matthews et al., 2004, Lane et 
al., 2009). Emotion-induced changes in HRV are associated with the insula, PAG and caudate 
nucleus (Lane et al., 2009).  
 
The application of spectral analytical techniques to short or long-term neurocardiovascular 
changes is now widely utilized as a measure of cardiovagal activity (see figure 19). Power 
spectral analysis can be performed using parametric or nonparametric methodologies:  
⇒ The Fast Fourier transformation (FFT) nonparametric method is typified by discrete 
peaks of the frequency bands. FFT is a simple and quickly performed equation.  
⇒ The Autoregressive model (Ori et al., 1992) results in a continuous spectrum of events. It 
is more complex than the FFT model and must be suitable to the experimental model.  
	
Figure	19. Depiction of LF and HF activity at supine rest (left panel) and at 90° HUT in a healthy subject (right panel). 
During HUT, the LF component predominates over HF due to the additional sympathetic load provoked by orthostatic 
load. From Task Force, 1996. 
 
For these studies, FFT was the model of spectral analysis used to examine the data of the supine 
unstimulated baseline and 60° baseline HUT and 60° HUT with psychological stimuli. The RR 
intervals of each participant were transformed into bands with different spectral frequencies. 
The results can be transferred into Hertz (Hz) by dividing the mean RR interval length. In this 
experiment, this calculation was performed by the PowerLabs ECG and accompanying 
Labchart software post hoc. Spectral analysis of HRV was used as the main frequency-domain 
measure. In addition to the continuous recording of BP and HR reactions to the pressor 
responses, regular BP recordings were taken at 5 min intervals using an armcuff and Dinamap 
Pro Series as an additional measure of BP. 
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3.3. Psychological & psychophysiological methods 
3.3.1. The Schandry Task - a measure of cardiac interoception 
Heartbeats have a distinct cycle and rhythmicity allowing them to be easily measured, 
moreover, cardiac interoception is positively correlated with the interoception of other 
autonomically mediated organs (Whitehead and Drescher, 1980). The Schandry mental 
tracking task is a way of measuring cardioception, wherein the subject is asked to count 
individual heartbeats within a brief undisclosed window of time, between 21-45 seconds 
(Schandry, 1981).  
 
With the relatively recent interest in conscious interoception, important methodological issues 
have developed with its measurement, interpretation and inconsistent and interchangeable 
use of terms such as, ‘interoceptive accuracy’, ‘interoceptive awareness’, ‘interoceptive 
sensitivity’ or simply ‘interoception’. To address these issues, Garfinkel and colleagues 
(Garfinkel and Critchley, 2013, Garfinkel et al., 2015) recently stratified ‘interoceptive 
awareness’ as a metacognitive measure of the degree to which objective interoceptive 
accuracy (as measured by a heartbeat tracking tasks, for example) relates to subjective 
sensibility in one’s performance in the interoceptive task, i.e., if someone has good 
interoceptive awareness, the level of their interoceptive accuracy will match their sensibility in 
their accuracy. 
 
Interoceptive accuracy scores will be yielded by counting the R waves in the event-marked 
ECG traces and averaging the following equation over the 3 tracking tasks of each stage of 
the protocol (supine baseline, HG, CP, HUT) and for global scores for the entirety of the 
experiment: 1 − (|nbeatsreal− nbeatsreported|) / ((nbeatsreal+nbeatsreported)/2).  
 
Measures of interoceptive awareness will be taken from the participants’ subjective appraisals 
(interoceptive sensitivity) of their heartbeat tracking task performance (interoceptive 
accuracy) during the experimental protocol. Interoceptive awareness scores will be extracted 
by obtaining the r value of interoceptive accuracy and interoceptive sensibility.  
 
3.3.2. The orienting response (OR) 
The orienting response (OR) is a collection of transient physiological and behavioural 
adjustments, typified by increased parasympathetic tone, such as bradycardia or reduced 
SCRs elicited by the conscious occurrence of a motivationally or emotionally salient stimulus. 
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This “investigatory reaction” to a novel stimulus was first described by Pavlov in his animal 
studies as a behavioural adjustment of a being’s faculties and resources to a novel cue 
(Pavlov, 1927b). It is proposed that the physiological downregulation facilitates cognitive 
processing and appropriate behavioural response (Turpin, 1986). The skin conductance 
response (SCR) does not differentiate between ORs and CDRs (Sokolov, 1963b) and was 
therefore not included for the purposes of this thesis.  
 
3.3.3. The International Affective Picture System (IAPS) 
The International Affective Picture System (IAPS) is a database of images of varying quantified 
valences (categorised into neutral, pleasant and unpleasant), dominance ratings and arousal 
scores. Originally developed by the National Institute of Mental Health, the IAPS were validated 
in a cohort of 100 America college students (50% female). The IAPS has been extensively and 
reliably used as a robust investigative tool in emotional paradigms in clinical and non-clinical 
cohorts (Lang PJ, 2005, Jasson et al., 1997) and is one of the most well-validated psychological 
tools available. The IAPS has been used in research on mental disorders such as schizophrenia, 
major depression, anxiety or psychopathic personality traits.  
 
3.3.4. Self-report questionnaires  
For the purposes of better understanding the prevalence and source of any significant co-
morbid psychological symptoms amongst VVS, EH and PoTS patients, a battery of well- 
validated questionnaires was used to survey patients and controls. These questionnaires were 
generally completed on the day of testing and were broadly divided into self-report measures 
looking at affective items only and those looking at affective factors in relation to somatic 
parameters. See appendix for copies of the questionnaires.  
⇒ Anxiety sensitivity index (ASI); An 18 item questionnaire designed to assess apprehension 
of anxiety-related sensations based on beliefs about their harmful consequences (Reiss et 
al., 1986). Response options range from 0 = ‘not at all like me’ to 4 = ‘extremely like me’.’ 
⇒ Balanced Emotional Empathy Scale (BEES): Is a 30 item questionnaire designed to record 
the subject's vicarious experience of another's emotional experiences (Mehrabian, 1996). 
Response options range from 0 = ‘not at all like me’ to 4 = ‘extremely like me’. Response 
options range from -4 = ‘very strong disagreement’ to +4 = ‘very strong agreement’. 
⇒ Beck Depression Inventory (BDI): A 21 item multiple-choice questionnaire designed to 
assess the severity of depression (Beck et al., 2001). Response options range from 0 = e.g., 
‘I do not feel I am worthless’ to 3 = e.g., ‘I feel utterly worthless’. 
⇒ Body vigilance scale (BVS): Is an 18 item questionnaire designed to measure the subject’s 
tendency to selectively attend to physiological changes (Schmidt et al., 1997). Response 
options range from 0 = ‘not at all like me’ to 10 = ‘extremely like me’. 
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⇒ Cardiac anxiety scale (CAS): An 18 item questionnaire designed to assess ‘cardiophobia’, 
i.e., the interpretation of cardiac symptoms, sensations and related behaviours (Eifert, 
1992). Response options range from 1 = ‘never’ to 5 = ‘always’. 
⇒ Childhood traumatic events scale (CTES): Is a 13 item questionnaire designed to assess 
traumatic events during adulthood and childhood. Responses options range from  1 = not 
at all traumatic to 7 = ‘extremely traumatic’ (Pennebaker and Susman, 1988).  
⇒ The Self-consciousness Scale (SCS-R) (revised): Is a 23 item questionnaire designed to 
assess private and public self-consciousness and social anxiety (Scheier and Carver, 1985). 
Response options range from 0 = ‘not at all like me’ to 4 = ‘a lot like me’. 
⇒ State Anxiety Inventory (SAI): A 20 item questionnaire designed to assess   anxiety at the 
time of filing out the questionnaire (Spielberger, 1983). The questionnaire is taken from the 
state-trait anxiety inventory (STAI) which also includes a set of 20 questions examining trait 
anxiety, which was not included in the current study for the sake of time and that the SAI 
section provided a more current measure in relation to autonomic symptoms.  The SAI 
includes a number of negatively scored items to negate confounding self-reporting issues. 
Response options range from 0 = ‘not at all like’ to 4 = ‘very much so’.  
 
3.5. Statistical analysis 
Statistical analysis was performed online using SPSS version 18. Descriptive statistics are 
presented as mean (± 1 SD) for normally distributed data. Quantitative variables were 
compared between groups using an ANOVA when there were more than two groups or by 
independent t-tests for 2 groups. When necessitated, non-parametric tests were used to 
compare between two groups (Mann Whitney U Test) and when the analysis involved more 
than two groups to be compared, a Kruskal-Wallis test was used. Pearson correlation 
coefficients were used to study pairwise correlations between normally-distributed variables. 
Spearman rank order correlations were used for analysis of relationships of qualitative variables 
or non-normally distributed variables. Mixed model repeated measures ANOVA was used for 
comparison of data collected over more than two different time points in 2 or more different 
participant groups or 2 or more conditions in the same participant group. Statistical 
significance was defined as a 2-tailed p value of <0.05. 
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Chapter 4. Functional syncope: 
conversion disorder & aberrant response 
to orthostatic intolerance 
4.1. Introduction 
The cause of 10-26% of syncope cases remains unknown and psychiatric illness is more 
prevalent in these patients, particularly if episodes are recurrent or include somatic 
symptomology (Brignole et al., 2005, Krahn et al., 1995, Krahn et al., 1998, Mathias et al., 2001). 
‘Psychogenic pseudosyncope’ is the behavioural occurrence of apparent syncope 
(unresponsiveness and loss of postural tone) during physiological indices that would not result 
in cerebral hypoperfusion, as measured by beat-to-beat HR, BP, ECG, EEG and/or cerebral 
blood flow. In this chapter, I present the largest cohort so far. I evaluate the characteristics of 
this cohort in relation to dysautonomia, anxiety and functional neurological disorders.  
 
One may argue against the clarity, objectivity and accuracy of the term ‘psychogenic 
pseudosyncope’ due to actual episodes of VVS being caused by psychogenic factors, such 
as the site of blood, frustration or humiliation. Therefore, the term ‘functional syncope’ (FS) will 
be used in place of the less objective, inaccurate and repetitive term ‘psychogenic 
pseudosyncope’. FS was chosen to be preferable to other options (see table 4), as it allows for 
the fact that some patients may also have autonomic disorders, such as autonomic (neurally) 
mediated syncope (AMS) or the postural tachycardia syndrome (PoTS), in which case a term 
such as ‘non-autonomic mediated syncope’, which mirrors AMS, negates an autonomic 
component and may be confusing for clinician and patient. 
 
FS appears to be a conversion disorder yet there is a paucity of FS literature (van Dijk and 
Wieling, 2013) and direct observation in a clinical setting is rare (Luzza et al., 2004). Moreover, 
FS is often reported or described with little attempt to try and unpick the psychophysiological 
mechanisms that may be involved in its presentation, such as the diminished interoception in 
patients with OI reported in chapter 6 of this thesis, which may be one potential factor linking 
symptomatic autonomic dysfunction with FS. Other functional disorders, such as fibromyalgia, 
irritable bowel syndrome and chronic fatigue syndrome have been reported in PoTS (the most 
common form of OI), therefore, this chapter will  
I. review the historical casenotes of FS patients to ascertain whether FS is a typical 
conversion disorder 
II. investigate any underlying autonomic or dysautonomic contributions to FS, 
III. describe the presentation and incidence of FS during autonomic testing 
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Table 4. Possible alternatives and rationale to the currently used ‘psychogenic pseudosyncope’. 
Term and abbreviation Advantages Disadvantages 
Behavioural syncope (BS) ü Discounts an organic cause 
ü More accurate than 
‘functional’ 
û Not currently used 
û Risk of stigmatizing or alienating patient 
Functional syncope (FS) ü Can be aligned with 
Functional Neurological Symptoms 
(FMS) and Functional Movement 
Disorder (FMD) 
û Not currently used 
û Unnecessarily broad as in most cases, a 
neurological cause has been discounted 
and an autonomic cause has been fully 
discounted after autonomic testing 
Non-autonomic (neurally) 
mediated syncope (NAMS) 
ü Comparable to currently 
used ‘autonomic (neurally) 
mediated syncope’ 
ü Discounts an autonomic 
cause 
ü Allows for subsequent 
neurological investigations if 
required 
ü Low risk of stigmatizing or 
alienating patient 
û Not currently used 
û Long 
û negates an autonomic component 
û may be confusing for clinician and 
patient 
Non-autonomic syncope 
(NAS) 
ü Discounts an autonomic 
cause 
ü Allows for subsequent 
neurological investigations if 
required 
ü Low risk of stigmatizing or 
alienating patient 
û Not currently used 
Psychogenic pseudosyncope 
(PSS) 
ü Broad 
ü Currently in use 
û Repetitive 
û Risk of stigmatizing or alienating patient 
Syncope of unknown 
aetiology (SoUA) 
ü Broad û Not currently used 
û Long 
û Provides no clinical insight 
 
 
4.2. Methods 
The medical records of all consecutive patients referred over a 7 year period for suspected 
syncope or pre-syncope to two London-based national referral centres for cardiovascular 
dysautonomia were reviewed. FS was defined as unresponsiveness and loss of postural tone 
during normal ECG, HR and BP activity that would not induce a syncopal episode. 
Demographic and clinical characteristics of this population are described.   
4.2.1. Procedure 
A detailed history was obtained in all cases, with an emphasis on information to help explain 
the cause of syncope, including potential symptom exacerbation in relation to orthostasis, 
postprandial hypotension or tachycardia and whether syncope was associated with blood-
injury phobia and/or emotional provocation. Information on familial syncope and the relation 
to neck movement was sought, particularly in elderly patients. 
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Using established protocols, including, HUT, prolonged head up tilt testing (pHUT), supine 
exercise testing and liquid meal challenge, central and peripheral stimuli (Valsalva 
manoeuvre, pressor responses to mental arithmetic, isometric exercise, and cutaneous cold 
application) were used in the assessment of autonomic function, including, sympathetic and 
parasympathetic nerve function (Mathias et al., 2013, Mathias and Bannister, 2013). 
Parasympathetic cardiac function was tested using respiratory sinus arrhythmia (RSA) 
responses to deep breathing, hyperventilation and the Valsalva manoeuvre and pressor 
exercises investigated vasomotor integrity (Mathias et al., 2013) (see Clinical autonomic 
investigations). In those with suspected blood-injury phobia relating to VVS, suitable 
observations and precautions were made during venepuncture on HUT and pHUT (45 min 
maximum). In patients >50 years in whom autonomic failure (AF) was excluded, carotid sinus 
massage (CSM) was performed to exclude carotid sinus hypersensitivity (CSH) during supine 
baseline and HUT, unless contraindicated due to carotid artery disease. A symptomatic fall in 
systolic blood pressure (SBP) of 30 mmHg or below or a BP fall of over 50 mmHg without 
symptoms, and/or with HR below 40 beats per min (BPM) was regarded as abnormal (Mathias 
et al., 2013). FS was defined as apparent syncopal behaviour (unresponsiveness, loss of 
postural tone) during normative cardiovascular autonomic indices that would not cause 
cerebral hypoperfusion and subsequent TLoC.  
 
4.2.2 Instrumentation 
HR and ECG were continually monitored online (PowerLab 16/30/ECG (Bioamp) (AD 
Instruments, Oxford, United Kingdom) and analysed online (Labchart 7). BP was continually 
recorded using digital photplethysmography (Finometer, Smart Medical, Gloucestershire, 
United Kingdom) and acute BP and HR measures were taken using automated 
sphygmomanometry (Dinamap Pro400V2, GE Healthcare, Buckinghamshire, United Kingdom). 
Videotelemetry used in some patients in whom FS diagnoses were suspected. 
 
4.3. Results 
68 patients (63 female) provided a positive diagnosis of FS (mean age: 37.5 + 15.1 yr) during 
clinical autonomic testing. After initial analysis, it became clear that the incidence of FS had 
to be divided into three patient groups;  
i. FS group (n=29, 42.7%) experienced episodes of FS during testing. 
ii. FS/PoTS group (n=30, 44.1%) experienced episodes of FS during testing but also met 
the diagnostic criteria for the postural tachycardia syndrome (PoTS) during HUT, pHUT 
or stand. 
iii. FS/AMS group (n=9, 13.2%) experienced episodes of FS and actual autonomic 
mediated syncope (AMS) during HUT, pHUT or standing. 
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4.3.1. Historical Profiles 
The FS group reported the most prodromal symptoms. The FS group was predominantly female 
(n=26, 90%) and had a mean age of 40 + 15.1 years. Loss of consciousness (n=10, 34.5%), 
dizziness (n=10, 34.5%), and palpitations (n=8, 27.6%) where the primary historical symptoms 
previously reported in relation to their referral. 13.8% (n=4)  reported injury during these episodes 
and 13.8% (n=4) also had a cardiac arrhythmia. 24.1% (n=7) reported gastrointestinal (GI) 
symptoms related to diarrhoea or constipation, 13.8% (n=4) reported bladder urgency or 
incontinence during previous syncope and 17.2% (n=5) had experienced motor abnormalities, 
such as tremor or myoclonus before, during or after syncope. 17.2% had experienced visual 
disturbances during syncopal episodes and 31.1% were currently receiving treatment for 
psychiatric symptoms (n=9); 27.6% (n=8) for depression, 6.9% (n=2) for anxiety and 3.5% (n=1) 
for posttraumatic stress disorder (PTSD) (see table 5).  
 
Current medications for the FS subgroup included, 13 x psychotropic, 6 x analgesic, , 4 x 
antihistamine, 4 x antispasmodic, 2 x anti-hypertensive, 2 x thyroid hormone, 2 x anti-
inflammatory, 2 x  beta blocker, 2 x proton pump inhibitors, 1 x antifibrinolytic, 1 x laxative , 17 
x other non-prescription.  
 
The FS/PoTS group was 100% (n=30) female with a mean age of 27.7 + 11.6 yr. Just over half 
(n=16, 53.3%) had a pre-existing diagnosis or presented with sigs of ehlers-danlos syndrome III 
or joint hypermobility syndrome EDSIII/JHS (Beighton et al., 1998), a predisposing 
rheumatological trait for PoTS (Mathias et al., 2012). Historically, 26.7% (n=8) reported previous 
complete TLoC and 23.3% (n=7) experienced constipation or diarrhoea. 16.7% (n=5) were 
currently receiving treatment for an affective disorder and 3.3% (n=1) for anorexia nervosa 
(see table 5).  
 
Current medications for the FS/PoTS subgroup included 11 x vasopressor/antihypotensive 
agent, 8 x asthma/bronchospasm medication, 5 x psychotropic, 4 x antispasmodic, 3 x OCP, 
3 x analgesic, 2 x anticonvulsant drug, 2 x anticonvulsant drug, 1 x antiviral, 1 x sinoatrial node 
inhibitor, anti-inflammatory, 1 x antihistamine, 1 x insulin, 1 x diuretic.  
 
The small (n=9) FS/AMS group was predominantly female (n=7, 77.8%), had a mean age of 
40.4 + 18.3 years and 66.7% (n=6) had a pre-existing diagnosis of EDSIII/JHS. 66.7% (n=6) also 
reported dizziness during previous syncopal episodes. TLoC and nausea (both 44.4%, n=4) were 
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this groups primary syncope-related symptoms. 44.4% (n=4) also reported experiencing 
functional motor symptoms during these historic syncopal episodes (see table 5).   
  
On the day of testing, current medications for the FS/AMS subgroup included, 3 x analgesics, 
2 x vasopressor/antihypotensive agent, 2 x antiepileptic, 2 x asthma/bronchospasm 
medication, 1 x anti-hypotenisve, 1 x proton pump inhibitor, 1 x anti-inflammatory, 2 x 
asthma/bronchospasm, 1 x antihistamine.  
 
4.3.2. Clinical profiles 
Prolonged head up tilt (pHUT) (73.1%) and head up tilt (HUT) (50%) proved the most effective 
tests of provoking FS. During orthostatic challenge, 4/29 (13.8%) pooled in the periphery on HUT 
and 1/7 (14.3%) during pHUT. 2 (6.9%) had FS episodes during hyperventilation, 2 (6.9%) during 
Valsalva manoeuvre, 2 (6.9%) during stand, 14 (48.3%) during HUT. 7/29 (24.1%) FS patients 
underwent pHUT, of whom, 7/7 (100%) experienced FS during pHUT. 3 (10%) FS episodes 
occurred whilst the patients was in the department but not attached to any monitoring 
equipment (see figure 20). During FS episodes, aside from unresponsiveness and loss of postural 
tone (defining symptoms of FS) functional motor symptoms (n=10, 33.3%) and eyelid 
fluttering/rolling (n=10, 34.5%) were the main comorbid FS symptoms observed (see figure 21). 
The main reported symptoms pre-or-post FS episodes were dizziness (n=6, 20.7%) and 
thermoregulatory symptoms, such as hot flush or clammy hands (n=6, 20.7%) (see figure 22).  
 
During orthostatic challenge, 7/30 (23.33%) FS/PoTS patients were observed to pool in the 
periphery on HUT and 10/17 (58.8%) during pHUT. 3 (10%) patients had FS episodes during 
hyperventilation, 1 (3.3%) during Valsalva manoeuvre, 6 (20%) during stand, 15 (50%) during 
HUT. 17/29 FS/PoTS patients underwent pHUT (56.7%), of whom, 10/17 (58.8%) experienced FS 
during pHUT. 3 (10%) FS episodes occurred whilst in the department but not attached to any 
monitoring equipment. The main FS symptoms observed were functional motor symptoms 
(n=10, 33.3%) (see figure 13). The main reported symptoms pre-or-post FS were dizziness (n=10, 
30%) and thermoregulatory symptoms (n=6, 20.7%) (see figure 22).  
 
During orthostatic challenge, 2/9 (22.2%) FS/AMS patients were observed to pool in the 
periphery on HUT and 2/4 (50%) during pHUT. 1 (11.1%) had an FS episode during 
hyperventilation, 1 (11.1%) during isometric exercise, 1 (11.1%) during stand, 3 (33.3%) during 
HUT. 4 underwent pHUT (44.4%), of whom, 1 (25%) experienced FS during pHUT. 2 (22.2%) FS 
episodes occurred whilst in the department but not attached to any monitoring equipment. 
During FS episodes, the main symptoms observed were eyelid fluttering/eye rolling (n=4, 44.4%) 
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and functional motor symptoms (n=3, 33.3%) (see figure 21). The main reported symptom pre-
or-post FS episode nausea (n=2, 22%) (see figure 22).  
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Table 5. Historical data of patients who experienced an episode of functional syncope during autonomic testing. Subjects were broadly divided into three groups, those who were found to have 
undiagnosed PoTS ('FS/PoTS'), those who were found to experienced functional syncope episodes and actual episodes of autonomic-mediated syncope (FS/AMS) and those who only presented 
episodes of functional syncope during testing (‘FS’). 
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FS n=29 90% 40.3 31% 31.% 34.5% 34.5% 13.8% 13.8% 27.6% 13.8% 24.1% 13.8% 13.8% 17.2% 3.5% 17.2% 
FS/PoTS n=30 100% 27.7 53.3% 6.7% 13.3% 26.7% 13.3% 10.0% 6.7% 13.3% 23.3% 10.0% 3.3% 16.7% 3.33 3.3% 
FS/AMS n=9 78% 40.4 66.7% 0.00 77.8% 44.4% 33.3% 22.2% 11.1% 44.4% 0.00% 0.00% 0.00% 44.4% 11.1% 22.2% 
 
                                                 
Figure 20. Incidence of functional syncopal episodes during testing. FS/PoTS = functional syncope patients with the 
postural tachycardia syndrome; FS = functional syncope only; FS/AMS = functional syncope patients with autonomic-
mediated syncope 
Figure 21. Observed 
symptoms during functional 
syncope episodes 
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Figure 22. Symptoms reported by the patient pre/post functional syncope episode. 
 
4.3.3. Cardiovascular autonomic data 
At supine baseline the mean HR of the FS group was 71.7 + 11.7 beats per minute (BPM). The 
FS/PoTS mean supine baseline HR was 79.1 + 12.6 BPM and the mean HR of the FS/AMS group 
at supine baseline was 61.2 + 7.9 BPM (see figure 23). During episodes of FS, the mean HR of 
the FS group was 84.9 + 17.4 BPM, the mean HR of the FS/PoTS group was 129.33 + 30.3 and the 
mean HR of FS/AMS patients during episodes of FS was 76.80 + 34.1.  
 
Figure 23. Group heart rate (BPM) during baseline and functional syncope episode. FS = functional syncope group, 
FS/PoTS = comorbid functional syncope and postural tachycardia syndrome group, FS/AMS = comorbid functional 
syncope and autonomic mediated syncope group. Error bars = standard deviation 
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During supine baseline, the mean systolic blood pressure (SBP) and diastolic blood pressure 
(DBP) of the FS group was 119.1 + 15.2 mmHg and 68.9 + 8.7 mmHg respectively. The FS/PoTS 
group’s mean SBP and DBP at baseline was 119.2 + 13.6 mmHg and 68.5 + 11.3 mmHg 
respectively. The mean SBP and DBP of the FS/AMS group at supine baseline was 111.5 + 9.4 
mmHg and 65.5 + 3.9 mmHg respectively (see figure 24). During episodes of FS, the BP profile 
of the FS group was 130.9 + 24.6 (mmHg) SBP and 73.1 + 11.9 (mmHg) DBP. FS/PoTS mean BP 
during FS was 133 + 21.7 (mmHg) SBP and 75.6 (mmHg) DBP and FS/AMS patients’ mean SBP 
during episodes of FS was 66.2 + 20.1 (mmHg) and DBP was 35.2 + 17.3 mmHg.   
 
 
Figure 24. Group systolic blood pressure (SBP) and diastolic blood pressure (DBP) during baseline and 
functional syncope episode. FS = functional syncope group, FS/PoTS = comorbid functional syncope 
and postural tachycardia syndrome group, FS/AMS = comorbid functional syncope and autonomic 
mediated syncope group. Error bars = standard deviation 
4.4. Discussion 
This study investigated the poorly understood phenomena of FS in a cohort of 68 patients 
referred for suspected syncope or pre-syncope who experienced episodes of FS during testing. 
FS was defined as syncopal behaviour (unresponsiveness, loss of postural tone) during 
normative cardiovascular autonomic indices that would not induce cerebral hypoperfusion 
and subsequent TLoC.  
 
pHUT (73.1%) and HUT (50%) proved the most effective tests in inducing FS. 30 (44.1%) FS 
patients (mean age: 28 + 12), all female, met the PoTS diagnostic criteria, over half of whom 
(53.3%) also presented with JHS/EDSIII. 9 FS patients experienced actual episodes of AMS 
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(mean age 40.4 + 18.3) during autonomic testing. Of the 29 remaining FS patients (mean age 
40.3 + 15.1), 31% were currently receiving psychiatric treatment, compared with 6.7% in the 
FS/PoTS subgroup and none in the FS/AMS subgroup. Prior to autonomic assessment, the FS 
subgroup appeared to be the most symptomatic, reporting the most prodromal symptoms 
and episodes of TLoC.  
 
During autonomic testing, eyelid fluttering/eye rolling (FS/PoTS=23.3%, FS=34.48%, 
FS/AMS=44.4%) and functional motor symptoms were the most common accompanying 
behaviours of FS in addition to unresponsiveness and loss of postural tone. Motor symptoms are 
common during FS episodes but are under-reported and poorly understood (Tannemaat et 
al., 2013). 44.4% of the FS/AMS subgroup also reported previous involuntary motor symptoms 
prior to testing as part of their typical syncope prodrome. Dizziness (FS/PoTS=33%, FS=21%, 
FS/AMS=11%) and thermoregulatory symptoms (FS/PoTS=20%, FS=21%, FS/AMS=11%) were the 
most commonly reported symptoms prior to FS. 
 
To date, the 68 FS patients identified in this study is the largest FS sample in the literature 
(previously n=43 (Tannemaat et al., 2013)). The current findings confirm and extend the 
indications from previous studies that FS patients were predominantly female, remained 
unresponsive during FS for significantly longer than a typical syncopal episode and that FS 
patients’ eyes remained closed and resistant to opening. However, either due to the patients 
being referred to a national tertiary referral centre for autonomic disorders or because of the 
efficacy of the clinical protocols in unmasking autonomic dysfunction, two other FS groups 
were also clearly defined who either met the diagnostic criteria for PoTS or experienced an 
actual syncopal event as well as an FS event during testing. The prevalence of OI and the size 
of the FS/PoTS subgroup is particularly striking, particularly as PoTS has recently been strongly 
associated with functional GI disorders (Safder et al., 2009) (Chelimsky et al., 2015), particularly 
in paediatric patients (Kovacic et al., 2014). The current study indicates that the association 
between PoTS and functional phenomena is not limited to GI symptoms.  
 
The small number of previous FS studies have consistently found a prevalence of psychiatric 
morbidity in test subjects (Luzza et al., 2003, Luzza et al., 2004, Benbadis and Chichkova, 2006) 
as was the case in the FS only subgroup, suggesting that FS was likely to be a manifestation of 
a conversion disorder rather than of OI (Raj et al., 2014) in the FS group, as only 6.7% FS/PoTS 
patients and no FS/AMS patients had a current or previous history of psychiatric morbidity. This 
supports previous findings that the elevated levels of anxiety in PoTS and syncope (Kapoor et 
al., 1995, Linzer et al., 1991) do not generally reach clinical levels (Raj et al., 2009). PoTS and 
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panic disorder share psychological (e.g., health anxiety, anxiety sensitivity, impaired 
concentration) and physiological (e.g., palpitations, tachycardia, chest pain, dyspnea) 
(Mathias et al., 2012) symptomatology and can co-exist (Esler et al., 2006) but the 
differentiating factor between the two conditions is that PoTS is provoked by orthostatic stress 
due to the breakdown of autonomic reflexes rather than anxiety (Khurana, 2006, Masuki et al., 
2007). This is clearly illustrated by the current data, in which HUT, pHUT and standing provoked 
more episodes of FS than hyperventilation in the FS/PoTS group, which is a useful clinical 
exercise for increasing sympathetic nerve activity (SNA) but is also a reliable interoceptive 
threat in anxiety sensitive individuals and healthy controls (Melzig et al., 2011), is a more 
anxiogenic exercise than orthostatic challenges (Arch and Craske, 2010) and induces panic 
attack symptoms, such as anxiety, derealisation and paraesthesia (Funayama et al., 2013). This 
is further evidence that the tachycardia in PoTS patients during orthostatic challenge is related 
to a breakdown of autonomic reflexes and not psychogenic (Masuki et al., 2007).  
 
Although there is a dearth of neuroimaging research on OI, recently, Umeda and colleagues 
(fMRI) have positively associated neuroticism scores in PoTS patients with enhanced left 
cerebellum and periaqueductal grey (PAG) activity during processing of emotional visual 
stimuli (Umeda et al., 2009). The PAG is a key area in defence behaviours, such as tonic 
immobility, as well as cardiovascular and respiratory function (Monassi et al., 1999, Dampney 
et al., 2013), so it may be possible that FS in the FS/PoTS group was due to an exaggerated 
phylogenetic defence response exacerbated by the over-representation of neuroticism in 
PoTS patients.  
 
FS and non-epileptic seizurenon-epileptic seizures share many commonalities (Benbadis and 
Chichkova, 2006) and it is noteworthy that basal autonomic hypervigilance and positively 
biased processing during social threat have been found in non-epileptic seizure patients 
(Bakvis et al., 2009), leading to the proposition of non-epileptic seizure as a dissociative 
response to physical or emotional threat (Bakvis et al., 2010). This sounds remarkably similar to, 
but should not be confused with, descriptions of the psychosocial stressors that can cause VVS. 
Although there is a lack of psychophysiological studies on AMS, Buodo and colleagues 
evidenced attenuated electrodermal Stimulus Processing Negativity (SPN) during anticipation 
of unpleasant images in VVS patients (Buodo et al., 2012), suggestive of a lack of emotional 
adaption and anticipation.  
 
A recent study of 22 female non-epileptic seizure patients recorded significantly lower sensory 
gating (p50) and disturbed attention processing regardless of episode frequency or disease 
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duration, potentially leading to aberrant perception of stressful events that cognitively 
overload the individual’s capacity to cope and providing a neurological predisposition to be 
overwhelmed by stressors (Almis et al., 2013). This reaction may equally be provoked by 
interoceptive threat, such as symptomatic OI and further impacted by the impaired 
interoceptive accuracy found in PoTS and AMS patients in chapter 6 of this thesis. Impaired 
interoceptive accuracy may also help explain why the FS/PoTS patients were referred for 
syncope or pre-syncope rather than tachycardia or palpations. Further evidence of diminished 
interoception can be found in the fact that prodromal palpations (n=2, 6.7%) and pre/post FS 
palpitations (n=2, 6.7%) and prodromal chest pain (n=1, 3.33%), and pre/post FS chest pain 
(0%) both typical PoTS-related symptoms, were not commonly reported by the FS/PoTS 
subgroup, restating the body vigilance survey findings in chapter 5 of this thesis and further 
emphasising the possibility of a brain-body disconnection in these patients.  
 
From a simple classical conditioning perspective, the cardiovascular data during episodes of 
FS in the two OI groups raises the possibility that FS has become a learned response to OI 
symptoms in FS/PoTS and FS/AMS patients, who may have subconsciously learned that 
assuming the supine position alleviated OI-related symptoms. Both OI groups would appear to 
be symptomatic during episodes of FS, with FS/PoTS patients mean HR being 129.3 + 30.3 BPM 
(baseline FS/PoTS HR: 79.1 + 12.6 BPM) and the FS/AMS BP profile being that of a vasodepressor 
episode during FS: 66.2 + 20.1 SBP, 35.2 + 17.3 DBP, compared to baseline: 111.5 + 9.4 SBP and 
65.5 + 3.9 DBP, though this also raises the question of why the cluster of FS and eyelid 
fluttering/rolling and functional motor symptoms become part of the pre-syncopal symptom 
cluster in the FS/AMS group. The answer may lie in the prevalence of JHS/EDSIII in the FS/AMS 
group and that JHS/EDSIII is also associated functional disorders (Nijs et al., 2006, Kovacic et 
al., 2014, Acasuso-Diaz and Collantes-Estevez, 1998). The higher order interoceptive deficits 
described in chapter 6 of this thesis may also play a contributing role to this aberrant response 
to OI in both cohorts.  
  
Predictive coding models have been applied to schizophrenic patients to explain their 
reduced sense of agency, a symptom also shared with FS patients during an episode of FS. 
These models provide a cognitive, sensory and affective matrix to explain the common 
symptoms in schizophrenia as resulting from inaccurate sensory predictions and interpretations 
of actions (Blakemore et al., 2000) (Voss et al., 2010). Originally applied to computational and 
theoretical models, predictive coding uses Bayesian probability theory to calculate the 
strength of a given hypothesis on previous probability and related data (Clark, 2013). Seth and 
Critchley recently extended this predictive coding model to human interoceptive processing 
(Seth and Critchley, 2013). In predictive coding models of the brain, error code predictions are 
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constantly produced to process the afferent sensory inputs. The scale of any discrepancies in 
these predictions, known as a prediction error (variation between the brain’s prediction and 
the actual incoming afferent signal) must be kept to a minimum to maintain homeostasis and 
minimize miscalculations (Clark, 2013, Friston and Frith, 2015). This theoretical framework 
depicts the brain as a hierarchical structure, in which one level receives afferent input from the 
previous level (Felleman and Van Essen, 1991), with defined neuronal populations acting as 
prediction units and prediction error units. Prior beliefs and expectations provide top-down 
contributions to error predictions, as do bottom-up sensory and visceral inputs to minimise the 
size of prediction errors and maximise the evidence for its predictions.  
 
Seth and Critchley recently extended this predictive coding model to human interoceptive 
processing (Seth and Critchley, 2013), describing a model in which central interoceptive 
predictions supress autonomic homeostatic signals and somatic responses to visceral sensory 
signals. Friston’s ‘free energy principle’ theory (Friston, 2010), also known as ‘active inference’, 
proposes that should a prediction error become too large, thereby disrupting neural 
homeostasis, it can (i) be modified by retrogradley propagating the signal to the previous brain 
level that assimilated the signal, (ii) engage allostatic measures to meet the original prediction 
error or (iii) alter how the brain attends to the incoming afferent signal (Mesulam, 1998). In 
chapter 6 of this thesis, I propose this third predication error modification as a potential 
explanation for OI patients constantly underestimating their heartbeats. Here, I am proposing 
that the second prediction error modification strategy of engaging the motor system to meet 
the noisy incoming autonomic afferent feedback of tachycardia or pre-syncope may 
account for FS episodes generally occurring during symptomatic OI in FS/PoTS and FS/AMS 
patients. This strategy may have been chosen over modifying how afferent feedback was 
attended to because the experimental protocol described in chapter 6 was far less rigorous 
and arduous than the clinical protocols used in autonomic function tests (AFTs), which are 
designed to unmask any forms of dysautonomia. In fact, as soon as a patient reported any 
symptoms or their beat-to-beat data showed any OI trends during the interoception study, 
testing was halted.  
 
Individuals who somatise are more vigilant of bodily sensations, with prior beliefs (a key 
Bayesian factor) about illness and disease playing a significant role (Kirmayer and Robbins, 
1996) in the somatised presentation of their illness symptoms which are the product of an 
underlying psychiatric rather than organic pathology. This could potentially explain why the 
primary symptoms of syncope – unresponsiveness, loss of postural tone – were also distilled with 
the seizure-like symptoms of eyelid fluttering/rolling and clonic, myoclonic and other motor 
symptoms that do not typically occur in vasovagal syncope in all three FS groups during their 
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functional episodes. In chapter 5 of this thesis, PoTS and AMS patients were found to score 
highly in scales of body vigilance. In the AMS cohort, this body vigilance related to symptoms 
of pre-syncope and syncope, but the PoTS group reported a far wider spectrum of symptoms, 
as was the case in this study, as PoTS patients reported far more pre-and-post FS symptoms 
(see figure 3). This somatic attribution style of vigilance and sensitivity to physical sensations 
may also explain why more PoTS patients encountered episodes of FS than AMS patients.  
 
Patients with functional tremor have been found to misattribute the agency of voluntary 
movement so that they judge both the intent to move and the act of moving as occurring 
simultaneously in an aberrant attribution style (Edwards et al., 2011). It could be argued that it 
is even easier to adopt this attribution style if the individual was also tachycardic or pre-
syncopal at the time, especially OI pre-diagnosis. The interoception data in chapter 6 indicates 
a higher order deficit when AMS and PoTS patients’ conscious cardiac interoceptive accuracy 
but the current data is also suggestive of a subconscious or pre-conscious disruption of brain-
body integration driven by episodes of OI.  
 
Functional or conversion disorders are associated with psychiatric morbidity or malingering, so 
the fact that so few FS/PoTS and FS/AMS had a history of an psychiatric disorder and were 
found to have a diagnosable form of OI is reassuring as, presumably, the various clinical care 
pathways may well have filtered out patients with pronounced mental health needs to more 
appropriate care providers. However, only the FS group had a higher prevalence of 
psychiatric morbidity, suggesting that delineating organic and psychiatric disorders can be 
problematic without appropriate allied clinical and psychiatric assessments. As with seizures 
and non-epileptic seizurenon-epileptic seizures (Andrade et al., 2006), OI and FS can co-exist 
(Mathias et al., 2000), making diagnostic protocols that can distinguish psychogenic 
autonomic arousal from OI essential in elucidating the often opaque presentation of FS.  
 
4.4.1. Summary of main findings: 
This study aimed to investigate the genesis and presentation of the poorly understood and 
under-reported phenomenon of functional syncope, concluding that; 
Ø FS appears to be a conversion symptom in the FS group 
Ø FS appears to be an aberrant response to undiagnosed PoTS and AMS in the FS/PoTS 
and FS/AMS groups.  
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4.4.2. Conclusions 
This study defined three groups of FS patients; the first experienced episodes of FS during 
autonomic testing, aged ~40 with a previous or current history of psychiatric morbidity. The 
second group on autonomic investigation had confirmed PoTS, was aged ~27, tended to have 
joint hypermobility/EDSIII and typically experienced FS whilst tachycardic on HUT or pHUT. The 
third group who were also found to have AMS was the smallest in number (n=9), aged ~40, 
tended to have joint hypermobility/EDSIII and typically experienced FS during pre-syncopal 
episodes whilst on HUT or pHUT. HUT and especially pHUT proved to be the most likely test to 
produce FS. In the FS only group, FS was likely to be a conversion symptom of an underlining 
psychiatric pathology due to the normal BP and HR data during FS and the overrepresentation 
of psychiatric illness in this group. The presence of the FS/PoTS group suggests that previous 
studies linking PoTS with functional GI disorders may also apply to a broader spectrum of 
functional disorders, though the prevalence of JHS/EDSIII may be a confounding factor 
(Acasuso-Diaz and Collantes-Estevez, 1998, Kovacic et al., 2014). JHS/EDSIII was also common 
in the FS/AMS group, indicating it may be a predisposing factor for all forms of OI, not just PoTS 
(Mathias et al., 2012). In light of the impaired interoception in PoTS and AMS reported in 
chapters 6 and 7 of this thesis, predictive processing models may offer an alternative to 
understanding FS, as the engagement of motor systems to reduce interoceptive prediction 
errors of previously undiagnosed OI during HUT could account for FS episodes generally 
occurring during symptomatic OI in FS/PoTS and FS/AMS patients in the current study, 
substantiated by the finding that FS/PoTS patients were referred for syncope not PoTS-related 
symptoms. This study also emphasises the efficacy of robust clinical autonomic protocols in 
delineating any underling autonomic pathology in functional disorders, of which, it may well 
play a contributing role.  
  
77	
	
Chapter 5. Comorbid cognitive-affective 
symptoms due to autonomic (neurally) 
mediated syncope, essential 
hyperhidrosis & the postural tachycardia 
syndrome 
5. Introduction 
The interaction of autonomic and psychological symptoms in AMS, EH and PoTS is a neglected 
area of research, however, one study has found that the functional disability in PoTS is closely 
correlated with catastrophising thoughts, which also mediate anxiety and somatic 
hypervigilance (Benrud-Larson et al., 2003), another common anxiety-based PoTS trait (Raj et 
al., 2009, Masuki et al., 2007, Raj, 2006). This is the only study to-date to investigate the 
association between emotional factors and autonomic symptoms in PoTS, rather than 
reporting global self-report items as a secondary outcome of symptomatic impairment. Given 
the prevalence of EH, PoTS and AMS, the common presentation of OI symptoms in primary 
care settings, as well as in ‘functional’ medically unexplained symptoms, there may be a 
proportion of individuals with an intermittent autonomic disorder who are misdiagnosed as 
having a mainly psychological basis to their autonomic symptoms, including malingering. This 
could be further complicated by the prevalence of sub-clinical affective symptoms in OI and 
EH. Therefore, specific aim # 2 of this thesis will thoroughly and systematically investigate 
cognitive-affective symptoms in EH, AMS and PoTS to decipher if these psychological 
symptoms are related to dysautonomia symptoms that functionally overlap with physical 
manifestations of anxiety and panic or are trait-like phenomena independent of 
dysautonomia. 
 
5.1. Methods  
5.1.1. Participants 
Ninety-two individuals completed the battery of self-report questionnaires aimed at 
elucidating the prevalence and potential cause of any affective morbidity in intermittent 
dysautonomia (n=71) patients in comparison to 22 healthy controls (11 females, mean age 35 
+ 8.02). Patient questionnaire data were grouped by clinical cohort of 30 x PoTS patients (26 
female, mean age 35 + 10.70) 20 x EH patients (mean age 41.87 + 11.65) and 22 x AMS patients 
(16 female, mean age 38.50 + 13.43). All patients had established diagnoses from and were 
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under the care of the London Autonomic Units at St Mary’s Hospital and the National Hospital 
for Neurology and Neurosurgery (NHNN) from March 2012 to December 2014. Patients were 
asked in clinic, pre/post testing or sent a questionnaire in the mail to participate in the survey. 
 
5.1.2. Self-report questionnaires 
The battery of questionnaires was selected with the main purposes of (i) describing the 
prevalence and severity of co-morbid psychological symptoms in PoTS, AMS and EH, and (ii) 
to examine if these symptoms, if present, were pre-existing trait-like phenomena or 
perpetuated in some way by organic symptoms related to autonomic dysfunction.  
 
5.2. Results 
5.2.1. Beck Depression Inventory (BDI) 
PoTS (p=.000) and EH patients (p=.008) had significantly higher BDI scores than controls (see 
figure 25). The 21 items of the BDI can be divided into 15 x affective depressive symptoms, 2 x 
cognitive depressive symptoms and 4 x somatic depressive symptoms. AMS, EH and PoTS 
groups scored significantly higher than controls on both the cognitive depressive symptom 
items of ‘indecisiveness (PoTS [p=.000], AMS [p=.003], EH [p=.001]) and ‘concentration 
difficulty’ (PoTS [p=.000], AMS [p=.008], EH [p=.005]). EH, AMS and PoTS patients also scored 
higher on the somatic depressive item of ‘changes in sleep pattern’ (PoTS [p=.008], AMS 
[p=.020], EH [p=.002]). PoTS and EH patients in general scored higher on BDI items than AMS 
patients. PoTS patients scored than controls all somatic depressive items.  
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Figure 25. Global Beck Depression Inventory (BDI) scores for postural tachycardia syndrome (PoTS), essential 
hyperhidrosis and autonomic mediated syncope (AMS) patients in comparison to healthy controls. Error bars = +/- 
standard deviation, * = statistically significant (p=.05)  
 
5.2.2. Anxiety sensitivity index (ASI) 
PoTS patients were found to be significantly more sensitive to anxiety than controls (see figure 
26). ‘It scares me when I feel faint’ was the one item of the ASI that all 3 clinical cohorts were 
found to score more highly on than healthy controls (PoTS p=.034), AMS (P=.022), EH (p=.047). 
PoTS and EH patients were more sensitive to;	
⇒ It scares me when I feel “shaky” (trembling): PoTS (p=.007), EH (p=.030) 
⇒ When I cannot keep my mind on a task, I worry that I might be going crazy: PoTS (p=.003), 
EH (p=.050) 
⇒ When I am nervous, I worry that I might be mentally ill: PoTS (p=.006), EH (p=.043) 
 
			*	
			*	
			*	
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Figure 26. Mean Anxiety Sensitivity Scores for scores for postural tachycardia syndrome (PoTS), essential 
hyperhidrosis (EH) and autonomic-mediated syncope (AMS) patients in comparison to healthy controls. Error bars = 
+/- standard deviation, * = statistically significant (p=.05) 
 
PoTS patients were more anxiety sensitive to the ASI items of ‘When I cannot keep my mind on 
a task, I worry that I might be going crazy’ (p=.050), ‘It scares me when I feel faint’ (p=.034), 
‘When I am nervous, I worry that I might be mentally ill’ (p=.008).  
 
5.2.3. Body vigilance scale (BVS) 
AMS patients reported being more sensitive to changes in their body (p=.043) and paid close 
attention to bodily sensations (p=.015). It is noteworthy that the cardiothoracic items of 
‘palpitations’ (p=.176) and ‘chest pain’ (p=.225) were not significantly higher in PoTS patients. 
However, this group was found to dedicate the most attention to specific BVS items and the 
EH cohort the least. AMS and EH patients were found to invest significantly more time scanning 
their bodies for symptoms (EH, p=.022, AMS, p=.045) and EH patients were found to be 
hypervigilant only in relation to thermoregulatory items (‘sweaty/clammy hands’ [EH, p=.000; 
PoTS, p=.014, AMS, p=.021) and ‘hot flash’ [EH, p=.003; PoTS, p=.025) (see figure 27).  
 
Figure 27. Body Vigilance Scale mean item scores for postural tachycardia syndrome (PoTS), essential hyperhidrosis 
and autonomic-mediated syncope (AMS) patients in comparison to healthy controls. Error bars = +/- standard 
deviation, * = statistically significant (p=.05) 
 
			*	
			*	
			*	
			*	
			*	
			*	
			*	
			*	
			*	
			*	
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5.2.4. Cardiac anxiety scale (CAS) 
Predictably, PoTS patients had greater mean and specific cardiac-related anxiety compared 
to controls and EH and AMS patients (see figure 28). The PoTS group also claimed to have 
greater interoceptive sensibility, such as ‘My racing heart wakes me up at night’ (PoTS, p=000) 
and ‘I can feel my heart in my chest’ (PoTS, p=.001). PoTS patients also reported that they had 
significant (PoTS, p=.007) impairment in concentration. The CAS items that were increased in 
the EH group related to avoiding increased physical exertion and/sudomotor activation (‘I 
avoid activities that make me sweat’ [EH, p=.000], ‘I avoid physical exertion’ [EH, p=.002, PoTS, 
p=.001]. There were no significant global or individual findings in the AMS group.  
 
Figure 28. Cardiac Anxiety Scale (CAS) mean scores for postural tachycardia syndrome (PoTS), essential 
hyperhidrosis and autonomic-mediated syncope (AMS) patients in comparison to healthy controls. Error bars = +/- 
standard deviation, * = statistically significant (p=.05) 
 
5.2.5. State anxiety inventory (SAI)  
PoTS patients had significantly greater (p=.020) overall state anxiety (see figure 29). In terms of 
individual items on the SAI, the only other significant finding was that of PoTS patients feeling 
more confused than healthy controls (p=.027).  
			*	
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Figure 29. Mean state anxiety scores for postural tachycardia syndrome (PoTS), essential hyperhidrosis and 
autonomic-mediated syncope (AMS) patients in comparison to healthy controls. Error bars = +/- standard deviation, 
* = statistically significant (p=.05) 
 
 
5.2.6. The Self-consciousness Scale (SCS-R) (revised) 
There were no significant differences in overall SCS-R scoring (see figure 22). AMS patients did 
not differ from healthy controls on any of the individual SCS-R items, however, PoTS and EH 
patients were found to be more sensitive to noticing changes in their mood (PoTS, p=.021; EH, 
p=.013) and EH patients were also more concerned with how they presented themselves 
(p=.022).  
 
Figure 30. Mean Self-Consciousness Scale scores for postural tachycardia syndrome (PoTS), essential hyperhidrosis 
and autonomic-mediated syncope (AMS) patients in comparison to healthy controls. Error bars = +/- standard 
deviation, * = statistically significant (p=.05) 
 
			*	
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5.2.7. Childhood Traumatic Events Scale (CTES) 
There were no significant group differences in either childhood or adult physical, sexual or 
emotional trauma between AMS (p=.232), PoTS (p=.685) and EH (p=.413) patients in 
comparison to controls (see figure 31). Nor were there any significant differences in the 
subjective severity of how traumatic any childhood (AMS, p=.0.83; PoTS, p=.0.525; EH, p=.0.55) 
or adult events (AMS, p=.0.70; PoTS, p=.0.74; EH, p=.0.79) were felt to be by the participants.  
 
Figure 31. Mean Childhood Traumatic Event Scale scores for postural tachycardia syndrome (PoTS), essential 
hyperhidrosis and autonomic-mediated syncope (AMS) patients in comparison to healthy controls.	Error bars = +/- 
standard deviation, * = statistically significant (p=.05) 
 
5.3. Central & visceral symptom associations 
In order to better understand the prevalence and presentation of comorbid psychological 
symptoms in the three autonomic cohorts, correlation analysis was applied to both individual 
questionnaire items and also questionnaire mean scores. This analysis lead to the correlations 
between cognitive-affective, visceral and dysautonomic symptoms, establishing the following 
symptom categories of;  
⇒ affective-attentional sensitivity and derealisation,  
⇒ affective-attentional sensitivity,  
⇒ somatic anxiety sensitivity,  
⇒ somatic hypervigilance and attentional deficits 
⇒ somatic sensitivity and derealisation.  
   
The strongest correlations amongst PoTS patients were those relating to somatic anxiety 
sensitivity (x12), followed by somatic hypervigilance and attentional deficits (x7) and finally 
affective-attentional sensitivity and derealisation (x2) (see table 6). 
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POTS CENTRAL & VISCERAL SYMPTOM ASSOCIATIONS 
SOMATIC 
ANXIETY 
SENSITIVITY 
Total anxiety sensitivity score Total cardiac anxiety score (rs = 778, 
p=.000**) 
When I notice that my heart is beating 
rapidly, I worry that I might have had a 
heart attack 
I get frightened (rs = 778, p=.000**) 
Total anxiety sensitivity score I pay attention to my heart beat  
(rs = 751, p=.000**) 
It scares me when I feel “shaky”  
(trembling) 
Total cardiac anxiety score (rs = 725, 
p=.000**) 
I am very sensitive to changes in my 
internal bodily sensations.  
Total cardiac anxiety score (rs = 722, 
p=.000**) 
I am very sensitive to changes in my 
internal bodily sensations. 
I avoid activates that make my heart beat 
faster (rs = 710, p=.000**) 
I am the kind of person who pays close 
attention to internal bodily sensations. 
Total cardiac anxiety score (rs = 710, 
p=.000**) 
I am worried Time spent each day “scanning” your 
body for sensations (rs = 673, p=.000**) 
Unusual body sensations scare me I get frightened (rs = 664, p=.000**) 
It scares me when I feel “shaky” (trembling) I get frightened (rs = 664, p=.000**) 
Time spent each day “scanning” your body 
for sensations 
I pay attention to my heart beat (rs = 634, 
p=.000**) 
I am very sensitive to changes in my 
internal bodily sensations. 
I pay attention to my heart beat (rs = 621, 
p=.000**) 
I am worried Time spent each day “scanning” your 
body for sensations (rs = 619, p=.000**) 
SOMATIC 
HYPERVIGILANCE & 
ATTENTIONAL 
DEFICITS 
It scares me when I am unable to keep my 
mind on a task 
I avoid activities that make me sweat (rs = 
710, p=.000**) 
I am very sensitive to changes in my 
internal bodily sensations.  
I have difficulty concentrating on anything 
else (rs = 683, p=.000**) 
When I cannot keep my mind on a task, I 
worry that I might be going crazy 
I avoid physical exertion (rs = 663, 
p=.000**) 
I am the kind of person who pays close 
attention to internal bodily sensations. 
I have difficulty concentrating on anything 
else (rs = 643, p=.000**) 
It scares me when I feel faint Concentration Difficulty (rs = 607, p=.000**) 
AFFECTIVE-ATTENTIONAL 
SENSITIVITY & 
DEREALISATION 
I am jittery Feelings of unreality (rs = 636, p=.000**) 
I am jittery Feeling detached from self (rs = 635, p=.000**) 
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Table 6. Associations between central and visceral symptoms in postural tachycardia (PoTS) patients 
	
EH subjects’ most common categories, in order of prevalence were affective-attentional 
sensitivity and derealisation (x8), somatic anxiety sensitivity (x7), somatic hypervigilance and 
attentional deficits (x3) and affective-attentional sensitivity (x2) (see table 7).  
 
EH CENTRAL & VISCERAL SYMPTOM ASSOCIATIONS 
AFFECTIVE-
ATTENTIONAL 
SENSITIVITY & 
DEREALISATION 
When I am nervous, I worry that I might be 
mentally ill 
Feeling detached from self (rs = 803, p=.000**) 
When I am nervous, I worry that I might be 
mentally ill 
Feelings of unreality (rs = 741, p=.000**) 
When I cannot keep my mind on a task, I 
worry that I might be going crazy 
Feeling detached from self (rs = 718, p=.000**) 
Total depression score Feelings of unreality (rs = 707, p=.000**) 
Total depression score Feeling detached from self (rs = 679, p=.001**) 
Total Anxiety Sensitivity score Feeling detached from self (rs = 666, p=.004**) 
Concentration Difficulty Feeling detached from self (rs = 660, p=.002**) 
Concentration Difficulty Feelings of unreality (rs = 654, p=.002) 
SOMATIC 
ANXIETY 
SENSITIVITY 
It scares me when my heart beats rapidly Total cardiac anxiety score (rs = 740, 
p=.006**) 
Total anxiety sensitivity score I avoid activities that make my heart beat 
faster (rs = 727, p=.001**) 
When I notice that my heart is beating 
rapidly, I worry that I might have had a 
heart attack 
Changes in Sleeping Pattern (rs = 727, 
p=.001**) 
It scares me when my heart beats rapidly I can feel my heart in my chest (rs = 701, 
p=.004**) 
I can feel my heart in my chest Total body vigilance Score (rs = 665, p=.004**) 
I feel at ease I am very sensitive to changes in my internal 
bodily sensations (-.650, p=.003**) 
Total cardiac anxiety score Total body vigilance score (rs = 647, p=.003**) 
SOMATIC 
HYPERVIGILANCE & 
ATTENTIONAL DEFICITS 
It scares me when I feel faint.  I have difficulty concentrating on anything 
else (rs = 693, p=.002**) 
Total anxiety sensitivity score Concentration Difficulty (rs = 686, p=.002**) 
I have difficulty concentrating on anything 
else 
Total body vigilance score (rs = 646, p=.004**) 
AFFECTIVE-ATTENTIONAL 
SENSITIVITY 
It scares me when I am unable to keep my 
mind on a task,, I worry that I might be 
going crazy 
Concentration Difficulty (rs = 704, p=.005**) 
When I am nervous, I worry that I might be 
mentally ill 
Concentration Difficulty (rs = 672, p=.003**) 
Table 7. Associations between central and visceral symptoms in essential hyperhidrosis (EH) patients 
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The strongest symptom associations amongst AMS patients were somatic anxiety, affective-
attentional sensitivity and derealisation, somatic sensitivity and derealisation and somatic 
hypervigilance and attentional deficits (see table 8). 
 
AMS CENTRAL & VISCERAL SYMPTOM ASSOCIATIONS 
SOMATIC 
ANXIETY 
SENSITIVITY 
Unusual body sensations scare me I get frightened (rs = 839, p=.000**) 
Total anxiety sensitivity score I get frightened (rs = 838, p=.000**) 
Unusual body sensations scare me I like to be checked out by a doctor (rs = 803, p=.000**) 
When I notice that my heart is beating 
rapidly, I worry that I might have had a heart 
attack 
I get frightened  
(rs = 739, p=.000**) 
Total cardiac anxiety score Time spent each day “scanning” your body for sensations (rs = 739, p=.000**) 
It scares me when I feel “shaky”  
(trembling)  
I get frightened (rs = 734, p=.000**) 
I get frightened Total body vigilance score(rs = 699, p=.001**) 
Unusual body sensations scare me 
Total cardiac anxiety score  
(rs = 695, p=.002**) 
AFFECTIVE-
ATTENTIONAL 
SENSITIVITY & 
DEREALISATION 
I feel highly strung Feeling detached from self (rs = 841, p=.000**) 
I feel highly strung Feelings of unreality (rs = 839, p=.000**) 
It scares me when I feel “shaky” 
(trembling) 
Feelings of unreality (rs = 672, p=.002**) 
Total anxiety sensitivity score Feelings of unreality (rs = 667, p=.002**) 
Concentration Difficulty Feeling detached from self (rs = 663, p=.003**) 
I am jittery Feelings of unreality (rs = 662, p=.003**) 
I get frightened Feelings of unreality (rs = 635, p=.004) 
SOMATIC 
SENSITIVITY & 
DEREALISATION 
Unusual body sensations scare me Feelings of unreality (rs = 690, p=.001**) 
Unusual body sensations scare me Feeling detached from self (rs = 652, p=.002**) 
It scares me when I feel faint Feelings of unreality (rs = 651, p=.003**) 
It scares me when my heart beats rapidly 
Feelings of unreality  
(rs = 641, p=.003**) 
SOMATIC 
HYPERVIGILANCE & 
ATTENTIONAL DEFICITS 
I have difficulty concentrating on anything 
else 
Time spent each day “scanning” your 
body for sensations (rs = 637, p=.003**) 
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Table 8.	Associations between central and visceral symptoms in autonomic mediated syncope (AMS) patients	
 
5.4. Discussion 
The aim of this study was to examine the genesis of the co-morbid psychological symptoms in 
AMS, EH and PoTS patients. A battery of validated questionnaires was used to survey patients 
in comparison to healthy controls. These questionnaires were broadly divided into measures 
looking at psychological items only and those looking at psychological factors in relation to 
somatic and dysautonomia factors. 
 
5.4.1. Depressive Symptoms 
PoTS and EH patients were significantly more depressed than controls, however, all three 
clinical cohorts reported greater cognitive depressive symptoms of indecisiveness and 
concentration difficulty than controls.  
 
There is a lack of literature on cognitive symptoms in patients with AMS and EH, however, a 
small number of studies have investigated the cause of ‘brain fog’ in PoTS by examining 
cerebral perfusion, flow velocity, fatigue and noradrenergic coupling, yet the cause of this ill-
defined symptom cluster remains unknown (Ross et al., 2013). Cognitive function is also 
impaired in fixed dysautonomia, especially during orthostasis, despite no clinical evidence of 
neurological deficits (Heims et al., 2006a) (Guaraldi et al., 2014) and it remains unclear whether 
this is due to common pathological processes effecting cognitive or autonomic 
neuroanatomy from cerebral hypoperfusion or an as yet unknown cause. It may be of 
relevance that a recent study has concluded that memory formation is poorer at systole in 
comparison to diastole (Garfinkel et al., 2014) in healthy controls, therefore, the dysfunctional 
baroreflex in AMS and PoTS may contribute to cognitive symptoms when OI patients are 
symptomatic.  
 
However, the current data also reports cognitive symptoms in EH patients, who have no OI 
and no pathological changes in cerebral perfusion, suggesting that these comorbid cognitive 
symptoms may be centrally mediated due to the differing peripheral cardiovascular (AMS, 
PoTS) and sudomotor (EH) pathophysiological profiles in the study patient groups. As with the 
functional syncope patients in chapter 4, Friston’s ‘free energy principle’  (Friston, 2010) may 
help explain these symptoms as a manifestation of EH or OI producing noisy interoceptive 
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prediction errors and the brain having to alter how it attends to incoming afferent signals 
(Mesulam, 1998) (see also chapter 6).   
 
EH remains a neglected area of study, particularly in terms of pathophysiological 
investigations, so the finding that these patients also report cognitive symptoms lacks a 
comprehensive backdrop of literature to draw on. Hyperhidrotics also reported changes in 
sleep pattern, which is of interest as sleep is integrated with thermoregulation (Collins, 2013). 
Sleep disruption has not previously been reported in EH or AMS but poor quality sleep, daytime 
sleepiness and fatigue have been reported in PoTS (Bagai et al., 2011). In the current findings, 
PoTS patients also reported significant fatigue, lack of energy and reduced appetite, which 
corresponds with previous findings that working memory, accuracy and information 
processing are impaired during orthostasis in PoTS (Ocon, 2013).   
 
5.4.2. Anxiety sensitivity 
PoTS patients were found to have significantly greater global anxiety sensitivity. Anxiety 
sensitivity to feeling faint was the only ASI item of that all 3 clinical cohorts were found to score 
significantly higher on than controls. As with cognitive depressive traits, PoTS and EH patients 
reported symptoms relating to being unable to concentrate, further emphasising the likelihood 
of a common central dysregulation in intermittent dysautonomia. Ocon and colleagues have 
found that cerebral autoregulation is impaired during orthostasis in VVS (Ocon et al., 2009a) 
and PoTS (Stewart et al., 2012, Ocon, 2013). Diminished cerebral and sub-cortical blood flow 
impairs brain perfusion, likely contributing to the cognitive deficits subjectively experienced as 
brain fog or mental fatigue in OI, (Stewart et al., 2012), however, this does not explain the 
reporting of cognitive deficits by EH subjects who experience no fluctuations in cerebral 
autoregulation. These findings require further investigation into the previously unreported 
cognitive symptoms in EH and whether this can elucidate a common pathway shared with 
the attentional symptoms in PoTS and AMS beyond the previously reported neurovascular 
investigations in OI subjects, which may only partly account for these common comorbid 
symptoms.  
 
5.4.3. Somatic Hypervigilance 
AMS patients were significantly more sensitive to physiological changes in their body, perhaps 
because pre-syncopal symptoms are somatic markers of an impending and potentially 
injurious syncopal episode. This may also explain AMS patients paying more attention to such 
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bodily changes, in order that they know when to adopt contingent behaviour to prevent a 
faint. The PoTS group were the most preoccupied with specific physiological phenomena, such 
as numbness, tingling, faintness, dizziness, hot flash and sweaty clammy hands, though 
interestingly, not palpitations or chest pain, suggestive of diminished interoception. The pre-
syncope and neuropathic symptoms the PoTS group were found to be hypervigilant of may 
be reflective of broader pathophysiological factors in neuropathic and hyperadrenergic PoTS 
phenotypes. The finding that PoTS patients did not report hypervigilance of palpations and 
chest pain, though initially counterintuitive, does support the findings of a recent study 
investigating cardiac interoception in PoTS, which found that the interoception of palpations 
was separate to that of tachycardia (Khurana, 2014). However, in the current data, 
palpitations were not self-reported as being prevalent, though it could be argued that this may 
be due to the questionnaires being completed in a state of rest.  
 
Predictably, EH patients paid significantly more attention to the hyperhidrosis-related BVS items 
of ‘hot flash’ and ‘sweaty clammy hands’. Likewise, the only noteworthy symptoms that 
significantly preoccupied AMS patients were ‘dizziness’ and ‘faintness’. No subjects reported 
any significant dissociative symptoms from the BVS, therefore we can deduce that the 
cognitive symptoms reported above were not the result of dissociative fugue or dissociative-
memory impairment.  
 
5.4.4. ‘Cardiophobia’ 
Understandably, PoTS had elevated levels of ‘cardiophobia’, scoring highly on items related 
to both avoiding physical exertion and the interoception of cardiac symptoms, such as being 
awoken by increased heart rate or checking their pulse. As with the depression and anxiety 
sensitivity questionnaires, PoTS patients also reported difficulty in concentrating, though it is of 
note that neither EH nor AMS subjects scored highly for the cognitive item on this questionnaire. 
In this instance, EH participants acted as a clinical control group but did score highly in relation 
to avoiding physical exertion and exercise, presumably as a way of minimizing their excessive 
sudomotor activity.  
 
Although PoTS patients scored highly on items related to subjective interoception, such as ‘My 
racing heart wakes me up at night’ and ‘I can feel my heart in my chest’ the lack of reported 
cardiothoracic symptoms in the BVS as well as in PoTS patients who also experienced 
functional syncope in chapter 4, lead one to question the accuracy of this interoception. This 
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view is supported by the use of interoceptive exercises in chapters 7 and 6, indicating 
subjective sensitisation rather than interoceptive accuracy in PoTS, AMS and EH. 
 
5.4.5. State anxiety 
State anxiety proved to be the least prevalent trait in the surveyed AMS and EH patients. PoTS 
patients again proved to be the most symptomatic, scoring greater mean state anxiety scores 
than controls. In line with the prevailing cognitive symptoms experienced by PoTS patients, this 
cohort also reported a significantly increased prevalence of feeling confused, further 
underlining the role of cognitive as well as emotional symptoms in the PoTS psychiatric profile, 
more so than in EH and AMS participants.   
 
5.4.6. Self-consciousness 
PoTS and EH patients were found to be more sensitive to noticing changes in their mood and 
EH patients were also more concerned with how they presented themselves, most likely due 
to the social stigma that is applied to inappropriately and profusely sweating. However, other 
items and global self-consciousness scales did not differ significantly between groups, 
indicating normative levels of social anxiety in the selected control and clinical populations. 
This leads to the conclusion that the psychological symptoms experienced by AMS, EH and 
PoTS patients are not due to neurotic traits but rather derived from the physiological and 
homeostatic dysregulation caused by their intermittent autonomic disorder, as evidenced by 
anxiety being firmly aligned with somatic events, visceral sensations, attentional deficits and 
the vigilance and anxious apprehension of these phenomena.    
 
5.4.7. Trauma 
There were no significant between groups differences in the incidence of subjective severity 
of adult or childhood trauma, indicating that the autonomic dysregulation in the EH, AMS and 
PoTS cohorts was not related to trauma but symptomatic of an organic clinical condition, as 
per their diagnoses.  
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5.4.8. Central & visceral symptom associations 
Somatic anxiety sensitivity was particularly common in both OI groups. As already stated, there 
is some literature on the ill-defined ‘brain fog’ in PoTS but the current data indicates that these 
cognitive symptoms may also be common not just in other forms of OI, such as AMS, but also 
in EH, indicating that these symptoms may relate to the central integration of (aberrant) 
afferent autonomic signalling. This anxiety sensitivity to cognitive and autonomic aberrations 
that are defining symptoms of OI may also elucidate the prevalence of functional symptoms 
in PoTS and AMS patients during autonomic testing in see chapter 4 of this thesis.  
 
Although not an initially pervasive symptom, derealisation (one’s surroundings feel unreal) was 
found to be highly positively correlated with affective-attentional sensitivity, particularly in the 
EH and AMS groups. Derealisation is typically a transient symptom (Medford, 2014) unless 
associated with the symptom cluster of hypoemotionality and feelings of disembodiment that 
define depersonalisation disorder (DPD) (Sierra et al., 2005, Baker et al., 2003). DPD is a 
defensive, emotionally-disengaging response that is subconsciously implemented to 
accommodate threat deemed as beyond ones’ control (Lee et al., 2012), sharing some 
parallels with the vasovagal response.  
 
DPD symptoms overlap with corticolimbic disconnections (Mayer-Gross, 1935), supporting the 
hypothesis that emotional formation has become out-of-step with the neural processes 
required for emotion formation in depersonalised subjects. Inverse correlations between skin 
conductance responses and dorsal prefrontal cortex responses (Lemche et al., 2008, Lemche 
et al., 2007) indicate a central correlate for the autonomic dysregulation during emotional 
stress in DPD (Owens et al., 2015). It could be argued that the present autonomic patient data 
represents a comparable but less severe dysregulation of brain-body integration, manifesting 
in the association between sub-clinical derealisation and sensitisation/hypervigilance of 
anxiety, depression and attentional deficits in EH, AMS and PoTS. Moreover, it is noteworthy 
that derealisation was predominantly associated with sensitivity to anxiety, depression and 
attentional deficits rather than visceral symptoms, as DPD patients often report the additional 
anxiety caused by the awareness (sensitivity) of their affective and cognitive (particularly 
memory) DPD symptoms. Taken together with the functional syncope data in chapter 4, 
sensitivity to visceral symptoms appears to be associated with functional symptoms, whereas 
sensitivity to central symptoms is associated with derealisation, as there is no evasive behaviour 
other than dissociation or distraction (perhaps contributing to attentional deficits) that will 
alleviate the distress caused by the sensitivity and awareness of these affective and attentional 
symptoms.   
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The strongest correlations amongst all intermittent dysautonomia patient groups related to 
anxiety sensitivity to visceral sympathetic arousal and attentional deficits, lending further 
support to the conclusion that the common comorbid cognitive-affective symptoms in EH, 
AMS and PoTS are not trait-like neurotic symptoms but consequential rather than causative of 
intermittent dysautonomia.  
 
5.4.9. Summary of key findings 
This study was designed to profile comorbid cognitive-affective symptoms in disorders 
of autonomic over-reactivity, concluding that; 
Ø Cognitive-affective symptoms in EH, PoTS and AMS appear to be more aligned with 
vigilance and apprehension of physical symptoms rather than be neurotic or trauma-
related phenomena.  
Ø Cognitive symptoms are also present in AMS and EH, not only PoTS. 
5.4.10. Conclusion 
Trauma was not a likely mediator of the pervasive cognitive-affective symptoms reported by 
intermittent dysautonomia patients. PoTS patients in particular have pronounced anxiety, 
attentional difficulties and fixation on somatic symptom-related phenomena. Somatic and 
cognitive symptoms predominated as the source of distress in all patients groups, rather than 
anxiety being a neurotic trait-like phenomena, e.g., self-consciousness or social anxiety. 
Cognitive symptoms were also present in EH, demonstrating that these higher order symptoms 
may relate to the central integration of (aberrant) afferent autonomic signalling. Derealisation 
was positively correlated with affective-attentional sensitivity, particularly in the EH and AMS 
groups, further indicating a central dysregulation of brain-body integration. This may help 
explain why visceral symptoms appear to be associated with functional symptoms, whereas 
sensitivity to cognitive-affective symptoms is associated with dissociation. Together, these data 
indicate how brain and body are coupled by the ANS, how this link can be decoupled by 
intermittent dysautonomia and that the prevalent psychological symptoms in these conditions 
are consequential rather than causative of intermittent dysautonomia.  
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Chapter 6. Brain-body integration in 
disorders of intermittent cardiovascular & 
sudomotor overactivity 
6. Introduction 
Afferent signalling of visceral nerve activity, known as ‘interoception’, is required for autonomic 
mediation of homeostasis and contributes to emotion and behaviour at varying levels of 
consciousness (see figure 32) (Critchley et al., 2004), from baroreceptors modulating cardiac 
responses to fluctuations in BP to maintain cerebral perfusion, to discarding an item of clothing 
as an act of behavioural thermoregulation. 
 
Figure 32. Varying levels of interoception. 
 
Interoceptor (arterial baroreceptors) activity influences cognitive-affective processes on a 
preconscious level (Garfinkel et al., 2014) and sensory signals also influence endocrine 
function, e.g., the sight or smell of food causes insulin release (Teff, 2011). Empathy is an 
emotion influenced by interoception (Grynberg and Pollatos, 2015), as autonomic arousal to 
emotional stimulation predicts empathy levels (Bogdanov et al., 2013). Interoception and 
empathy allow us to build cognitive interpersonal models and predict outcomes of our own 
and others’ behaviour. It has been proposed that predictions of experienced versus expected 
interoceptive error signals of bodily events can be a ‘bottom up’ source of anxiety (Paulus and 
Stein, 2006). Therefore, if one were to feel dizzy, tachycardic or too hot or sweaty whilst being 
aware that the situation did not require these aberrant allostatic adaptions, the interoceptive 
processing of these error signals would create anxiety at the discordant bodily states, as 
Homeostatic regulatory interoceptor processes, e.g., 
baroreceptor, chemoceptor function
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defined by aberrant autonomic activity. However, the amount of anxiety caused by any 
discrepancies would depend on how interoceptively sensitive one is.  
 
Heart rate variability (HRV) has been used as a surrogate marker of central sympathetic and 
parasympathetic dominance on visceral autonomic processes (Task Force, 1996). It has been 
proposed that the reduced vagal tone, as measured by high frequency HRV (HF-HRV), in 
affective disorders serves to disinhibit sympathoexcitation, causing sympathetic dominance of 
somatic and psychological processes. Increased cardiac reactivity, attentional threat bias 
(Mathews, 1990) and somatic hypervigilance (Verkuil et al., 2007) in anxious patients has been 
taken as further support of a persistent state of increased autonomic and psychological 
arousal in anxiety and depression. This psychophysiological coupling via the ANS of body and 
brain causes an excitatory feedback loop that perpetuates trait sympathoexcitation and 
anxiogenesis, hence interoception’s contributory role to anxiety disorders (Dunn et al., 2010) 
via somatic hypervigilance (Clark, 1986). 
 
These findings lead one to consider what happens to cognitive-affective processes in 
conditions of exaggerated autonomic responsivity (Eccles et al., 2015), particularly if these 
autonomic conditions have a prevalence of comorbid affective morbidity, such is the case in 
PoTS (Raj et al., 2009), AMS (Cohen et al., 2000b) and EH (Karaca et al., 2007). With the relatively 
recent interest in conscious interoception, important methodological issues have developed 
with its measurement, interpretation and inconsistent and interchangeable use of terms such 
as, ‘interoceptive accuracy’, ‘interoceptive awareness’, ‘interoceptive sensitivity’ or simply 
‘interoception’. To address these issues, Garfinkel and colleagues (Garfinkel and Critchley, 
2013, Garfinkel et al., 2015) recently stratified ‘interoceptive awareness’ as a metacognitive 
measure of the degree to which objective interoceptive accuracy (as measured by a 
heartbeat tracking tasks, for example) relates to subjective sensibility in one’s performance in 
the interoceptive task, i.e., if someone has good interoceptive awareness, the level of their 
interoceptive accuracy (IA) will match their sensibility in their accuracy. Therefore, to 
investigate the potential influences of clinical disorders of intermittent cardiovascular (PoTS, 
AMS) and sudomotor (EH) autonomic overactivity on brain-body integration processes, such 
as interoception, specific aim # 3 of this thesis will; 
I. assess somatic hypervigilance (anxiety attributable to fear and worry of bodily symptoms 
that are common in EH, AMS and PoTS) in AMS, EH and PoTS in comparison to controls. 
II. assess empathy (an emotion influenced by interoception (Grynberg and Pollatos, 2015) 
that predicts autonomic arousal during emotional stimulation (Bogdanov et al., 2013) in 
AMS, EH and PoTS in comparison to controls to examine the potential influence of ‘bottom-
up’ somatic perturbation on higher order affect. 
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III. define the subjective measure of interoceptive sensibility, objective measure of 
interoceptive accuracy and metacognitive measure of interoceptive awareness in AMS, 
EH and PoTS in comparison to healthy controls.   
IV. assess HRV to examine autonomic variability and how this relates to brain-body integration 
in AMS, EH and PoTS in comparison to healthy controls from the perspective of 
‘neurovisceral phenotypes’, which emphasises the importance of autonomic variability in 
emotion regulation.  
 
These areas will be sequentially and systematically examined to attempt to construct a 
framework of neurovisceral architecture and how this may inform emotion and behaviour 
through homeostatic drives, in an attempt to elucidate the comorbid psychological symptoms 
that commonly present in EH, AMS and PoTS.  
 
6.1. Methods 
6.1.1. Participants 
All experimental procedures were ethically approved by University College London 
Healthcare Trust Research and Design Office. The study was conducted in compliance with 
the Helsinki declaration (Bahit et al., 2013). 23 x healthy controls (13 females, mean age 35 + 
7.56 years) and 21 x PoTS patients (19 female, mean age 36 + 10.84 years), 17 x EH patients (5 
female, mean age 46 + 13.26) and 16 x AMS patients (13 female, mean age 37 + 13.00) were 
tested. Autonomic diagnoses were received from the Autonomic Unit, National Hospital for 
Neurology and Neurosurgery (University College London Hospitals) or the Autonomic and 
Neurovascular Medicine Unit, St Mary’s Hospital (Imperial College Healthcare Trust). Written 
informed consent was provided by all participants prior to participation. Autonomic testing 
was carried at the Autonomic Unit, National Hospital for Neurology and Neurosurgery or 
Autonomic and Neurovascular Medicine Unit, St Mary’s Hospital, national referral centres for 
cardiovascular and sudomotor dysautonomia. 
 
6.1.2. Self-report measures 
To record the prevalence of empathy and somatic hypervigilance, the following 
questionnaires were completed by the participants prior to testing. Mehrabian’s Balanced 
Emotional Empathy Scale (BEES) records the subject's vicarious experience of another's 
emotional experiences. (Mehrabian, 1996).  
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The Body vigilance scale (BVS) examines the tendency to selectively attend to physiological 
changes in one’s body (Schmidt et al., 1997). 
 
6.1.3. Interoception protocol 
Ambient temperature of the treatment room was maintained at 21°c throughout testing for all 
participants and hear rate (HR) and heart rate variability (HRV) were recorded using the 
PowerLab 16/30/ECG (Bioamp) (AD Instruments, Oxford, United Kingdom) and analysed using 
the Labchart 7 software package for the three experiments. Blood pressure (BP) was 
continually recorded using Finometer (Smart Medical, Gloucestershire, United Kingdom) and 
intermittent BP and HR measures were taken using Dinamap Pro400V2 (GE Healthcare, 
Buckinghamshire, United Kingdom).  
 
6.1.3.1. Supine baseline interoception phase 
Participants lay in the supine position for 10 mins to establish a baseline recording of systolic 
blood pressure (SBP), diastolic blood pressure (DBP), heart rate variability (HRV) and heart rate 
(HR) before carrying out the heartbeat tracking task (Schandry, 1981) during the 3rd, 6th and 
9th minutes of supine baseline, the participant was asked to carry out a heartbeat tracking task 
involving the individual being asked to silently count each individual heartbeat from when the 
experimenter said “start” to when he said “stop”. Participants were instructed to manually take 
or touch their pulse and to declare that they couldn’t feel their pulse pressing against any 
clothing or apparatus. This task was repeated two more time. Randomised epochs of the 
supine baseline mental tracking task were 25, 35 or 45 seconds. The choice of epoch was 
taken from previous studies using the mental tracking task that have identified the optimum 
task windows (Dunn et al., 2010, Pollatos et al., 2009). Immediately after each heartbeat 
tracking task once the number of counted heartbeats had been relayed to the researcher, 
the subject was asked to rate their confidence in the accuracy of their heartbeat counting on 
an analogue scale of 1 (‘not confident at all/guessing’) to 10 (‘extremely confident/counted 
every beat’). This provided a rating of interoceptive sensibility.  
 
6.1.3.2. Supine pressor interoception phase  
Pressor exercises were carried out in the supine position, so that orthostatic demand does not 
confound the pressor responses. Pressor maneuverers are reliable and robust clinical 
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assessment of vasomotor integrity (RK Khurana, 1996, Mathias et al., 2013, Mathias, 2003). 
During isometric handgrip exercise (HG), the participants were requested to sustain a handgrip 
at 1/3 of maximum voluntary contraction pressure for 3 mins using a gauge directly in front of 
them. At 30, 88 and 144 seconds the participants performed the heartbeat tracking task. 
Randomised epochs of the HG mental tracking task were 21, 26, 36 seconds. After each task 
was performed, the subject was also required to give a confidence rating between 1 (‘not 
confident at all/guessing’) to 10 (‘extremely confident/counted every beat’) to provide a 
measure of interoceptive sensibility. 
 
After the isometric exercise had been completed, a second baseline of a minimum of 3 mins 
elapsed allowing autonomic activity to return to baseline levels before the cutaneous cold 
pressor (CP) exercise was carried out. The subjects’ right hand was placed in an icepack 
chilled to 4°C for a minimum of 90 seconds, tolerance permitting. At 3 seconds, 40 seconds 
and 54 seconds the participants performed the heartbeat tracking task. Interoceptive 
sensibility measures were taken for each task. 
 
6.1.3.3. Head up tilt interoception phase 
Cardiovascular autonomic activity was then allowed to return to baseline levels (minimum of 
3 mins) before 10 mins 60° head-up tilt (HUT). In healthy subjects, the initial BP fall induced by 
HUT should recover within 60 seconds because when decreased venous return to the heart 
causes reduced stroke volume and cardiac output, arterial baroreceptors and 
cardiopulmonary mechanoreceptors then signal autonomic brain centres to increases SNA, 
raising HR and causing vasoconstriction of the blood vessels in various vascular beds to 
compensate for postural and gravitational demands  At 3 minutes, 6 minutes and 9 minutes 
the participants performed the heartbeat tracking task. Randomised epochs of the heartbeat 
mental tracking task were 25, 35, 45 seconds. Interoceptive sensibility measures were taken for 
each task. 
 
Interoceptive performance was analysed post-hoc by examining task and global 
interoceptive accuracy, interoceptive sensibility and interoceptive awareness. Interoceptive 
accuracy scores were yielded by counting the R waves in the event-marked ECG traces and 
averaging the following equation over the 3 tracking tasks of each stage of the protocol 
(supine baseline, HG, CP, HUT) and for global scores for the entirety of the experiment: 1 − 
(|nbeatsreal− nbeatsreported|) / ((nbeatsreal+nbeatsreported)/2).  
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Measures of global interoceptive awareness were taken from the participants’ subjective 
appraisals (interoceptive sensitivity) of their heartbeat tracking task performance 
(interoceptive accuracy) during the experimental protocol. Interoceptive awareness scores 
were extracted by obtaining the r value of interoceptive accuracy and interoceptive 
sensibility.  
 
6.1.4. Heart rate variability (HRV) 
The high frequency (HF) band of heart rate variability (HRV) is a measure of vagal efferent 
activity and is comparable to RSA. Low frequency (LF) heart rate variability (HRV) was, until 
recently, believed to depict sympathetic cardiac influences (Malliani et al., 1991) however, LF 
power as a purely sympathetic measure has been called into question (Goldstein et al., 2011, 
Parati et al., 2006) as research has shown that endogenous fluctuations in LF power provide 
information about sympathetic regulation of BP, such as vasomotor tone and baroreceptor 
activity. Moreover, recent studies have positively correlated LF power and baroreceptor 
sensitivity (Goldstein et al., 2011, Moak et al., 2007) as well as reduced LF power and baroreflex-
cardiovagal failure (Rahman et al., 2011). Therefore, LF power may well provide information 
about sympathetic mechanisms but perhaps not cardiac sympathetic nerve activity 
specifically but rather of baroreflex function and dysfunction. HRV was assessed post hoc for 
the baseline, pressor and HUT sections of the current study. 
 
6.2. Results 
6.2.1. Body vigilance scale (BVS) 
The AMS patients reported being more sensitive to changes (p=.043) in their body and paid 
close attention to bodily sensations (p=.015). Interestingly, the cardiothoracic items of 
‘palpitations’ (p=.176) and ‘chest pain’ (p=.225) were not significantly higher in PoTS patients 
who were found to dedicate the most attention to specific BVS items, and the EH cohort the 
least. AMS and EH patients were found to invest significantly more time scanning their bodies 
for symptoms (EH, p=.022, AMS, p=.045) and EH patients were found to be significantly more 
hypervigilant only in relation to thermoregulatory items (‘sweaty/clammy hands’ [EH, p=.000; 
PoTS, p=.014, AMS, p=.021) and ‘hot flash’ [EH, p=.003; PoTS, p=.025) (see figure 33).  
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Figure 33. Body Vigilance Scale mean item scores for postural tachycardia syndrome (PoTS), essential hyperhidrosis 
and autonomic (neurally) mediated syncope (AMS) patients Vs healthy controls. Error bars = +/- standard deviation, 
* = statistically significant (p=.05) 
 
6.2.2. Empathy scores 
There were no differences in overall empathy scores between the control and clinical groups. 
However, relative to controls, PoTS patients scored higher on the following BEES items, ‘I can 
almost feel the pain of elderly people who are weak and must struggle to move about,’ 
(p=.009), ‘It really hurts me to watch someone who is suffering from a terminal illness.’ (p=.039), 
and ‘I would not watch an execution.’ (p=.025). PoTS patients scored lower on the following 
BEES items, ‘The unhappiness or distress of a stranger are (sic) not especially moving for me.’ 
(p=.034), ‘Helpless old people don't have much of an emotional effect on me.’ (p=.030) and 
‘I am rarely moved to tears while reading a book or watching a movie.’ (p=.048) (see figure 
3).  
 
AMS patients scored significantly higher on the BEES item, ‘It upsets me to see someone being 
mistreated.’ (p=.036) relative to controls. 
 
			*	
			*	
			*	
			*	
			*	
			*	
			*	
			*	 			*	
			*	
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Although the EH group produced the highest mean BEES score (EH: 16.3 + 14.1 (p=.283, 
Controls: 11.3 + 6.8, PoTS: 7.9 + 15.1 (p=.217, AMS: 9.2 + 15.4 (p=.894), they did not score 
significantly higher on any individual item (see figure 34).  
 
Figure 34. Balanced Emotional Empathy Scale mean global scores for postural tachycardia syndrome (PoTS), 
essential hyperhidrosis and autonomic-mediated syncope (AMS) patients Vs healthy controls. Error bars = +/- 
standard deviation, * = statistically significant (p=.05) 
 
 
6.2.3. Interoceptive measures 
6.2.3.1. Interoceptive accuracy (IA) 
OI and EH patients consistently underestimated their heartbeats during testing. PoTS patients 
interoceptive accuracy was poorer during isometric exercise (p=.024) and cold pressor 
(p=.025) in comparison to healthy controls (see figure 35). EH patients interoceptive accuracy 
was poorer during baseline (p=.009), isometric exercise (p=.002) and HUT (p=.001) relative to 
controls. AMS patients interoceptive accuracy was also poorer during baseline (p=.049), 
isometric exercise (p=.033) and HUT (p=.048).  
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Figure 35. Interoceptive accuracy during supine baseline, isometric exercise, cold pressor and head up 
tilt (HUT). PoTS = postural tachycardia syndrome; EH = essential hyperhidrosis, AMS = autonomic 
(neurally) mediated syncope. Error bars = +/- standard deviation, * = statistically significant (p=.05) 
	
6.2.3.2. Interoceptive sensibility 
There were no between group differences in interoceptive sensibility at any stage of the 
protocol (see table 9).  
Table 9. Group interoceptive sensibility scores at various stages of the protocol 
 Supine Baseline  Isometric Exercise  Cold Pressor  Head-up Tilt  
Controls 5.0 + 4.5 4.0 + 4.5 5.0 + 2.3 3.7 + 7.8 
Postural Tachycardia 
Syndrome 
5.2 + 1.8 5.2 + 1.8 4.5 + 2.1 5.1 + 1.7 
Essential Hyperhidrosis 3.8 + 2.4 3.6 + 2.1 4.1 + 2.4 4.2 + 1.9 
Autonomically Mediated 
Syncope 
4.2 + 2.1 3.9 + 1.9 3.7 + 1.7 3.9 + 2.3 
 
*	 *	
*	
*	 *	
*	 *	
*	
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6.2.3.3 Interoceptive awareness 
There were no between group differences in metacognitive interoceptive awareness (see 
table 10). 
Table 10. Group interoceptive awareness scores. 
Group Interoceptive 
Awareness 
Controls .29 + .37 
Postural Tachycardia Syndrome .22 + .53 
Essential Hyperhidrosis -.05 + .54 
Autonomically Mediated 
Syncope 
.22 + .42 
 
6.2.4. Emotion and interoception correlations 
6.2.4.1. Somatic vigilance & interoception 
In the healthy control group, baseline interoceptive accuracy was negatively correlated with 
the amount of time spent scanning their body for sensations (rs= -.466, n= 19, p=.044), the 
attention paid to the sensations of ‘tingling’ (rs= -.479, n= 19, p=.038), ‘numbness’ (rs= -.558, n= 
19, p=.013) and ‘faintness’ (rs= -.456, n= 19, p=.050), ‘choking’ (rs= -.460, n= 19, p=.048), ‘nausea’ 
(rs= -.620, n= 19, p=.005), ‘stomach upset’ (rs= -.503, n= 19, p=.028), sweaty and clammy hands’ 
(rs= -.506, n= 19, p=.027) and the total Body Vigilance Scale scores (rs= -.459, n= 19, p=.048) (see 
table 3). Isometric exercise interoceptive accuracy was negatively correlated with the amount 
of attention paid to ‘chest pain’ (rs= -.500, n= 19, p=.029) and HUT interoceptive accuracy was 
negatively correlated with the amount of attention paid to ‘tingling’ (rs= -.500, n= 19, p=.035), 
‘stomach upset’ (rs= -.498, n= 19, p=.035) and ‘faintness’ (rs= -.531, n= 19, p=.023). Both isometric 
and HUT interoceptive accuracy were negatively related to the amount of attention paid to 
’vision changes’ (isometric; rs= -.559, n= 19, p=.013; HUT: rs= -.490, n= 19, p=.039) and ‘dizziness’ 
(isometric; rs= -.489, n= 19, p=.034; HUT: rs= -.551, n= 19, p=.018) (see table 11).  
 
There was a positive relationship between cold pressor interoceptive accuracy and the 
amount of attention PoTS patients paid to ‘shortness of breath’ (rs= .616, n= 21, p=.003), 
‘dizziness’ (rs= .616, n= 21, p=.003), ‘choking’ (rs= .607, n= 21, p=.004) and total Body Vigilance 
Scale scores (rs= .453, n= 21, p=.039) (see table 11).  
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In AMS subject, the amount of time invested in scanning their bodies for symptoms was 
negatively correlated with supine baseline interoceptive accuracy and (rs= -.564, n= 16, 
p=.023) and cold pressor interoceptive accuracy (rs= -.642, n= 15, p=.010) (see table 11).  
 
6.2.4.2. Empathy & interoception  
In the control group, there was a significant negative relationship between baseline 
interoceptive accuracy and the BEES item ‘It is difficult for me to experience strongly the 
feelings of characters in a book or movie,’ (rs= -.582, n= 15, p=.044) (see table 11). 
 
In the PoTS cohort,  there were significant negative relationships between baseline 
interoceptive accuracy and ‘I cannot feel much sorrow for those who are responsible for their 
own misery’ (rs= -.526, n= 15, p=.044), ‘I don't get overly involved with friends' problems,’ (rs= -
.572, n= 15, p=.026), and ‘The unhappiness or distress of a stranger is not especially moving for 
me’, (rs= -.587, n= 15, p=.021). A significant positive relationship between ‘I am moved deeply 
when I observe strangers who are struggling to survive’ and baseline interoceptive accuracy 
(rs= .605, n= 15, p=.017) was also found (see table 11).  
 
EH cold pressor interoceptive accuracy and the BEES item ‘The unhappiness or distress of a 
stranger are not especially moving for me’ was negatively correlated (rs= -.747, n= 10, p=.013), 
whereas cold pressor interoceptive accuracy and ‘Another's happiness can be very uplifting 
for me’, were positively correlated (rs= .651, n= 10, p=.042) (see table 11).  
 
There were no correlations between BEES and interoceptive measures in the AMS group.  
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 Supine Baseline Interoceptive Accuracy 
Isometric Exercise 
Interoceptive 
Accuracy 
Cold Pressor Interoceptive Accuracy HUT Interoceptive Accuracy 
Controls 
-Time scanning 
- Numbness 
- Tingling 
- Faintness 
- Choking 
- Nausea 
- Stomach upset 
- Sweaty clammy hands 
- Total Body Vigilance Scale score 
- Chest pain 
- Vision changes 
- Dizziness 
 
- Tingling 
- Faintness 
- Stomach upset 
- Vision changes 
- Dizziness 
- It is difficult for me to experience strongly the feelings of 
characters in a book or movie    
PoTS 
- I cannot feel much sorrow for those who are responsible 
for their own misery 
+ I am moved deeply when I observe strangers who are 
struggling to survive 
- I don't get overly involved with friends' problems 
- The unhappiness or distress of a stranger is not especially 
moving for me. 
 
+ Choking 
+ Dizziness 
+ Shortness of breath. 
+ Total body vigilance scores 
 
EH   
+ Another's happiness can be very uplifting for me 
- The unhappiness or distress of a stranger is not 
especially moving for me. 
 
AMS -Time scanning  -Time scanning  
Table 11. Body vigilance and empathy correlations with interoceptive accuracy. PoTS = postural tachycardia syndrome; EH = essential hyperhidrosis, AMS = autonomic (neurally) mediated 
syncope. 
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6.3. Heart rate variability profiles 
During the interoception protocol, PoTS patients LF power (p=.045), indicating sympathetic (via 
baroreflex function) and vagal activity, and HF power (p=.030), indicating parasympathetic 
(vagal) nerve function, were significantly reduced during HUT (see table 12). EH patients LF 
power (p=.042) and HF power (p=.046) were also reduced during HUT. AMS patients produced 
a reduction in LF power (p=.013) only during HUT. 
  
Table 12. Heart rate variability profiles during testing. PoTS = postural tachycardia syndrome; EH = 
essential hyperhidrosis, AMS = autonomic (neurally) mediated syncope. Error bars = +/- standard 
deviation, * = statistically significant (p=.05) 
 Supine baseline Isometric exercise Cold pressor HUT 
Controls LF: 4274.74 + 5111.70 
HF: 2480.12 + 1935.96 
LF/HF: 1.69 + 0.81 
LF: 1550.03 + 1423.20 
HF: 1509.11 + 2205.23 
LF/HF: 4.08 + 11.07 
LF: 4164.89 + 7052.03 
HF: 2446.63 + 3766.44 
LF/HF: 2.29 + 1.89 
LF: 3049.96 + 2337.62 
HF: 1409.27 + 1186.36 
LF/HF: 3.07 + 2.63 
PoTS LF: 6982.36 + 10403.18 
HF: 4338.44 + 1935.96 
LF/HF: 1.90 + 1.16 
LF: 2792.79 + 6763.06 
HF: 1662.65 + 2963.18 
LF/HF: 1.61 +1.05 
LF: 6020.67 + 10678.52 
HF: 3855.06 + 6793.70 
LF/HF: 2.33 1.75 
LF: 1410.46 + 1211.28* 
HF: 887.93 + 3256.28* 
LF/HF: 4.19 + 3.75 
EH LF: 3109.65 3919.12 
HF: 1957.20 + 2158.35 
LF/HF: 1.70 1.15 
LF: 2981.8378 + 9073.36863 
HF: 1743.6891 + 3802.59247 
LF/HF: 2.39 + 1.84 
LF: 1757.55 + 2153.61 
HF: 3181.58 + 5658.50 
LF/HF: 2.42 + 2.49 
LF: 1778.78 + 2004.13* 
HF: 984.40 + 1433.92* 
LF/HF: 3.78 + 3.13 
 
AMS LF: 4688.10 + 7116.17 
HF: 3749.40 + 6775.03 
LF/HF: 1.72 + .91 
LF: 960.00 + 880.14 
HF: 1044.78 + 1276.50 
LF/HF: 2.38 + 2.52 
LF: 7167.07 + 13818.53 
HF: 4141.47 + 7754.45 
LF/HF: 2.68 + 2.53 
LF: 1554.77 + 1309.08* 
HF: 1599.70 +  2167.32 
LF/HF: 2.87 + 3.77 
 
6.3.1. Heart rate variability, interoception & emotion 
The heartbeat tracking task measures cardiac interoception yet, despite neuroimaging studies 
that have identified the neural correlates of conscious interoception (Critchley et al., 2004), 
the peripheral mechanism for conscious cardiac interoception remains less well-defined 
(Cameron, 2009). Therefore, the relationship between sympathetic and parasympathetic 
activity and balance and how these variables relate to subjective, objective and 
metacognitive interoceptive measures may clarify the visceral and psychological pathways 
of interoception its influence on homeostatic and high order functions, which, in turn, may 
improve understanding of the comorbid psychological symptoms in PoTS, EH and AMS.  
 
In the control group, baseline interoceptive sensibility was positively related to baseline LF 
power (rs= .816, n= 18, p=.000) and HF power (rs= .676, n= 18, p=.002). Isometric exercise
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interoceptive sensibility was positively related to isometric exercise LF power (rs= .523, n= 17, 
p=.031) and HF power (rs= .573, n= 17, p=.016). Cold pressor interoceptive accuracy was 
positively correlated with cold pressor HF power (rs= .504, n= 17, p=.039*). Total body vigilance 
scale (BVS) scores were positively correlated (rs= .474, n= 19, p=.040*) with supine baseline LF/HF 
ratio (see table 13).  
 
In the PoTS cohort, cold pressor interoceptive sensibility and cold pressor LF/HF ratio were 
negatively related (rs= -.727, n= 9, p=.027). HUT interoceptive accuracy was negatively related 
to HUT HF power (rs= -.457, n= 9, p=.043). Interoceptive awareness was positively correlated 
with cold pressor LF power (rs = .689, n= 11, p=.019) and HF power (rs = .648, n= 11, p=.031). Total 
body vigilance scale (BVS) scores were negatively correlated with HUT LF power (rs = -.510, n= 
20, p=.022) and HF power (rs = -.519, n= 20, p=.019) (see table 13).  
 
In the EH group, supine baseline interoceptive sensibility was positively correlated with baseline 
LF power (rs= .580, n= 13, p=.038) and HUT interoceptive sensibility was negatively correlated 
to HUT LF power (rs= -.635, n= 13, p=.020) and HF power (rs= -.566, n= 13, p=.044) (see table 13).  
 
In the AMS group of subjects, HUT interoceptive accuracy was negatively related to HUT HF 
power (rs= -.658, n= 13, p=.015). Isometric exercise interoceptive sensibility was positively 
related to isometric exercise LF power (rs= .556, n= 13, p=.049). Interoceptive awareness was 
positively correlated with baseline LF/HF (rs= .738, n= 12, p=.006) and HF power during isometric 
exercise (rs= .635, n= 11, p=.036) (see table 13). 
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Table 13. Body vigilance and empathy, interoceptive and heart rate variability (HRV) correlations. PoTS = postural tachycardia syndrome; EH = essential hyperhidrosis, AMS = autonomic (neurally) 
mediated syncope.  
 Supine Baseline HRV Isometric Exercise HRV Cold Pressor HRV HUT HRV 
Controls +Interoceptive sensibility/LF-HRV 
+Interoceptive sensibility/HF-HRV 
+Total body vigilance/LF/HF  
+Interoceptive sensibility/LF-HRV 
+Interoceptive sensibility/HF-HRV 
+Interoceptive accuracy/HF-HRV  
PoTS   -Interoceptive sensibility/LF/HF 
+Interoceptive awareness/LF-HRV 
+Interoceptive awareness/HF-HRV  
-Interoceptive accuracy/HF-HRV 
-total body vigilance/LF-HRV 
-total body vigilance/HF-HRV 
EH +Interoceptive sensibility/LF-HRV  -Interoceptive accuracy/LF-HRV -Interoceptive sensibility/LF-HRV 
-Interoceptive sensibility/HF-HRV 
AMS +Interoceptive awareness/HF-HRV +Interoceptive awareness/HF-HRV  -Interoceptive accuracy/HF-HRV 
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6.4. Discussion 
This study examined brain-body integrative processes in patients with clinical disorders that 
cause intermittent but recurrent overactivity of the autonomic nervous system (ANS). This was 
undertaken by firstly examining vigilance of autonomic symptoms and empathy – an emotion 
highly related to interoception - in EH, AMS and PoTS patients in comparison to controls. Next, 
interoceptive accuracy, sensibility and awareness were examined in patients in comparison 
to controls and how these factors interacted with vigilance of physical events and empathy 
were analysed. Finally, heart rate variability (HRV) was studied, particularly high frequency HRV 
(HF-HRV) which is a measure of vagal (parasympathetic) tone. These objectives were 
established because (i) of the contribution the ANS makes to emotion - particularly somatic 
anxiety and empathy, (ii) the prevalence of anxiety in postural tachycardia syndrome (PoTS) 
(Benrud-Larson et al., 2003), essential hyperhidrosis (EH) (Karaca et al., 2007) and autonomic 
mediated syncope (AMS) and (iii) because of previous research that has proposed reduced 
HRV in anxious subjects as perpetuating sympathoexcitation and anxiogenesis. These 
investigations were designed to identify the contributing factors of the overrepresentation of 
anxiety symptoms in PoTS, AMS and EH from the perspective of brain-body integration via the 
ANS.  
 
6.4.1. Body vigilance findings 
The PoTS group were found to have higher global BVS scores and the AMS groups spent more 
time scanning their body for symptoms. Specific physical symptoms that were increased in the 
AMS (faintness, dizziness, sweaty/clammy hands) and EH (sweaty/clammy hands, hot flash) 
groups were directly symptom-related, whereas the symptoms PoTS patients spent more time 
scanning for than controls were related to pre-syncope (dizziness, faintness, sweaty/clammy 
hands) and neuropathic (tingling, numbness) symptoms, though curiously not the cardio-
thoracic items of palpitations and chest pain.  
 
The fact that AMS patients reported being significantly more sensitive and paid more attention 
to changes in their body can be viewed from a homeostatic perspective, in consideration that 
these symptoms can often be a somatic marker of an imminent syncopal episode, therefore 
warning for the need of contingent behaviour to avoid trauma.  
 
The pre-syncope and neuropathic symptoms the PoTS group were hypervigilant of may be 
reflective of the broader pathophysiological factors in neuropathic and hyperadrenergic PoTS 
phenotypes. The finding that PoTS patients did not report hypervigilance of palpations and 
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chest pain, though initially counterintuitive, does support the findings of the only other study to 
investigate cardiac interoception in PoTS, which found that the interoception of palpations 
was separate to that of tachycardia (Khurana, 2014). However, in the current data, 
palpitations were not self-reported as being prevalent either. The current data reinforce this 
conclusion as the non-cardiothoracic BVS symptoms that related to orthostatic intolerance 
(OI) were reported to be the subject of somatic hypervigilance by the PoTS group.  
 
Overall, global somatic hypervigilance was higher in PoTS and its reporting in EH and AMS 
patients related directly to their conditions. Although AMS patients were reported to be more 
vigilant and sensitive to changes in their body, this may be justifiable to a certain extent due 
to the syncope-related trauma they may suffer if these symptoms become too pronounced 
and a syncopal episode occurs.  
 
6.4.2 Empathy findings 
There were no group differences in global empathy scores. PoTS patients scored more highly 
on 5 questionnaire items, three of which related to physical frailty and infirmity. The role of 
autonomic arousal in empathy has been established, which is why it was of interest to ask 
patients with autonomic overactivity to complete the Balanced Emotional Empathy Scale 
(BEES). However, the questionnaires were undoubtedly completed in a restful state and the 
current data may have differed if autonomic symptoms had been provoked during empathy 
reporting.  
 
6.4.3 Interoception findings 
Subjects with anxious ‘Type A’ personalities have been found to consistently overestimate their 
heartbeats (Essau and Jamieson, 1987), yet interoceptive accuracy was diminished in the 
patients groups despite their increased somatic anxiety, with EH, PoTS and AMS patients 
consistently underestimating their heartbeats. These findings compliment the questionnaire 
survey data in chapter 5 of this thesis, in that the anxiety-related phenomena in autonomic 
patients is not typical of anxiety only patients but rather appears to be mostly defined by 
visceral factors. However, there were no between-group differences in interoceptive sensibility 
or interoceptive awareness. PoTS interoceptive accuracy was significantly diminished during 
isometric exercise and cold pressor and AMS and EH interoceptive accuracy was significantly 
diminished at supine baseline, isometric exercise and HUT.  
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As PoTS patients’ heart rate (HR) increased and OI was provoked on HUT, it is noteworthy that 
neither their interoceptive accuracy nor sensibility increased. One peripheral explanation of 
this could be that conscious cardiac interoception may involve mechanoreceptors in more 
than one location, not only those located in the heart.  
  
EH and AMS interoceptive accuracy was significantly diminished during supine baseline, 
isometric exercise and HUT, yet PoTS interoceptive accuracy was significantly diminished 
during both pressor exercises only. In EH, the autonomic disorder is thermoregulatory and 
predominantly causes sudomotor overactivity, whereas AMS and PoTS are forms of OI and 
therefore predominantly involve intermittent breakdown of baroreflex arcs and cardiovascular 
autonomic dysfunction. Yet all three clinical autonomic cohorts consistently underestimated 
their heartbeats and EH and AMS in particular had identical profiles. This points towards the 
involvement of a common central dysregulation causing these interoceptive findings, as both 
sudomotor and cardiovascular forms of autonomic dysfunction have comparable 
interoceptive deficits.    
 
Despite a lack of neuroimaging studies into OI, Umeda et al., (Umeda et al., 2015) recently 
evidenced left insula volume reductions in 11 PoTS patients that correlated with affective 
symptoms. Reduced right insula volumes in 32 AMS patients have recently been correlated 
with BP falls on HUT (Kim et al., 2014). This implication of the insula (interoceptive, nociceptive 
and autonomic centre) in OI neuropathophysiology is not likely due to age-related 
neurodegeneration because of the patients’ ages (32 and 24 years respectively). The insula is 
part of the central autonomic network (Benarroch, 1993), as evidenced by increased anterior 
and posterior insula activity during isometric exercise and Valsalva manoeuvre (King et al., 
1999) (Harper et al., 2000). Activation of the insula cortex, particularly the right, correlates with 
interoceptive accuracy and anxiety in healthy controls (Critchley et al., 2004). The right insula 
depicts internal bodily state that can be consciously accessed. Sympathetic responses are 
lateralized to the right hemisphere (Oppenheimer et al., 1992) and the left insular cortex is 
involved in parasympathetic cardiovascular regulation, e.g., acute left insular stroke disrupts 
the correlation between HR and BP (Oppenheimer et al., 1996).  
 
As with orthostatic intolerance (OI), there is a lack of brain imaging literature on EH. However, 
in healthy controls, a relationship between arousal-induced sympathetic skin responses (SSRs) 
and activation of the right anterior insula exists as well as the right orbitofrontal cortex and right 
anterior insula, confirming right hemisphere sympathetic lateralization (Critchley et al., 2000b). 
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If we consider interoception from a Bayesian (maximization of expected utility) perspective, 
active inference refers to neural representations based on previous experience (Clark, 2013, 
Friston and Frith, 2015) and may help explain why the three dysautonomia patient groups 
consistently underestimated their heartbeats. Moreover, the mechanisms of how interoceptive 
error code predications of expected versus received bodily events are generated within in the 
lamination gradients of corticocortical pathways (Barbas and Rempel-Clower, 1997) also 
offers a possible framework for the cognitive-affective symptoms in the EH and OI patients. 
Active inference accounts propose that should a prediction error (variation between the 
brain’s prediction and the actual incoming afferent signal) become too large and thereby 
disrupt the maintenance of homeostatic processes, the prediction can be modified by 
retrogradley propagating the signal back, by engaging allostatic measures to more closely 
meet the original incoming afferent signal or by altering how the brain regards the incoming 
afferent signal (Mesulam, 1998). This third predication error modification may explain why the 
EH and OI patients underestimated their heartbeats at rest and during autonomic arousal and, 
in the case of AMS and PoTS patients, symptom provocation.  
 
Cardiac interoception may have been underestimated by the clinical cohorts due to 
cognitive control networks (Seeley et al., 2007) altering the weight of various afferent inputs. 
This may also explain why PoTS patients did not report palpations and chest pain as symptoms 
of somatic hypervigilance. This demand on cognitive control networks may also contribute to 
the previously reported cognitive difficulties in PoTS (Raj et al., 2009, Ross et al., 2013, Ocon, 
2013) and help clarify why EH, AMS and PoTS patients reported significant symptoms of 
indecisiveness and difficulty in concentrating in the previous chapter (5) of this thesis. 
Autonomic arousal is integrated with decision-making, as reflected by activation of the 
‘Default Mode Network’, particularly the dorsal anterior cingulate cortex during risk assessment 
and HR increases during anticipation of the outcome and also outcome feedback of 
gambling (Coricelli et al., 2005).  
 
These neuroimaging studies tested healthy controls to discover the influence of ANS activity 
on the brain during decision-making, but we can speculate on what may happen during 
decision-making in patients with EH, AMS and PoTS, especially when symptomatic. Autonomic 
reactivity indicates the behavioural salience of an object, this reactivity is generated via 
interoceptive signals that are received via the spinal cord, the lamina I spinothalamocortical 
pathway in particular, are gated by the brainstem and ultimately integrated with cognitive-
affective process in the right anterior insula (Critchley et al., 2004). Damasio and colleagues 
have reported how behaviour is influenced by this interoceptive feedback to maximise reward 
and avoid punishment (Damasio et al., 1991, Bechara et al., 1997a). Therefore, it is reasonable 
to assume that if this interoceptive feedback of increased autonomic activity is too noisy or 
causes large prediction errors requiring alterations in how the brain attends to interoceptive 
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signals that inform behavioural learning, then cognitive and attentional difficulties will occur, 
at least during dysautonomic symptom provocation. This study and that in the previous 
chapter (5), suggests these deficits may occur at rest also, perhaps due to the conditioning of 
brain-body integrative processes over time.  
 
Sudomotor and cardiovascular autonomic disorders appear to have comparable deficits in 
interoceptive accuracy but not interoceptive sensibility or awareness. Recent neuroimaging 
studies in OI and psychophysiological studies of the neural correlates of SSRs suggest that these 
interoceptive deficits may, at least in part, be mediated by the central autonomic network, 
particularly the insula. However, functional neuroimaging studies of the central autonomic 
network in AMS, PoTS and EH are required.  
 
6.4.4 Emotional & interoceptive integration 
Somatic vigilance was used in the current study as an emotional variable of interoception and 
anxiety of ANS activity. Empathy is an interoceptively influenced emotion. To test the 
relationship between somatic vigilance, empathy, the ANS and interoception using clinical 
autonomic techniques, it was intended that further insight into brain-body integration could 
be gained in healthy controls and also to explore any potential effects of neurovisceral 
disruption by intermittent ANS dysfunction, in this case, cardiovascular (PoTS, AMS) and 
sudomotor (EH).  
 
In healthy controls, interoception appeared to be working correctly as the more 
interoceptively accurate controls were at rest (supine baseline) and during autonomic arousal 
(isometric exercise and HUT), the less time they reported spending scanning their body for 
symptoms of sympathoexcitation, indicating interoception’s modulatory homeostatic role. This 
pattern of association was reversed in the PoTS cohort. The more interoceptively accurate PoTS 
subjects were during cold pressor, the more time they reported investing in scanning their 
bodies in general and for PoTS-related symptoms, suggesting that interoception appears to be 
anxiogenic rather than homeostatic in this cohort.  
 
The BVS survey data alone found that cardiothoracic symptoms were not the target of somatic 
hypervigilance in PoTS, yet the symptoms associated with interoceptive accuracy in PoTS were 
not only primary symptoms of PoTS (dizziness, shortness of breath, choking), but the relationship 
of hypervigilance of these symptoms with interoceptive accuracy was positively related, again 
suggesting that interoception may be involved in somatic anxiety rather than homeostasis in 
PoTS. Conversely, in controls, global and individual items of somatic vigilance were negatively 
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correlated with interoceptive accuracy, suggesting that interoceptive accuracy was not 
somatically anxiogenic, yet in the PoTS cohort, cold pressor interoceptive accuracy and global 
and PoTS-related somatic hypervigilance were positively related. This could be interpreted as 
a breakdown of neurovisceral integration in PoTS subjects, where interoceptive accuracy 
appears to be more aligned with somatic anxiogenesis rather than homeostasis, as is the case 
in controls.  
 
In the other group of OI participants included in the study, AMS interoceptive accuracy was 
negatively correlated with the amount of time spent scanning one’s body for symptoms, a 
profile comparable to controls and normative neurovisceral integration in that accurate 
interoception is not anxiogenic. There were no correlations between the body vigilance scale 
(BVS) and interoceptive measures in the hyperhidrotic cohort.  
 
In healthy controls, poor interoceptive accuracy was associated with reduced empathy but 
only in a single questionnaire item, not in global Balanced Emotional Empathy Scale (BEES) 
scores. PoTS and EH items and interoceptive accuracy appear to be correlated as previous 
research in healthy controls (Fukushima et al., 2011) would predict, i.e., better interoceptive 
accuracy is negatively related to reduced empathy. In autonomic disorders, empathy is 
normal, body vigilance and it’s interaction with interoception is not. 
 
6.4.5 Heart rate variability, emotional & interoceptive integration 
Amongst controls, baseline and isometric exercise interoceptive sensibility were positively 
related to greater HRV in high and low frequency bands, suggesting subjective interoception 
parameters are related to greater parasympathetic and baroreflex activity, seemingly 
reflecting normative brain-body integration, i.e., greater confidence in the awareness of one’s 
homeostatic state positively correlated with cardiovascular autonomic adaptability. Controls’ 
total body vigilance scores were also positively correlated with sympathetic dominance of the 
LF/HF ratio at baseline, further supporting previous research findings that sympathoexcitation 
perpetuates anxious mood and cognitive states, as demonstrated by Pollatos and co-workers 
(Pollatos et al., 2007), who found that subjects with high reactivity during isometric exercise 
had greater interoceptive accuracy and trait anxiety.  
 
The positive association between controls’ interoceptive accuracy and parasympathetic 
activity during the thermoregulatory and nociceptive stressor of the cold pressor test supports 
the view that thermoregulation and nociception could be considered as part of the 
interoception system that maintains homeostasis rather than ‘exteroceptive’ senses. This is 
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sustained by the association between interoceptive accuracy and autonomic adaptions 
during cold pressor and the recent findings that thermoception and nociception interact as 
part of interoceptive homeostasis during heat and cold stress (Alfonsi et al., 2015).  
 
No relationships were identified between HRV on HUT and interoceptive measures in controls. 
This is unsurprising in consideration that interoceptive accuracy is both higher in anxious 
individuals (Pollatos et al., 2009, Dunn et al., 2010) and also at supine rest in controls (Cameron, 
2009) when minimal allostatic demand cannot confound viscerosensory perception. Together, 
these findings in the control group provide further evidence that increased basal sympathetic 
outflow is positively related to interoceptive accuracy and sub-clinical somatic anxiety, that 
subjective (interoceptive sensibility) and objective (interoceptive accuracy) measures of 
interoception may relate to autonomic cardiovascular flexibility and that interoception is a 
homeostatic regulator of multimodal afferent feedback. 
 
In PoTS participants, LF reduced during HUT when tachycardia was provoked, lending further 
evidence to the view that LF power is not just a measure of cardiac sympathetic nerve activity 
(Goldstein et al., 2011). Positive correlations were found between cold pressor HRV and 
interoceptive awareness. Interoceptive sensibility was negatively correlated with cold pressor 
LF/HF ratio, i.e., subjective interoceptive confidence correlated to parasympathetic 
dominance of the LF/HF ratio which may relate to reduced activation of cardiac, thoracic or 
cutaneous mechanoreceptors sensing of cardiac activity. This finding was complimented by 
the negative correlation between interoceptive accuracy and HUT HF power, i.e., objective 
interoceptive accuracy decreased with parasympathetic tone during provocation of 
orthostatic intolerance (OI).  
 
Previous research has found cardiovascular arousal increases interoception (Schandry et al., 
1993), yet the opposite appears be true of OI and EH patients on tilt.  
 
As with controls at rest, the EH group’s subjective measure of interoceptive sensibility positively 
related to baseline HRV. EH interoceptive accuracy negatively related to cold pressor 
sympathetic and parasympathetic HRV, also complimenting the cold pressor data in controls. 
As with the PoTS cohort, EH global body vigilance scales were negatively correlated with HUT 
LF and HF HRV power. Subjective interoceptive sensibility was also negatively correlated with 
HUT HRV, a similar pattern of aberrant bran-body interaction as the PoTS group.  
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The AMS group’s LF power reduced during HUT, in line with previous research also finding 
reduced LF power on HUT in comparison to baseline in AMS patients (Prinz-Zaiss et al., 1995, 
Shim et al., 2014). Similar to control baseline measures, AMS interoceptive measures were 
positively related to HRV, particularly parasympathetic HRV, at rest and during isometric 
exercise. As with the other OI cohort (PoTS), AMS interoceptive accuracy on tilt was negatively 
related to HUT HF-HRV, reiterating the argument that symptom provocation on tilt may impair 
interoception in OI.  
 
LF power was reduced in all three patient groups and HF power was also reduced in EH and 
PoTS subjects during HUT. Previous research using HRV to investigate neurovisceral integration 
would argue that this would be reflected in a predisposition for physical sympathoexcitation 
and anxiogenic thought processes in these groups. In the instance of EH, AMS and PoTS, the 
sympathetic and parasympathetic overexcitation in EH, PoTS and AMS is due to primary 
dysautonomia, however, the positive correlation between controls’ body vigilance scale (BVS) 
scores and sympathetic dominance of the LF/HF ratio at baseline provides further evidence of 
disrupted neurovisceral integration in dysautonomia.  
 
In the current BVS data, the chapter 5 questionnaire surveys and previous research, EH (Karaca 
et al., 2007), PoTS (Benrud-Larson et al., 2003) and AMS (McGrady et al., 2001) patients have 
been found to be significantly more anxious than controls. In chapter 5 and the current study 
this anxiety is mostly attributable to somatic anxiety, hypervigilance and interoception of 
dysautonomic symptoms that are similar to physical manifestations of acute anxiety and 
panic. Anxious individuals, e.g., Type A, have increased interoceptive accuracy and also 
overestimate their heart rate but in this study of patients with primary autonomic disorders of 
intermittent over-activation, although patients were more (somatically) anxious, they also 
significantly underestimated their heartbeats, this may be attributable to changes to afferent 
pathways at rest in EH and AMS and also during autonomic arousal in EH, AMS and PoTS.  
 
The negative correlations of interoceptive measures and HUT HRV could be interpreted as a 
further breakdown of brain-body integration, particularly as there were no HUT HRV 
correlations with affective or interoceptive parameters in the control group. Metacognitive 
measures provide insights into high-order executive processes (Thompson and Thompson, 
1998). The diverging findings of negative correlations between HUT HRV and subjective (EH) 
and objective (AMS, PoTS) interoception findings in comparison to the positive correlations 
between supine baseline and pressor HRV and metacognitive interoceptive measures in PoTS 
and AMS patients may relate to previous evidence of higher order cognitive differences in OI 
patients (Raj et al., 2009, Ross et al., 2013), and may elucidate why OI patients reported 
significant (PoTS (p=.000), AMS (p=.008), EH (p=.005)) attentional difficulties in the chapter 5 
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survey data. The fact that EH patients cognitive and interoceptive measures are also 
attenuated points towards a common pathophysiological pathway(s) in sudomotor and 
cardiovascular autonomic disorders, perhaps accounting for the common presentation of 
anxiety in all three patient groups. Moreover, it may also provide some support to how, in 
patients with intermittent autonomic disorders, metacognitive higher order and cognitive 
processes have become associated with visceral activity via a dysfunctional autonomic 
nervous system.  
 
6.4.6. Summary of key findings 
This study investigated interoception in EH, AMS and PoTS in comparison to healthy controls. It 
also was designed to examine the potential interrelationship between emotion, 
interoception and autonomic variability, concluding that; 
Ø Interoception was reduced in all three patient groups, potentially due to a common 
central dysregulation of interoception 
Ø Interoception appears to be anxiogenic rather than homeostatic in EH, AMS and 
PoTS. 
6.4.6 Conclusions 
Autonomic patients consistently underestimated their cardiac activity, even during autonomic 
arousal, despite having increased levels of somatic anxiety. Diminished interoception may be 
due to a common central dysregulation, such as interoceptive error code predictions, as both 
sudomotor and cardiovascular forms of autonomic dysfunction had comparable 
interoceptive accuracy deficits. Recent neuroimaging studies in OI also suggest that these 
interoceptive deficits may, at least in part, be mediated by the insula. From a peripheral 
perspective, the PoTS interoceptive accuracy data suggests conscious cardiac interoception 
could involve non-cardiac mechanoreceptors. In PoTS, AMS and EH, interoception appears to 
be anxiogenic, as opposed to its homeostatic role in controls. Interoception of excessive 
autonomic activity that should inform behavioural learning causes large prediction errors 
requiring alterations in how interoceptive signals are attended to, potentially contributing to 
the cognitive and attentional difficulties reported in chapter 5. Should this be true, it would 
provide further evidence for Stein and Paulus’ (Paulus and Stein, 2006) interoceptive view of 
anxiety and Antonio Damasio’s ‘somatic marker hypothesis’ (Damasio, 1999) that 
discrepancies and aberrations in interoceptive expectations are somatic sources of anxiety 
and disrupt cognition. This may be a possible therapeutic pathway for psychological 
symptoms in autonomic disorders and potentially of therapeutic use in panic disorder.  
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Chapter 7. Supine & orthostatic orienting 
responses & cardiac interoception in 
orthostatic intolerance 
7. Introduction 
Despite the inconsistencies in defining emotion-specific autonomic signatures (Hodgson and 
Rachman, 1974, Rachman and Hodgson, 1974, Kreibig, 2010), a reliable and robust early 
response to a novel stimulus, especially unpleasant, is cardiac deceleration (Fanselow, 1994). 
Cardiac deceleration is a peripheral component of the ‘orienting response’ (OR), which is a 
series of involuntary sensory, motor and autonomic adjustments (see figure 36) that occur in 
response to an emotionally salient stimulus  to ‘increase analyser sensitivity’ (Sokolov, 1963a).  
 
The OR is differentiated from the cardiac defence response (CDR) by the cardiac deceleration 
during the OR to a moderate or novel stimulus facilitating attention and perception of the 
stimulus. In contrast, the defining cardiac acceleration during the CDR to an intense or aversive 
stimulus reduces attention and perception to protection against the stimulus (Pavlov, 1927a, 
Sokolov, 1963b, Fernandez and Vila, 1989). It is widely accepted form psychophysiological 
research that the OR is therefore the opposite of the CDR. The issue of stimulus intensity has 
received empirical support (Turpin, 1986), however, there is no formal definition or criteria on 
the level of stimulus intensity that differentiates ORs from CDRs, neither have any studies 
investigated the effect of intensity in different sensory modalities. 
 
Originally believed to be a unitary reflex (Sokolov, 1963a), subsequent studies have evidenced 
that the electroencephalogram (EEG) and respiratory components of the OR represent 
novelty, peripheral vasoconstriction ORs reflect stimulus intensity and cardiac deceleration 
indicates stimulus detection (Barry, 2009). Greater ORs are proposed to represent greater 
emotional significance of the stimulus and greater interoceptive accuracy (IA) is associated 
with increased emotional experience (see Interoception in emotion, cognition & homeostasis), 
therefore, it is possible that a relationship may exist between IA and ORs and could provide an 
insight into holistic brain-body integration. However, this has not yet been investigated. 
 
The non-muscular visceral components of the OR are autonomically mediated but there have 
been no investigations into whether dysautonomia affects ORs or subsequent emotion 
formation and behaviour. This is worthy of investigation because the functional and organ-
specific autonomic patterns that maintain homeostasis are intermittently compromised in 
orthostatic intolerance (OI). In addition, many of these patients report comorbid affective, 
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psychological symptoms (see Palpations, dizziness, tremulousness: the postural tachycardia 
syndrome endophenotype of anxiety and Dizziness, nausea, dissociation: the vasovagal 
syncope endophenotype of anxiety) (Heims et al., 2006a, Guaraldi et al., 2014, Ross et al., 
2013, Ocon et al., 2009b, Stewart et al., 2012). 
 
 
 
Figure 36. Central and visceral correlates of the orienting response (OR). Blue = autonomically mediated OR 
components. 
	
From a clinical perspective, some unanswered questions remain, such as; (i) how do ORs 
compare at supine rest and during orthostasis between healthy controls and in patients with 
compromised baroreflex function, particularly as the two main forms of OI, PoTS and AMS 
(Freeman et al., 2011b) have an over-representation of comorbid cognitive-affective 
symptoms, such as anxiety (Raj et al., 2009, Cohen et al., 2000a) depression (Lee et al., 2013) 
and ill-defined ‘brain fog’ (Ocon et al., 2009b, Ross et al., 2013, Ocon et al., 2009a) (see also 
chapter 5 of this thesis)? (ii) Would investigating the possible relationship between IA and ORs 
provide an insight into brain-body integration or of these patients’ common comorbid 
psychological symptoms, as greater ORs are proposed to represent greater emotional 
significance of the stimulus and greater IA is associated with increased emotional experience? 
Therefore, Specific aim # 4 of this thesis will investigate; 
(i) the effects of orthostatic stress on ORs in PoTS and AMS in comparison to controls 
to examine the influence (if any) of dysautonomia-related dysregulated ORs  
Sense organs become more sensitive; 
pupils dilate, threshold to light reduced in 
retina (Wang and Munoz, 2015), auditory 
threshold lowered by 4-10 decibels 
(Gershundi, 1960). 
Skeletal muscles that direct sense 
organs are activated, e.g., head 
turns towards stimulus, or in canines 
as ‘pricking up of the ears’ 
Faster and lower electroencephalogram 
(EEG) activity indicating increased arousal 
(Nagai et al., 2004) 
General muscle tonus rises, as 
evidenced by increased 
electromyographic (EMG) activity 
Initial cessation of respiration 
followed by increased amplitude 
and decreased frequency (Davis, 
1955) 
Phasic heart rate deceleration 
(Abercrombie et al., 2008) (Turpin, 
1986) 
Galvanic skin response (GSR) 
occurs (Nagai et al., 2004) 
Peripheral 
vasoconstriction 
Cephalic vasodilation in the 
temporal area (Barry, 1990) 
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(ii) explore any interactions between ORs and IA in controls and OI.  
 
7.1. Methods 
7.1.1. Participants 
Healthy control participants (20; 10 females, mean age 36 + 8 years), PoTS patients (20; 18 
females, mean age 38 + 13 years) and AMS patients (16; 14 females, mean age 39 + 12 years) 
were recruited for the study. Autonomic diagnoses were received from the Autonomic Unit, 
National Hospital for Neurology and Neurosurgery (University College London Hospitals) or the 
Autonomic and Neurovascular Medicine Unit, St Mary’s Hospital (Imperial College Healthcare 
Trust). Written and verbal informed consent was provided by all participants prior to 
participation. Autonomic testing was carried at the Autonomic Unit, National Hospital for 
Neurology and Neurosurgery or Autonomic and Neurovascular Medicine Unit, St Mary’s 
Hospital; both national referral centres for cardiovascular and sudomotor dysautonomia. 
 
Ambient temperature of the laboratory was maintained at 21°C throughout testing for all 
participants and heart rate (HR) and heart rate variability (HRV) were continuously recorded 
online (PowerLab 16/30; ECG Bioamp, AD Instruments, Oxford, United Kingdom) and analysed 
offline (Labchart 7 software). Blood pressure (BP) was continually recorded using digital 
photoplethysmography (Finometer, Smart Medical, Gloucestershire, United Kingdom) and 
intermittent BP and HR were also recorded (Dinamap Pro400V2, GE Healthcare, 
Buckinghamshire, United Kingdom). Visual emotional stimuli were synchronised with beat-to-
beat data using the Superlabs Stim Tracker (Cedrus Corporation, USA).  
 
7.1.2. Experimental procedures 
7.1.3. Orienting responses (OR) 
After an 10-15 mins supine baseline, participants were requested to look at a screen 1 metre 
from their head and informed that they were about to be shown a series of images and that 
during all images that they should keep their eyes fixed on the screen but not say anything. 
Cardiac and peripheral vascular ORs were recorded and analysed post hoc. Participants 
were then presented with one of two randomly selected sets of images taken from the 
International Affective Picture System (IAPS). Image set 1 consisted of 12 neutral images, 13 
unpleasant images and 13 pleasant images (mean valence 5.07 + 1.4, mean arousal 4.38 + 
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2.2, dominance 1 mean 5.35 + 2.1, dominance 2 mean 4.60 + 2.1) that were presented in a 
pseudorandom order. Image set 2 consisted of 12 neutral images, 14 unpleasant images and 
12 pleasant images (mean valence 5.07 + 1.4, mean arousal 4.38 + 2.2, dominance 1 mean 
5.6 + 2.1, dominance 2 mean 5.2 + 2.1). Whichever of the two image sets was randomly 
selected to be presented in the supine position, the remaining set of images was presented 
during HUT so as to avoid OR habituation.  Each image was presented for 10 seconds.  
 
Emotion formation to each image was recorded using a visual analogue scale (VAS) 
presented after each image, requesting: “Please rate out loud the image you just saw using a 
number between 1 – 10; 1 being unpleasant, 5 being neutral and 10 being pleasant.’” 
 
Following another 5-10 mins second supine, participants then underwent a 3-5 mins 60° 
baseline head up tilt (HUT) before being presented with the remaining second set of images. 
ORs and emotion formation were recorded and analysed identically to the supine phase of 
the protocol.    
 
7.1.4. Interoceptive accuracy (IA) 
After the OR section of the protocol, participants rested while supine for 10 mins before the 
protocol started. After  3, 6 and 9mins, participants were asked to carry out a heartbeat 
tracking task  (Schandry, 1981) involving silently counting their own individual heartbeats during 
the three epochs (Schandry, 1981). Participants were instructed to not manually take or touch 
their pulse and to declare that they couldn’t feel their pulse pressing against any clothing or 
apparatus. Randomised epochs of the supine phase of the heartbeat mental tracking task 
were either 25, 35 or 45 seconds, elected to the optimum task windows from previous studies 
(Pollatos et al., 2009).  
 
Next, during isometric handgrip exercise (HG), the participants were requested to sustain a 
handgrip at 1/3 of maximum voluntary contraction for 3 mins using a gauge directly in front of 
them. At 30 seconds, 88 seconds and 144 seconds the participants performed the heartbeat 
tracking task. Randomised epochs of the HG mental tracking task were 21, 26, 36 seconds.  
 
Cutaneous cold pressor (CP) task was carried out. The subjects’ right hand was placed in an 
icepack chilled to 4°C for a minimum of 90 seconds, tolerance permitting. At 3 seconds, 40 
seconds and 54 seconds the participants performed the heartbeat tracking task.  
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Cardiovascular autonomic activity was then allowed to return to baseline levels (minimum of 
3 mins) before a 10 mins 60° head-up tilt (HUT) was conducted. At 3, 6 and 9 minutes the 
participants performed the heartbeat tracking task. Randomised epochs of the heartbeat 
mental tracking task were 25, 35, 45 seconds.  
 
Interoceptive accuracy scores were yielded post hoc by counting the R waves in each task 
epoch and averaging the following equation over the 3 tracking tasks of each stage of the 
protocol (supine baseline, HG, CP, HUT):  
1. − (|nbeatsreal− nbeatsreported|) / ((nbeatsreal+nbeatsreported)/2). 
7.2. Results 
7.2.1. Supine and HUT baseline data 
Supine and HUT baseline data is shown in table 14. There were no between-group differences 
amongst healthy controls and OI patients.  
Table 14.Supine baseline and head up tilt (HUT) autonomic indices in healthy controls, postural tachycardia 
syndrome (PoTS) patients and autonomically mediated syncope (AMS) patients. HR = heart rate, BPM = beat per 
minute, SBP = systolic blood pressure, DBP = diastolic blood pressure 
 Supine HR 
(BPM) 
Supine SBP 
(mmHg) 
Supine DBP 
(mmHg) 
HUT HR (BPM) HUT SBP 
(mmHg) 
HUT DBP 
(mmHg) 
Controls 72 + 11.9 127.7 + 29.1 68.7 + 20.5 80.7 + 10.1 131.8 + 21 75.3 + 14.1 
PoTS 73.3 + 11.2 127.7 + 15.3 67.3 + 8.6 94.7 + 14.1* 126 + 28.6 67.1 + 13.3 
AMS 71.1 + 12.1 136.3 + 43.8 60.9 + 22.4 71.5 + 12.7 138.3 + 42 61.8 + 21.7 
 
7.2.2. Supine & HUT orienting responses to emotionally neutral 
stimuli 
7.2.2.1. Within group findings 
Healthy controls produced larger supine cardiac ORs (i.e., greater cardiac deceleration) at 1s 
(p=.010) and 2s (p=.042) in comparison to HUT presentation of neutral images. There were no 
other significant within group differences in control or OI cohorts (see figure 37).  
 
124 
7.2.2.2. Between group findings 
During the presentation of supine and HUT neutral images, there were no differences in 
autonomic indices or appraisal of neutral images in AMS patients in comparison to healthy 
controls.  
 
There were no between-group differences amongst healthy controls and PoTS patients during 
supine neutral image presentation, however, during HUT neutral image presentation, the PoTS 
group produced a significantly higher HR (p=.002-.047) for the entire 10s epoch of neutral 
image presentation.  
 
Figure 37. Cardiac orienting responses to neutral images whilst supine and during head up tilt (HUT, dotted lines). 
Postural tachycardia syndrome (PoTS) patients and autonomic (neurally) mediated syncope (AMS) patients. 
 
7.2.2.3. Supine & HUT responses to emotionally pleasant stimuli 
7.2.2.4. Within group findings 
In comparison to their viewing of pleasant images in the supine position, AMS participants 
produced an attenuated (p=.010) (i.e., reduced HR deceleration) cardiac OR at 1s during HUT 
viewing of pleasant images (see figure 30). There were no other within-group differences in the 
three cohorts.   
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7.2.2.5. Between group findings 
During the presentation of supine and HUT pleasant images, there were no differences in 
autonomic indices or appraisal of pleasant images in AMS patients in comparison to healthy 
controls.  
 
During tilted presentation of pleasant images, the PoTS group had a significantly higher HR for 
the entire 10s of stimuli exposure (p=.001-.008).  
 
Figure 38. Cardiac orienting responses to pleasant images whilst supine and during head up tilt (HUT, dotted lines). 
Postural tachycardia syndrome (PoTS) patients and autonomic (neurally) mediated syncope (AMS) patients. 
 
 
7.2.2.6. Supine & HUT responses to emotionally unpleasant stimuli 
7.2.2.7. Within group findings 
There were no within group differences in the two OI patient groups, however, control subjects’ 
DBP ORs at 1s (p=.040), 4s (p=.032), 7s (p=.046), 8s (p=.019), 9s (p=.009), 10s (p=.008) were 
diminished in comparison to supine viewing (see figure 39). Controls also produced an 
attenuated (i.e., reduced HR deceleration) cardiac OR at 1s (p=0.14) and 2s (p=.020) during 
HUT viewing of unpleasant images (see figure 40).   
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Figure 39. Diastolic blood pressure (DBP) orienting responses to unpleasant images whilst supine and during head up 
tilt (HUT, dotted lines). Postural tachycardia syndrome (PoTS) patients and autonomic (neurally) mediated syncope 
(AMS) patients. 
 
 
Figure 40. Cardiac orienting responses to unpleasant images whilst supine and during head up tilt (HUT, dotted lines). 
Postural tachycardia syndrome (PoTS) patients and autonomic (neurally) mediated syncope (AMS) patients. 
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PoTS patients also produced a weakened cardiac OR at 1s of tilted unpleasant image viewing 
in comparison to their group’s cardiac OR at 1s (p=.013) of supine unpleasant image viewing 
(see figure 41).  
 
Figure 41. Systolic blood pressure (SBP) orienting responses to unpleasant images whilst supine and during head up 
tilt (HUT, dotted lines). Postural tachycardia syndrome (PoTS) patients and autonomic (neurally) mediated syncope 
(AMS) patients. 
 
AMS patients produced a diminished cardiac OR at 1s (p=.007) and 2s (p=.025) of HUT viewing 
of unpleasant images in comparison to supine (see figure 31). SBP ORs during HUT viewing of 
unpleasant images in the AMS group were significantly diminished (i.e., fall rather than rise in 
SBP) at 1s (p=.034), 9s (p=.048) and 10s (p=.049) in comparison to supine (see figure 33).   
 
7.2.2.8. Between group findings 
During supine presentation of unpleasant images, there were no between-group differences 
amongst healthy controls and the OI cohorts, including subjective appraisal of the emotional 
stimuli. During tilted viewing of unpleasant images, the PoTS group had a significantly higher 
HR for the entire 10s epoch of neutral image presentation (p=.002-.014).  
 
In comparison to healthy controls, PoTS patients produced exaggerated (i.e., greater increase 
in DBP) DBP ORs to unpleasant images on tilt for 1s (p=.039), 2s (p=.003), 3s (p=.002), 4s (p=.003), 
5s (p=.004), 6s (p=.004), 7s (p=.005), 8s (p=.006), 9s (p=.006) and 10s (p=.007) (see figure 34).  
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During viewing of unpleasant images on tilt, the AMS group also produced exaggerated DBP 
ORs in comparison to healthy controls during 4s (p=.008), 5s (p=.020), 6s (p=.014), 7s (p=.004), 
8s (p=.009), 9s (p=.011), 10s (p=.003) (see figure 42).  
Figure 42. DBP orienting responses to unpleasant images during head up tilt (HUT, dotted lines). Postural tachycardia 
syndrome (PoTS) patients and autonomic (neurally) mediated syncope (AMS) patients. 
 
 
7.2.2.9. Interoceptive accuracy (IA) 
PoTS patients’ interoceptive accuracy (IA) was significantly poorer during isometric exercise 
(p=.043) and cold pressor testing (p=.025) than healthy controls (see figure 35).  
 
AMS patients’ IA was significantly poorer during baseline (p=.028), isometric exercise (p=.010) 
and HUT (p=.015) (see figure 43).  
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Figure 43. Interoceptive accuracy during supine baseline, isometric exercise, cold pressor and head up tilt (HUT). 
PoTS = postural tachycardia syndrome; AMS = autonomic mediated syncope. 
 
7.2.2.10. Interoceptive correlations with neutral orienting data 
Healthy controls’ emotional assessment of neutral images on HUT was negatively correlated 
with IA on HUT (rs= -.566, n= 16, p=.022). 
 
PoTS patients’ DBP during 2-10 seconds (rs= .623 - .631) of neutral images on HUT was positively 
correlated with their IA on HUT.  
 
In the AMS cohort, neutral image ratings viewed whilst supine were negatively correlated (rs= 
-.745, n= 13, p=.003) with isometric exercise IA (see table 15). Ratings of neutral images during 
HUT were negatively correlated with cold pressor IA (rs= -.645, n= 13, p=.029). For the entire 10s 
epoch of supine neutral image presentation, SBP (rs= .875 -.883) and DBP (rs= .774 - .879) was 
positively correlated to cold pressor IA.  
 
 
 
 
*	 *	 *	*	 *	
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Table 15. Correlations between autonomic indices during supine and HUT viewing of neutral images and 
interoceptive accuracy (IA) during supine baseline and clinical autonomic manoeuvres (isometric exercise, cold 
pressor, head up tilt [HUT]). 
Neutral Baseline IA Isometric IA Cold Pressor IA HUT IA 
Controls    -HUT neutral image rating 
PoTS    +2-10s HUT DBP 
AMS  -Supine neutral image 
ratings 
+1-10s supine SBP 
+1-10s supine DBP 
-HUT neutral image ratings 
 
 
 
7.2.2.11. Interoceptive correlations with pleasant orienting data 
Controls’ ratings whilst supine of pleasant images were negatively correlated to isometric 
exercise IA (rs= -.534, n= 17, p=.027) (see table 16). During the entire 10 second epoch of tilted 
viewing of pleasant images, controls’ SBP (rs= .496 - .563) was positively correlated with baseline 
IA (see table 16).  
 
PoTS patients’ DBP (rs= .581 - .615) during pleasant images on tilt was positively correlated with 
HUT IA for the 10s duration of pleasant image presentation (see table 16).  
 
During 1-10 seconds of supine viewing of pleasant images, AMS patients’ SBP (rs= .871 - .876) 
and DBP (rs= .764 - .784) was positively correlated with cold pressor IA (see table 16).  
	
Table 16. Correlations between autonomic indices during supine and HUT viewing of pleasant images and 
interoceptive accuracy (IA) during supine baseline and clinical autonomic manoeuvres (isometric exercise, cold 
pressor, head up tilt [HUT]). 
Pleasant Baseline IA Isometric IA Cold Pressor IA HUT IA 
Controls +1-10s supine SBP -Supine pleasant image 
ratings 
  
PoTS    +1-10s supine DBP 
AMS   +1-10s supine SBP 
+1-10s supine DBP 
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7.2.2.12. Interoceptive correlations with unpleasant orienting 
data 
Healthy controls’ SBP during HUT viewing of unpleasant images was positively related (rs= .468 - 
.633) to isometric exercise IA for the entire 10 seconds of image exposure (see table 17).  
 
During 2-10 seconds of supine viewing of unpleasant images, PoTS cardiac ORs were 
negatively correlated with baseline IA (rs= -.553 - -.858), isometric exercise IA (rs= .581 - .615) and 
HUT IA (rs= .533 - .689) (see table 17). 
 
During 2-10 seconds of HUT viewing of unpleasant images, PoTS DBP was also positively 
correlated with baseline (rs= .578 - .598), isometric exercise (rs= .579 - .595) and HUT IA (rs= .643 - 
.655). SBP for the entire 10 second duration of unpleasant image exposure was positively 
correlated (rs= .597 - .629) with isometric exercise IA. 
 
Cold pressor IA was positively correlated with AMS SBP (rs= .736 - .751) and DBP (rs= .608 - .712) 
during the 10 second entirety of unpleasant image exposure in the supine position (see table 
7). AMS cold pressor IA was negatively correlated with SBP (rs= -.665 - -.796) and DBP (rs= -.634 - 
-.784) ORs to unpleasant images on tilt for the entire 10 second epoch.  
 
Table 17. Correlations between supine and HUT autonomic indices during exposure to unpleasant images and 
interoceptive accuracy (IA) during baseline and clinical autonomic manoeuvres. 
Unpleasant Baseline IA Isometric IA Cold Pressor IA HUT IA 
Controls  +1-10s HUT SBP   
PoTS -2-10s supine cardiac 
ORs 
+2-10s HUT SBP 
+2-10s HUT DBP 
-2-10s supine cardiac 
ORs 
+1-10s HUT SBP 
+2-10s HUT DBP 
 -2-10s supine cardiac 
ORs 
+2-10s HUT SBP 
+2-10s HUT DBP 
AMS 
 
  +1-10s supine SBP 
+1-10s supine DBP 
-1-10s HUT SBP ORs 
-1-10s HUT DBP ORs 
 
 
7.3. Discussion 
This study aimed to investigate (i) the effects of orthostatic stress on ORs in PoTS and AMS in 
comparison to controls and (ii) to explore any interactions between ORs and IA due to the 
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magnitude of ORs representing the emotional significance of a stimulus and greater IA being 
associated with increased emotional experience, particularly anxiety – a common comorbid 
affective symptom in AMS and PoTS. These questions were addressed from the perspective 
that homeostatic processes (IA) and/or innate assimilative reflexes (ORs) may be susceptible 
to disruption by symptomatic OI and help elucidate the cause of the common comorbid 
affective and cognitive symptoms in OI. 
 
7.2.3. Orienting response findings 
Control cardiac ORs on tilt during 1s and 2s of neutral image presentation were weaker 
compared to 1s and 2s of supine presentation. The cardiac deceleration component of the 
OR indicates stimulus detection (Barry, 1977) (Barry, 2009), indicating an attenuation or delay 
in stimulus detection on HUT. However, physiologically, the engagement of the baroreflex 
during HUT may contribute to the initial attenuation of cardiac ORs on HUT in controls rather 
than being a psychogenically or stimulus derived finding. As supine ORs have not been 
compared with HUT ORs before, it is difficult to confidently identify the cause of this difference 
in early phase HUT ORs in comparison to supine ORs, however, the fact that emotional 
assessment of the stimuli did not differ between HUT and supine viewing, makes a physiological 
cause a possibility but may also indicate that other levels (e.g., subcortical, cortical, 
preconscious, conscious) of emotional integration compensated for this initial perturbation.  
 
As with controls’ HUT cardiac ORs to neutral images, there was a similar diminishing of cardiac 
ORs to pleasant images in the AMS group at 1s and 2s of stimulus exposure on HUT, yet the 
finding that unpleasant images also caused an attenuation of early cardiac ORs in all three 
groups during 1s (controls, AMS, PoTS) and 2s (controls, AMS) provides support for a 
stimulus/valence-related aspect to this finding rather than a physiological cause. This is 
substantiated by the attenuated early (1s) and late phase (9s, 10s) HUT SBP ORs (in comparison 
to supine) to unpleasant HUT images in the AMS group. It may also be possible that any 
downstream emotional effects of this early OR finding require a more sensitive instrument than 
the VAS used in this study.  
 
An alternative explanation may be found in recent studies examining embodied cognition 
and posture. Although supine subjects have been found to experience less negative emotion 
compared to standing (Harmon-Jones and Peterson, 2009), standing and HUT differ in that HUT 
negates the use of peripheral muscular pumps to aid venous return, thus offering a more 
thorough insight into the subject’s vasomotor integrity in various vascular beds by reclining the 
patient backwards away from the stimulus to 60-90°. This reclining withdrawal-oriented posture 
may account for the early stage attenuation in HUT ORs as it has been found to reduce cortical 
133 
responses (Price and Harmon-Jones, 2011) and eye blink reflex to emotional stimuli in 
comparison to approached-oriented (forward leaning) posture. The authors concluded that 
the blunting of central and peripheral responses to negatively valenced stimuli is attributable 
to the reclining posture being associated with reduced stimulus-approach motivation. 
Therefore, the initial attenuation of cardiac HUT ORs in the current data may be representative 
of delayed stimulus engagement in relation to withdrawal-motivated posture on tilt.  
 
In the AMS group, the reduced SBP ORs to unpleasant images on HUT are noteworthy, as 
increased SBP has been linked with coping demands and behaviour. Studies have shown that 
when faced with a threat stimulus, the decision to avoid the threat stimulus follows an increase 
in SBP which does not occur when the subject is powerless to avoid the noxious stimulus 
(Manuck et al., 1978) (Light and Obrist, 1980). Therefore, the current findings in the AMS cohort 
may represent a constitutional disposition to not engage in defence responses, such as fight 
or flight, supporting comparisons between the vasovagal reflex and tonic immobility (sham 
death) seen in many invertebrates when caught by a predator (Alboni et al., 2008, Diehl, 2005). 
A recent study using Stimulus Preceding Negativity (SPN) during emotional stressors in AMS 
patients has provided a central measure of reduced emotional variation, anticipation and 
regulation in these patients (Buodo et al., 2012). It is unfortunate that this study was only 
performed in the seated position, as repeating the protocol during orthostasis may have 
provided even greater insights into the elusive pathophysiology of AMS. Together these 
findings suggest an innate difference in AMS patients assimilation of unpleasant, aversive or 
noxious stimuli, arguably manifesting in their common blood injury phobia (Graham, 1961).  
 
The peripheral vasoconstriction OR is a neglected measure, meaning that there are currently 
no differential roles allocated to the SBP and DBP ORs but I believe the current data highlights 
the need for a more in-depth examination of the potential different meanings of SBP ORs and 
DBP ORs. AMS and PoTS patients produced greater DBP ORs to unpleasant images on HUT 
compared to controls. The peripheral vasoconstriction OR represents stimulus intensity, 
therefore, the unpleasant images during HUT either had greater intensity for OI patients, OI 
patients were less effected by the HUT-related withdrawal posture, or differences in β2-
adrenoreceptor or vasomotor function related to OI pathophysiological influenced orthostatic 
vasoconstriction. One could argue against the former, as image ratings did not differ between 
groups or within groups when comparing supine and HUT image ratings, however, the fact that 
this finding was specific to unpleasant images only indicates a psychological basis. There may 
be an argument for the VAS not directly requesting the subjects to relay image intensity, 
however, the fact that the VAS was a sliding scale, infers valence intensity, i.e., the higher the 
number towards 10, the more pleasant the image and the lower the number towards 1, the 
more unpleasant the image. The VAS was also sensitive enough to define a negative 
correlation in the control group between isometric exercise IA and supine ratings of pleasant 
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image (i.e., the greater the IA, the lower their ratings of supine pleasant images), and also HUT 
IA and supine ratings of neutral images (i.e., the greater the IA, the lower their ratings of supine 
neutral images).  
 
One of the aims of this study was to investigate the effects of orthostatic stress on ORs in PoTS 
and AMS in comparison to controls. HUT blunted initial OR activity, particularly during tilted 
viewing of unpleasant images, which also produced exaggerated DBP ORs in both OI groups, 
suggesting these images possessed greater intensity for the clinical cohorts and indicating that 
OI symptom provocation may contribute to negative affect, at least at an unconscious level. 
This potential for OI to exacerbate negative affect may help explain the prevalence of 
somatic anxiety in chapters 5 and 6. Though ORs were most disrupted by simultaneous HUT 
and unpleasant image presentation, it may be necessary to compare standing with HUT 
stimulus exposure or integrate auditory stimuli in light of recent posture-related research 
(Harmon-Jones and Peterson, 2009, Price and Harmon-Jones, 2011).   
 
7.2.4. Interoception findings 
OI patients consistently underestimated their heartbeats during testing. PoTS patients’ 
interoceptive accuracy was significantly poorer during isometric exercise and cold pressor in 
comparison to healthy controls and AMS patients’ interoceptive accuracy was significantly 
poorer during baseline, isometric exercise and HUT. Curiously, AMS IA during cold pressor was 
higher than the PoTS and healthy control groups, though not significantly so. The cold pressor 
manoeuvre causes vasoconstriction, making it a useful exercise to test autonomic integrity but 
it also has a strong nociceptive component. Nociception, and the apprehension of 
nociception, are common causes of AMS (van Lieshout et al., 1991, Humm and Mathias, 2010) 
and this sensitivity may relate to the cold pressor findings and the pervasive anxious 
apprehension of pain in AMS (McGrady et al., 2001, Graham, 1961).  
 
Interoception of visceral feedback is required for autonomic mediation of homeostasis, even 
on a physiological level, with baroreceptors and chemoreceptors serving as 'interoceptors', 
yet AMS and PoTS are conditions defined by the intermittent breakdown of these homeostatic 
mechanisms. It could be proposed from the current data that the breakdown of interoceptive 
homeostatic reflexes is also apparent at a conscious level of IA in OI subjects (see also chapter 
6).   
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7.2.5. Interoceptive & orienting response correlation findings 
Supine and HUT BP data (ORs and mean data) was more strongly related to IA than cardiac 
data in the AMS and PoTS subjects, lending further support (see also chapter 6) to 
mechanoreceptors in the great vessels, for example, the aortic arch, having primary cardiac 
interoceptive roles in OI, possibly accounting for their reduced cardiac IA in comparison to 
controls. This is further supported by PoTS DBP during HUT and neutral images being positively 
related to HUT IA and DBP during pleasant images being positively related to HUT IA. In contrast, 
in controls supine SBP during pleasant images positively related to baseline IA and HUT SBP 
during unpleasant images positively related to isometric IA. SBP indicates stroke volume, aortic 
compliance and left ventricular ejection velocity, whereas DBP indicates peripheral resistance 
of blood flow from arterioles to capillaries (Dampney et al., 2002), therefore peripheral 
vasomotor afferent signalling appears to be more closely related to cardiac IA than cardiac 
nerve activity in PoTS, whereas, controls cardiac IA in controls was more strongly related to 
systolic cardiac activity. This may explain the recent finding that the interoception of 
palpations in PoTS was separate to that of tachycardia (Khurana, 2014), as well as indicating 
differences in the central integration of afferent feedback in OI, as in chapter 6 where 
interoception was found to be anxiogenic rather than homeostatic in nature dysautonomia. 
 
During supine unpleasant image exposure, PoTS cardiac ORs negatively correlated with 
baseline, isometric exercise and HUT IA., i.e., greater cardiac deceleration to unpleasant 
images representing stimulus detection correlated with increased IA, substantiating the role of 
ORs and IA in emotion formation in this cohort. PoTS SBP and DBP during supine unpleasant 
images positively correlated with HUT IA, when orthostatic tachycardia would have been 
provoked, again indicating a dominant role of vasomotor or baroreceptor over cardiac 
afferent feedback in cardiac IA in PoTS. 
 
The areas implicated in this potential disruption of interoceptive feedback may relate to the 
recent study of 32 AMS patients (mean age 24) that evidenced reduced right insula volumes. 
These reductions were related to greater falls in SBP and DBP (Kim et al., 2014) during HUT. In 
animal studies, decreases in BP correlate with decreased right insula activity in anaesthetised 
cats (Henderson et al., 2004) and in humans, right insula activity co-varies with increases in HR 
and BP during task engagement (Critchley et al., 2000a). Cardiac IA has been found to 
decrease after right insula resection of a neoplastic lesion (Ronchi et al., 2015) and right 
hemisphere infarction involving the insula causes pervasive cardiovascular autonomic 
dysregulation in comparison to left hemisphere infarction involving the insula (Meyer et al., 
2004). Moreover, The role of the right insula in second-order conscious homeostatic 
representations has been further evidenced using false physiological feedback of HR during 
functional magnetic resonance imaging (fMRI) by Gray and colleagues (Gray et al., 2007), 
who examined emotional appraisal of neutral faces during baseline and isometric handgrip 
136 
exercise. False feedback of increased HR during emotional stimuli caused appraisal levels of 
emotional intensity/salience to increase. Using fMRI, Critchley and co-workers (Critchley et al., 
2004) found that activation of the insula cortex, particularly the right, highly correlated with 
interoceptive awareness and accuracy in healthy controls. The authors concluded that the 
right insula depicts internal bodily state that can be consciously accessed and insula activity 
was positively correlated with anxiety and interoceptive awareness. The anterior and mid 
insula cortices, Acc and somatomotor cortex were functionally associated with shifting one’s 
attention to interoceptive events. 
 
As with AMS, there is a dearth of brain imaging studies in PoTS, however, one recent study 
evidenced reduced left insula grey matter volumes in 11 PoTS patients (mean age 32) (Umeda 
et al., 2015). These reductions were negatively correlated with depression and anxiety scores. 
The reduced insula volumes in this study and that of Kim et al in AMS patients are unlikely to 
result from age-related neurodegeneration due to the age of the subjects, implicating the 
insula in both AMS and PoTS neuropathophysiology. The insula are also involved in pressor tone 
and initiation of the baroreflex (Kimmerly et al., 2005), which fails during orthostasis in AMS and 
PoTS. Along with the dorsal Acc, insula activity reflects the engagement of sympathetic activity 
coupled to mental and physical behaviours (Critchley et al., 2000a, Critchley et al., 2000b) and 
the role of the insula as part of the central autonomic network (CAN) (Benarroch, 1993) is 
further evidenced by increased anterior and posterior insula activity during isometric exercise 
and the Valsalva manoeuvre (King et al., 1999) (Harper et al., 2000). Together, these recent 
investigations into the neuropathophysiology of AMS and PoTS may provide a useful starting 
point for defining the central mechanisms that may be implicated in the current IA and OR 
findings.  
 
The second aim of this study was to investigate any interactions between ORs and IA in order 
to better understand the genesis and presentation of psychological symptoms in OI. From the 
AMS data, one could hypothesise that the strong relationship between cold pressor IA, which 
was more accurate than PoTS and controls, and HUT ORs during emotional stimuli provide 
further support for an innate difference in AMS patients’ brain-body integration of emotionally 
challenging stimuli, particularly during simultaneous autonomic and affective stress. It could 
be argued that this is manifested in the common blood-injury phobia in AMS.  
 
Human cognitive models of anxiety propose that anxiety is perpetuated by somatic 
hypervigilance (Wilhelm and Roth, 2001), biased ORs to perceived threat (Bar-Haim et al., 
2007) and attentional deficits (Eysenck et al., 2007). Somatic hypervigilance and attentional 
deficits are also common symptoms reported by AMS and PoTS patients (see chapters 5 and 
6 of this thesis) who also appear to have exaggerated peripheral vasoconstrictor ORs to 
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simultaneous orthostatic and emotional challenges. However, PoTS and AMS differ from typical 
anxious cohorts, in that anxiety symptoms are predominantly defined by somatic and 
dysautonomic factors. As attentional habits that are weighted towards threat (Mathews, 1990) 
and somatic hypervigilance (Verkuil et al., 2007) cause a cycle of anxiety, these aspects could 
be perpetuated by a having a condition that excessively increases autonomic activity, such 
as PoTS or AMS, particularly as the current data indicate, for the first time, how brain-body 
orienting and homeostatic processes susceptible to dysregulation by dysautonomia appear 
to be related this these patients, indicative of a 'bottom-up' model of emotion formation.  
 
The pathophysiology of VVS is still not yet fully understood (Meyer et al., 2004), the 
neuropathophysiology even less so, therefore the implication of structural differences in the 
insula of VVS patients may contribute to both the cardiovascular autonomic, interoceptive 
and cognitive-affective symptoms in these patients. The current IA data suggests that AMS 
and PoTS patients have difficulty either consciously accessing accurate interoceptive 
representations perhaps due to dysautonomia-related error code size (Seth and Critchley, 
2013) or that the internal state is improperly represented, potentially due to differences in brain-
body integration, in comparison to controls, as reflected by the IA being highly correlated with 
ORs in OI and reports of structural differences in key interoceptive centres (insula) in AMS.   
 
7.2.6. Summary of key findings 
This study examined supine and HUT ORs in EH, AMS and PoTS in comparison to healthy controls, 
concluding that; 
Ø HUT induced an attenuation or delay in initial stimulus detection on HUT. 
Ø Unpleasant images on HUT appeared to have greater intensity for AMS and PoTS 
patients according to their peripheral vasoconstrictor ORs, though this was not 
reflected in the valence VAS ratings, potentially due to the categorical differences 
between valence and intensity 
  
7.2.7. Conclusions 
These findings indicate greater stimulus detection is related to visceral sensitivity in PoTS and 
supports the argument for a reduced repertoire of defence responses in AMS, as evident by 
this cohort's reduced α1 and α2-adrenoceptor vasoconstrictive responses to unpleasant 
images during HUT and lack of association between IA and OR data in controls. The implication 
of the insula in the neuropathophysiology of OI may have profound downstream effects on 
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cardiovascular autonomic, emotional and interoceptive function and further study is 
warranted.  
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Chapter 8. Synthesis of findings 
This thesis was structured to examine the genesis and presentation of psychological symptoms 
that commonly present in AMS, EH and PoTS by utilising physiological and psychological tests 
that recruited varying levels of cerebral engagement (see figure 44) (Critchley et al., 2002). It 
has been proposed that the reduced vagal tone in affective disorders disinhibits 
sympathoexcitation, causing sympathetic dominance of central and peripheral processes. 
This autonomically mediated feedback loop perpetuates trait sympathoexcitation and 
anxiogenesis, likely explaining interoception’s contributory role to anxiety disorders via somatic 
hypervigilance. Excessive but intermittent sympathoexcitation is also a primary symptom in the 
pathophysiology of AMS, EH and PoTS, forms of dysautonomia in which subclinical anxiety and 
somatic hypervigilance are prevalent.  
 
Figure 44. Rational for experiments 
 
 
8.1. Subnormal interoception in PoTS predisposes to functional 
symptoms 
The findings in chapter 4 indicate that functional syncope is a conversion disorder in the 
functional syncope (FS) only group and an aberrant response to orthostatic intolerance (OI) in 
the FS/PoTS and FS/AMS groups, as these patients were OI symptomatic during FS. A 
neurological predisposition to be overwhelmed by stressors has been described in non-
epileptic seizure (Almis et al., 2013) and this reaction could potentially be provoked by the 
interoceptive threat of symptomatic OI and further impacted by the impaired interoceptive 
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accuracy found in PoTS and AMS in chapters 6 and 7 of this thesis. This is supported by the fact 
that FS/PoTS patients were referred for syncope or pre-syncope rather than cardiothoracic 
symptoms and, likewise, during testing, FS/PoTS patients rarely reported cardiothoracic 
symptoms. It may also be relevance that JHS/EDSIII - a rheumatological marker for PoTS - is also 
associated functional disorders (Nijs et al., 2006, Kovacic et al., 2014, Acasuso-Diaz and 
Collantes-Estevez, 1998).  
 
The prediction error modification strategy of motor engagement to meet the noisy incoming 
autonomic afferent feedback of tachycardia or pre-syncope may account for FS episodes 
generally occurring during symptomatic OI in FS/PoTS and FS/AMS. Individuals who somatise 
are more vigilant of bodily sensations (a common PoTS and AMS trait, see chapter 5), with prior 
illness beliefs (a key Bayesian factor) playing a significant role (Kirmayer and Robbins, 1996), 
potentially explaining the primary symptoms of syncope – unresponsiveness, loss of postural 
tone – being synthesised with the seizure-like symptoms of eyelid fluttering/rolling and clonic, 
myoclonic and other motor symptoms in FS. In chapters 4, 5 and 6, PoTS patients consistently 
reported a far wider spectrum of symptoms than AMS and EH and this somatic attribution style 
may explain why more PoTS patients encountered FS.  
 
Patients with functional tremor have been found to misattribute the agency of voluntary 
movement so that they judge both the intent to move and the act of moving as occurring 
simultaneously in an aberrant attribution style (Edwards et al., 2011). It could be argued that it 
is even easier to adopt this maladaptive attribution style if the individual is also tachycardic or 
pre-syncopal at the time, especially pre-diagnosis of OI when these autonomic symptoms 
could act as a somatic marker of unknown illness. Chapter 6 indicates a higher order deficit in 
OI and EH patients’ conscious cardiac interoceptive accuracy but the prevalence of FS in 
PoTS is suggestive of a subconscious or pre-conscious disruption of brain-body integration 
driven by episodes of OI.  
 
In light of the impaired interoception in PoTS and AMS, predictive processing models may offer 
an alternative to understanding FS as the engagement of motor systems to reduce 
interoceptive prediction errors of symptomatic OI, substantiated by the finding that FS/PoTS 
patients were referred for syncope not PoTS-related symptoms and reported mainly 
neuropathic rather than cardiothoracic symptoms pre and post FS.  
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8.2. Anxiety sensitivity to autonomic & cognitive aberrations due 
to intermittent dysautonomia  
Trauma was not a mediator of the pervasive cognitive-affective symptoms reported by 
intermittent dysautonomia patients and all three clinical cohorts reported greater cognitive 
depressive symptoms of indecisiveness and concentration difficulty than controls. Anxiety-
related phenomena in autonomic patients is not typical of clinical anxiety disorder patients 
but is rather defined by visceral factors. The fact that AMS patients reported being significantly 
more sensitive and paid more attention to changes in their body can be viewed from a 
homeostatic perspective, in that these symptoms can be a somatic marker of an imminent 
syncopal episode. PoTS patients in particular reported pronounced anxiety, attentional 
difficulties and somatic hypervigilant symptoms.  
 
Rather than anxiety being a neurotic trait-like phenomena, such as self-consciousness or social 
anxiety, somatic and cognitive symptoms predominated as the source of distress in all patients 
groups, demonstrating that these higher order symptoms may relate to the central integration 
of (aberrant) afferent autonomic signalling. Some insight into this potential central mediation 
may be garnered from the recent neuroimaging findings that reduced left insula grey matter 
volumes in PoTS (Umeda et al., 2015) have been negatively correlated with depression and 
anxiety scores, and that reduced right insula volumes in AMS are correlated with BP falls during 
HUT (Kim et al., 2014). 
 
Although PoTS patients reported themselves as having accurate subjective interoception via 
self-report measures, their lack of reported cardiothoracic symptoms in chapters 4 and 5, and 
the interoceptive findings in chapters 6 and 7, is more representative of subjective sensitisation 
rather than interoceptive accuracy, which was actually found to be diminished in all patient 
groups.  
 
The lack of state anxiety, social anxiety or self-consciousness indicates that the common 
psychological symptoms experienced by AMS, EH and PoTS patients are derived from the 
physiological and homeostatic dysregulation caused by their intermittent autonomic disorder, 
as evidenced by anxiety being firmly aligned with somatic events, visceral sensations, 
attentional deficits and the vigilance and anxious apprehension of these phenomena. This is 
substantiated by the strongest correlations amongst all intermittent dysautonomia patient 
groups relating to anxiety sensitivity to visceral sympathetic arousal and attentional deficits. 
  
This anxiety sensitivity to cognitive and autonomic symptoms that are defining symptoms of OI 
may also elucidate the prevalence of FS in OI patients during autonomic testing in chapter 4. 
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Sensitivity to visceral symptoms appears to be associated with functional symptoms, whereas 
sensitivity to central symptoms is associated with derealisation, presumably as there is no 
evasive behaviour other than dissociation or distraction (perhaps contributing to attentional 
deficits) that alleviates the distress caused by the sensitivity and awareness of these affective 
and attentional symptoms. This may also explain the incidence of FS during symptom 
provocation in undiagnosed OI patients with subnormal interoception (as evidenced in 
chapters 6 and 7). These findings indicate how the prevalent psychological symptoms in EH 
and OI are caused by rather than causative of intermittent dysautonomia. 
 
8.3. Interoception is anxiogenic in intermittent dysautonomia: 
interoceptive prediction error strategies as a potential explanation 
for attentional symptoms 
Despite increased somatic anxiety, EH, PoTS and AMS patients consistently underestimated 
their cardiac activity and EH and AMS groups had identical interoceptive profiles, providing 
further support for the involvement of a common (central) integrative dysregulation of visceral 
sensory information. This is supported by PoTS patients’ symptoms being provoked on HUT, yet 
neither their interoceptive accuracy nor interoceptive sensibility improving. In addition, AMS 
and EH subjects’ interoceptive accuracy significantly worsened on HUT, implicating non-
cardiac mechanoreceptors in OI and EH cardiac interoception and further evidencing 
differences between high order processing of visceral nerve activity between the autonomic 
cohorts and controls.  
 
The implication of the insula in OI neuropathophysiology may contribute to perturbed 
interoception in AMS and PoTS, as the right insula depicts internal bodily state that can be 
consciously accessed and the left insula is involved in parasympathetic cardiovascular 
regulation (Oppenheimer et al., 1996). Alternatively or additionally, the underestimated 
cardiac interoception may be due to cognitive control networks (Seeley et al., 2007) altering 
the interoceptive weight of afferent inputs from the periphery, also explaining PoTS patients 
under-reporting of cardiothoracic symptoms in chapters 4 and 5. This demand on cognitive 
control networks may also contribute to the attentional symptoms reported in chapters 5 and 
6. Behaviour is influenced by interoception to maximise reward and avoid punishment 
(Damasio et al., 1991, Bechara et al., 1997a) and it follows that if interoceptive feedback of 
increased autonomic activity is too dysregulating, i.e., causes large prediction errors requiring 
alterations in how the brain attends to interoceptive signals that inform behavioural learning, 
then cognitive and attentional difficulties will occur, at least during symptom provocation. 
However, the current data suggests these deficits may also occur at rest, perhaps due to the 
conditioning of brain-body integrative processes over time.  
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In healthy controls, interoception appeared to be serving its homeostatic purpose, as the more 
interoceptively accurate controls were, the less time they scanned their body for symptoms of 
sympathoexcitation. This was reversed in PoTS, further suggesting that interoception appears 
to be anxiogenic rather than homeostatic in this cohort. The Body Vigilance Scale survey data 
alone found that cardiothoracic symptoms were not the target of somatic hypervigilance in 
PoTS, yet the symptoms associated with interoceptive accuracy in PoTS were not only primary 
symptoms of PoTS (dizziness, shortness of breath, choking), but the relationship of 
hypervigilance of these symptoms to interoceptive accuracy was positively related, again 
suggesting that interoception is driving somatic anxiety in PoTS.  
 
Further evidence for this breakdown in the central processing of visceral activity can also be 
found in the fact that cardiovascular arousal increases interoception (Schandry et al., 1993), 
yet the opposite was true of AMS, EH and PoTS patients. This may also substantiate the 
implementation of strategies to accommodate large interoceptive predication errors in these 
cohorts. Together, these findings indicate that discrepancies and aberrations in interoceptive 
expectations are somatic sources of anxiety and disrupt cognition, supporting current 
‘peripheral’ theories of emotion. This may also offer a possible therapeutic pathway for 
psychological symptoms in OI and EH. 
 
8.4. Orienting & visceral sensory processes are dysregulated by 
dysautonomia  
Tilted viewing of unpleasant images produced exaggerated DBP ORs in both OI groups, 
suggesting these images possessed greater intensity and that OI symptom provocation may 
contribute to negative affect, at least at an unconscious level. This potential for OI to 
exacerbate negative affect may help explain the prevalence of somatic anxiety in chapters 
5 and 6. The lack of association between interoceptive accuracy and systolic blood pressure 
(stroke volume, aortic compliance and left ventricular ejection velocity) in favour of 
correlations between interoceptive accuracy and diastolic blood pressure (peripheral 
resistance of blood flow from arterioles to capillaries) in PoTS, in addition to AMS and PoTS 
supine and HUT blood pressure data (ORs and mean) being more strongly related to 
interoception than cardiac data, further implicates vasomotor afferent signalling of 
mechanoreceptors rather than cardiac nerve activity in OI cardiac interoception, 
conceivably accounting for these patients reduced cardiac interoceptive accuracy and also 
the recent finding that the interoception of palpations in PoTS is separable to tachycardia 
(Khurana, 2014). Conversely, healthy controls’ cardiac interoceptive accuracy was strongly 
aligned to systolic activity, restating differences in the way visceral activity is centrally 
processed between patients and healthy controls, as in chapter 6 where interoception was 
found to be anxiogenic rather than homeostatic in nature in OI. Barry’s ‘preliminary process 
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theory’ states that the peripheral vasoconstriction OR is an index of stimulus intensity (Barry, 
2009), however, it is important to note that PoTS and AMS valance ratings on the VAS to 
unpleasant images on HUT did not differ from that of controls. The IAPS database provides 
valence ratings for each image but during pilot study data collection, asking patients with OI 
to provide both valence and intensity ratings proved difficult and often meant the clinical 
participants needed significantly longer between images than controls to provide both 
measures. In hindsight, it may have been preferable to focus on intensity rather than valence 
ratings with the VAS, as the intention that the degree of valence on the sliding VAS would 
provide a proxy measure of intensity was not found.   
 
PoTS greater cardiac deceleration to unpleasant images representing stimulus detection 
correlated with increased interoceptive accuracy, which substantiates the integrative roles of 
ORs and IA in this cohort and supports the concept of visceral sensitisation in this cohort. 
Moreover, greater stimulus detection (cardiac declaration) was related to visceral sensitivity 
in PoTS. Chapter 7 provided further evidence for a reduced repertoire of defence responses 
in AMS, indicating that these patients’ common blood injury phobia may be a manifestation 
of innate differences in the assimilation of aversive stimuli.  
 
Anxiety is perpetuated by somatic hypervigilance (Wilhelm and Roth, 2001), biased ORs to 
perceived threat (Bar-Haim et al., 2007) and attentional deficits (Eysenck et al., 2007). Somatic 
hypervigilance and attentional deficits are also common symptoms reported by EH, AMS and 
PoTS patients but differing from clinical anxiety cohorts in that anxiety symptoms were 
predominantly defined by somatic and cognitive factors. Attentional habits that are weighted 
towards threat (Mathews, 1990) and somatic hypervigilance (Verkuil et al., 2007) cause a cycle 
of anxiety and could be perpetuated by a condition that excessively increases autonomic 
activity, particularly as the data in chapters 6 and 7 indicate how psychophysiological 
processes, such as orienting and interoception are dysregulated by dysautonomia, as 
supported by the lack of correlations between interoception and ORs in controls. 
 
8.5. Impact & future research 
The functional and psychosomatic findings in chapter 4, the somatic and cognitive anxiety 
sensitivity and depression in chapter 5, the aberrant affective and visceral integration in 
chapter 6 and the disruption of innate phylogenetic assimilative reflexes and homeostatic 
mediation in chapter 7 not only evidences the psychological impact of intermittent 
dysautonomia but also provides a potential treatment pathway for these symptoms. Further 
research is required on how treatment of dysautonomia interacts with these comorbid 
psychological symptoms, the neuropathophysiology of OI and EH at rest and during symptom 
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provocation and how these findings relate to autonomic and psychological symptoms to 
improve treatment and diagnosis of intermittent dysautonomia, and also how the autonomic 
nervous system couples brain and body to drive cognitive-affective processes in health and 
disease.   
 
Due to a number of constraints, the experiments undertaken in this thesis had some limitations. 
In chapter 4 examining FS, retrospective analysis, which dated back over a number of years, 
was limited to patient files and clinical data gathered by a number of varying clinicians, almost 
all of whom, would have had no interest in collecting data related to investigating FS. I would 
like to rectify this and build on the data I have collected so far carrying out a prospective study 
looking at a broader spectrum of functional neurological symptoms, including FS, during 
autonomic testing and if the presentation of these symptoms is influenced by the diagnosis 
and treatment of autonomic symptoms. I was only able to hypothesise about the possible 
reasons for FS occurring in PoTS and AMS patients, therefore it would also be useful to ask these 
patients to participate in the interoceptive exercises from chapter 6, to better understand how 
they interpret being symptomatic during HUT and pHUT. 
 
For a questionnaire survey, chapter 5 was underpowered (22 x healthy controls, 30 x PoTS 
patients, 20 x EH patients, 22 x AMS patients) and I will continue to collect data from OI and EH 
patients to ensure the findings are publishable. I also would like to investigate further the 
prevalence of the subtle dissociative symptoms correlation analysis revealed in EH patients. 
Psychological investigations are typically limited to anxiety in EH, however, a 2013 study (Ak et 
al., 2013) found alexithymia to be increased in EH. In light of this and the chapter 5 data, I think 
dissociative symptoms in EH warrants further study from a psychodermatological perspective 
(Poot et al., 2007), considering the role of the skin in emotional expression and selfhood 
(Koblenzer, 1983).   
 
I found that most PoTS, EH and AMS patients experience attentional problems. However, 
despite a small number of studies in PoTS investigating cerebral perfusion and noradrenergic 
coupling, the cause of this brain fog remains unknown in PoTS and is under-researched in AMS 
and EH (Ross et al., 2013). Cognitive function is also impaired in fixed ANS disorders, especially 
during orthostasis, despite no evidence of neurological deficits (Guaraldi et al., 2014, Heims et 
al., 2006a) and it is unclear whether this is due to common pathological processes effecting 
cognitive or autonomic neuroanatomy, from cerebral hypoperfusion, or an unknown cause. 
The baroreflex modulates cardiac responses to BP fluctuations and is intermittently 
compromised in AMS and PoTS and permanently compromised in AF. A recent study 
evidenced memory formation in healthy controls is poorer at systole compared to diastole 
(Garfinkel et al., 2014), therefore, I would like to investigate the potential role of the baroreflex 
146 
(and its central regulation) (Gianaros et al., 2012) in the expression of brain fog in intermittent 
and fixed ANS disorders, combining simultaneous functional neuroimaging, 
psychophysiological challenge and peripheral stimulation in comparison to healthy controls, 
to gain insight into the interaction of central and peripheral pathologies. 
 
Considering the interoceptive findings in chapters 6 and 7, I proposed that OI cardiac 
interoception may involve mechanoreceptors in more than one location, not only those 
located in the heart. Unfortunately, due to the Finometer using a finger cuff to collect beat-to-
beat BP data, it was not possible to collect any BP data during these studies which wold of 
been particularly relevant. As with chapter 5, the number of participants was low (23 x healthy 
controls, 21 x PoTS patients, 17 x EH patients, i6 x AMS patients) due to various constraints. I also 
propose the possibility of a centrally mediated dysregulation of brain-body integration causing 
the interoceptive findings, therefore, repeating these exercises during functional brain imaging 
may present some significant insights into possible neurobiological mechanisms that contribute 
to the common psychological symptoms in AMS, EH and PoTS.  
 
Due to the prevalence of blood-injury phobia in VVS (Humm and Mathias, 2010), the potential 
for pain to induce vasovagal episodes and the pain sensitivity in PoTS (Mathias et al., 2012), I 
would like to investigate in the future whether neuroimaging can elucidate interoception and 
nociception symptoms in OI, particularly in light of the recent implications of the insula 
(interoceptive, nociceptive and autonomic centre)  in OI neuropathophysiology (Umeda et 
al., 2015) (Kim et al., 2014). Additionally, subjective experience of pain is inversely correlated 
with BP (Delgado et al., 2014) and baroreceptor activity influences pain sensitivity (Gray et al., 
2010), yet this has not been investigated in AMS and PoTS, where the baroreflex is intermittently 
compromised and patients have low BP profiles. Therefore, I believe conducting a large scale 
imaging survey of potential structural abnormalities and combining simultaneous functional 
neuroimaging, low level pain fibre stimulation and interoception testing may be of value.  
 
In chapter 7, VAS data for neutral, pleasant and unpleasant valences was presented in mean 
form. I suspect matching each VAS image rating to each OR may have the potential to offer 
further findings into the effect of OI on HUT ORs. Unfortunately, due to time constraints, the 
reanalysed data could not be presented in this thesis. The inclusion of aversive sound stimuli 
may also be useful in examining ORs and CDRs to different sensory signals as well as utilising 
emotion regulation paradigms to progress the current.  
 
In distilling and synthesising the various findings of this thesis, I feel it is reasonable to conclude 
that subnormal interoception in PoTS predisposes to functional symptoms, the affective 
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symptoms many OI and EH patients report are primarily related to somatic factors rather than 
being trait-like phenomena, anxiety sensitivity to autonomic and cognitive aberrations in OI 
and EH is due to intermittent dysautonomia, interoception is anxiogenic in intermittent 
dysautonomia and orienting & visceral sensory processes are dysregulated by dysautonomia. 
I feel that these findings may provide a worthwhile contribution to the psychophysiology of 
dysautonomia.   
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Appendix	A:	The	Body	Vigilance	Questionnaire	
Schmidt, Lerew, & Trakowski (1997) 
 
In this section, we are interested in learning how sensitive you are to internal bodily 
sensations such as heart palpitations or dizziness.  Please fill it out according to how you have 
felt for the past week.   
 
1. I am the kind of person who pays close attention to internal bodily sensations. 
 
0 1 2 3 4 5 6 7 8 9 10 
Not at all like me   Moderately like me       Extremely like 
me 
 
 
2. I am very sensitive to changes in my internal bodily sensations. 
 
0 1 2 3 4 5 6 7 8 9 10 
Not at all like me   Moderately like me       Extremely like 
me 
 
 
3. On average, how much time do you spend each day “scanning” your body for sensations 
(eg., sweating, heart palpitations, dizziness)? 
 
0 1 2 3 4 5 6 7 8 9 10 
     No time       Half of the time            All of the 
time 
 
4. Rate how much attention you pay to each of the following sensations using the scale 
below.  Write the appropriate number on the line next to each item. 
 
0 1 2 3 4 5 6 7 8 9 10 
None         Slight       Moderate     Substantial  Extreme 
 
 1.  Heart palpitations   _____ 
 2.  Chest pain/discomfort   _____ 
 3.  Numbness    _____ 
 4.  Tingling    _____ 
 5.  Shortness of breath/smothering _____ 
 6.  Faintness    _____ 
 7.  Vision changes   _____ 
 8.  Feelings of unreality   _____ 
 9.  Feeling detached from self  _____ 
10.  Dizziness    _____ 
11.		Hot	Flash	 	 	 	 _____	
12.		Sweating/clammy	hands	 	 _____	
13.  Stomach Upset   _____ 
14.		Nausea		 	 	 _____	
15.		Choking/throat	closing	 	 _____	
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Appendix	B:	Beck	Depression	Inventory	
Name  Date  
    
 
Instructions: This questionnaire consists of 21 groups of statements. Please read each group 
of statements carefully, and then pick out the one statement in each group that best describes 
the way you have been feeling during the past two weeks, including today. Circle the number 
beside the statement you have picked. If several statements in the group seem to apply equally 
well, circle the highest number for that group. Be sure that you do not choose more than one 
statement for any group, including Item 16 (Changes in Sleeping Pattern) or Item 18 (Changes 
in Appetite). 
 
1.Sadness 6.Punishment Feelings 
0 I do not feel sad 0 I don’t feel I am being punished 
1 I feel sad much of the time 1 I feel like I may be punished 
2 I am sad all the time 2 I expect to be punished 
3 I am so sad or unhappy that I can’t stand it 3 I feel I am being punished 
2.Pessimism 7.Self-Dislike 
0 I am not discouraged about my future 0 I feel the same about myself as ever 
1 I feel more discouraged about my future than I used to be 1 I have lost confidence in myself 
2 I do not expect things to work out for me 2 I am disappointed in myself 
3 I feel my future is hopeless and will only get worse 3 I dislike myself 
3.Past Failure 8.Self-Criticalness 
0 I do not feel like a failure 0 I don’t criticise or blame myself more than 
usual 
1 I have failed more than I should have 1 I am more critical of myself than I used to be 
2 As I look back, I see a lot of failures 2I criticise myself for all of my faults 
3 I feel I am a total failure as a person 3 I blame myself for everything bad that happens 
4.Loss of Pleasure 9. Suicidal Thoughts or Wishes 
0 I get as much pleasure as I ever did from the things I enjoy 0 I don’t have any thoughts of killing myself 
1 I don’t enjoy things as much as I used to 1 I have thoughts of killing myself, but I would 
not carry them out 
2 I get very little pleasure from the things I used to enjoy 2 I would like to kill myself 
3 I can’t get any pleasure from the things I used to enjoy 3 I would kill myself if I had the chance 
5.Guilty Feelings 10. Crying 
0 I don’t feel particularly guilty 0 I don’t cry any more than I used to 
1 I feel guilty over many things I have done or should have 
done 
1 I cry more than I used to 
2 I feel quite guilty most of the time 2 I cry over every little thing 
3 I feel guilty all of the time 3 I feel like crying, but I can’t  
11. Agitation 17. Irritability 
0 I am no more restless or wound up than usual 0 I am no more irritable than usual 
1 I feel more restless or wound up than usual 1 I am more irritable than usual 
2 I am so restless or agitated that it’s hard to stay still 2 I am much more irritable than usual 
3 I am so restless or agitated that I have to keep moving or 
doing something 
3 I am irritable all the time 
12. Loss of Interest 18. Changes in Appetite 
0 I have not lost interest in other people or activities 0 I have not experienced any change in my 
appetite 
1 I am less interested in other people or things than before 1a My appetite is somewhat less than usual 
1b My appetite is somewhat greater than usual 
2 I have lost most of my interest in other people or things 2a My appetite is much less than before 
2b My appetite is much greater than usual 
3 It’s hard to get interested in anything 3a I have no appetite at all 
3b I crave food all the time 
13. Indecisiveness 19. Concentration Difficulty 
0 I make decisions about as well as ever 0 I can concentrate as well as ever 
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1 I find it more difficult to make decisions than usual 1 I can’t concentrate as well as usual 
2 I have much greater difficulty in making decisions than I 
used to 
2 It’s hard to keep my mind on anything for very 
long 
3 I have trouble making any decisions 3 I find I can’t concentrate on anything 
14. Worthlessness 20. Tiredness or Fatigue 
0 I do not feel I am worthless 0 I am no more tired or fatigued than usual 
1 I don’t consider myself as a worthwhile and useful as I 
used to 
1 I get more tired or fatigued more easily than 
usual 
2 I feel more worthless as compared to other people 2 I am too tired or fatigued to do a lot of the 
things I used to do 
3 I feel utterly worthless 3 I am too tired or fatigued to do most of the 
things I used to do 
15. Loss of Energy 21. Loss of Interest in Sex 
0 I have as much energy as ever 0 I have not noticed any recent change in my 
interest in sex 
1 I have less energy than I used to have 1 I am less interested in sex than I used to be 
2 I don’t have enough energy to do very much 2 I am much less interested in sex now 
3 I don’t have enough energy to do anything 3 I have lost interest in sex completely 
16. Changes in Sleeping Pattern  
0 I have not experienced any change in my sleeping pattern Subtotal Page 1 
1a I sleep somewhat more than usual 
1b I sleep somewhat less than usual 
Subtotal Page 2 
2a I sleep a lot more than usual 
2b I sleep a lot less than usual 
Total Score 
3a I sleep most of the day 
3b I wake up 1-2 hours early and can’t get back to sleep 
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Appendix	C:	Cardiac	Anxiety	Scale	
Please rate each item by circling the answer (number) that best applies to you: 
 Never Rarely Sometimes Often  Always 
1. I pay attention to my heart beat 1 2 3 4 5 
2. I avoid physical exertion 1 2 3 4 5 
3. My racing heart wakes me up at night  1 2 3 4 5 
4. Chest pain/discomfort wakes me up at 
night  
1 2 3 4 5 
5. I take it easy as much as possible 1 2 3 4 5 
6. I check my pulse 1 2 3 4 5 
7. I avoid exercise or other physical work 1 2 3 4 5 
8. I can feel my heart in my chest 1 2 3 4 5 
9. I avoid activities that make my heart 
beat faster 
1 2 3 4 5 
10. If tests come out normal, I still worry 
about my heart 
1 2 3 4 5 
11. I feel safe being around a hospital, 
physician or other medical facility  
1 2 3 4 5 
12. I avoid activities that make me sweat 1 2 3 4 5 
13. I worry that doctors do not believe my 
symptoms are real  
1 2 3 4 5 
When I have chest discomfort or when my 
heart is beating fast: 
Never Rarely Sometimes Often  Always 
14. I worry that I may have a heart attack  1 2 3 4 5 
15. I have difficulty concentrating on 
anything else  
1 2 3 4 5 
16. I get frightened 1 2 3 4 5 
17. I like to be checked out by a doctor 1 2 3 4 5 
18. I tell my family or friends  1 2 3 4 5 
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Appendix	D:	Anxiety	Sensitivity	Index	
A number of statements that people have used to describe 
themselves are given below. Read each statement and mark the 
appropriate number to indicate how you feel right now at this 
moment. There are no right or wrong answers. Don’t spend too 
much time on one statement but give the answer that best 
describes your present feelings.   
0. 
N
ot at all like 
m
e 
1. 
S
lightly 
disagree 
2. 
M
oderately like 
m
e 
3. 
Q
uite like m
e 
4. 
E
xtrem
ely like 
m
e 
1. When I cannot keep my mind on a task, I worry that I might be 
going crazy 
          
2. It scares me when I feel “shaky” (trembling)            
3. It scares me when I feel faint.           
4. It scares me when my heart beats rapidly           
5. When I notice that my heart is beating rapidly, I worry that I might 
have had a heart attack 
          
6. It scares me when I become short of breath            
7. When my stomach is upset, I worry that I might be seriously ill           
8. It scares me when I am unable to keep my mind on a task           
9. Unusual body sensations scare me           
10. When I am nervous, I worry that I might be mentally ill           
11. It scares me when I am nervous            
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Appendix	E:	State	Anxiety	Inventory	
A number of statements that people have used to describe themselves 
are given below. Read each statement and mark the appropriate 
number to indicate how you feel right now at this moment. There are no 
right or wrong answers. Don’t spend too much time on one statement 
but give the answer that best describes your present feelings.   
1. 
N
ot at all 
2. 
S
om
ew
hat 
3. 
M
oderately 
so 
4. 
V
ery m
uch 
so 
1. I feel calm         
2. I feel secure         
3. I am tense         
4. I am regretful         
5. I feel at ease         
6. I feel upset         
7. I am presently worrying over possible misfortunes          
8. I feel rested         
9. I feel anxious         
10. I feel comfortable         
11. I feel self-confident         
12. I feel nervous          
13. I am jittery         
14. I feel “highly strung”         
15. I am relaxed         
16. I feel content         
17. I am worried         
18. I feel confused          
19. I feel steady          
20. I feel pleasant         
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Appendix	F:	Self-consciousness	Scale	(revised)	
 Not at all 
like me 
A little like 
me 
Somewhat 
like me 
A lot like me 
1. I always try to figure myself out 0 1 2 3 
2. I’m concerned about my style of 
doing things 
0 1 2 3 
3. Generally, I’m not very aware of 
myself 
0 1 2 3 
4. It takes me time to overcome my 
shyness in new situations 
0 1 2 3 
5. I reflect about myself a lot 0 1 2 3 
6. I’m concerned about the way I 
present myself 
0 1 2 3 
7. I’m often the subject of my own 
fantasies 
0 1 2 3 
8. I have trouble working when 
someone is watching me 
0 1 2 3 
9. I never scrutinize myself  0 1 2 3 
10. I get embarrassed very easily 0 1 2 3 
11. I am self-conscious about the way I 
look 
0 1 2 3 
12. I don’t find it hard to talk to strangers 0 1 2 3 
13. I’m generally attentive to my inner 
feelings 
0 1 2 3 
14. I usually worry about making a good 
impression 
0 1 2 3 
15. I’m constantly examining my motives 0 1 2 3 
16. I feel anxious when I speak in front of 
a group 
0 1 2 3 
17. One of the last things I do before I 
leave home is look in the mirror 
0 1 2 3 
18. I sometimes have the feeling that I’m 
off somewhere watching myself 
0 1 2 3 
19. I’m concerned about what other 
people think of me 
0 1 2 3 
20. I’m alert to changes in my mood 0 1 2 3 
21. I’m usually aware of my appearance 0 1 2 3 
22. I’m aware of how my mind works 
when I work through a problem 
0 1 2 3 
23. Large groups make me nervous 0 1 2 3 
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Appendix	G:	Balanced	Emotional	Empathy	Scale	(BEES): 
Please use the following scale to indicate the degree of your agreement or disagreement 
with each of the statements below. Record your numerical answer to each statement in 
the space provided preceding the statement. Try to describe yourself accurately and in 
terms of how you are generally (that is, the average of the way you are in most situations 
-- not the way you are in specific situations or the way you would hope to be).  
+4 = very strong agreement 
+3 = strong agreement 
+2 = moderate agreement 
+1 = slight agreement 
0 = neither agreement nor disagreement 
-1 = slight disagreement 
-2 = moderate disagreement 
-3 = strong disagreement 
-4 = very strong disagreement 
 
_____ 1. I very much enjoy and feel uplifted by happy endings.  
_____ 2. I cannot feel much sorrow for those who are responsible for their own misery.  
_____ 3. I am moved deeply when I observe strangers who are struggling to survive.  
_____ 4. I hardly ever cry when watching a very sad movie.  
_____ 5. I can almost feel the pain of elderly people who are weak and must struggle to 
move about.  
_____ 6. I cannot relate to the crying and sniffling at weddings.  
_____ 7. It would be extremely painful for me to have to convey very bad news to 
another.  
_____ 8. I cannot easily empathize with the hopes and aspirations of strangers.  
_____ 9. I don't get caught up easily in the emotions generated by a crowd.  
_____ 10. Unhappy movie endings haunt me for hours afterward.  
_____ 11. It pains me to see young people in wheelchairs. 
_____ 12. It is very exciting for me to watch children open presents.  
_____ 13. Helpless old people don't have much of an emotional effect on me.  
_____ 14. The sadness of a close one easily rubs off on me.  
_____ 15. I don't get overly involved with friends' problems.  
_____ 16. It is difficult for me to experience strongly the feelings of characters in a book 
or movie.  
_____ 17. It upsets me to see someone being mistreated.  
_____ 18. I easily get carried away by the lyrics of love songs.  
_____ 19. I am not affected easily by the strong emotions of people around me.  
_____ 20. I have difficulty knowing what babies and children feel.  
_____ 21. It really hurts me to watch someone who is suffering from a terminal illness.  
_____ 22. A crying child does not necessarily get my attention.  
_____ 23. Another's happiness can be very uplifting for me.  
_____ 24. I have difficulty feeling and reacting to the emotional expressions of 
foreigners.  
_____ 25. I get a strong urge to help when I see someone in distress.  
_____ 26. I am rarely moved to tears while reading a book or watching a movie.  
_____ 27. I have little sympathy for people who cause their own serious illnesses (e.g., 
heart disease, diabetes, lung cancer).  
_____ 28. I would not watch an execution.  
_____ 29. I easily get excited when those around me are lively and happy.  
_____ 30. The unhappiness or distress of a stranger are not especially moving for me. 
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Appendix	H:	Childhood	Traumatic	Events	Scale	
For the following questions, answer each item that is relevant. Be as honest as you can. Each 
question refers to any event that you may have experienced prior to the age of 17. 
1. Prior to the age of 17, did you experience a death of a very close friend or family 
member?________ If yes, how old were you?_________ 
If yes, how traumatic was this? (using a 7-point scale, where 1 = not at all traumatic, 4 = 
somewhat traumatic, 7 = extremely traumatic)_________ 
If yes, how much did you confide in others about this traumatic experience at the time? (1 = 
not at all, 7 = a great deal)_________ 
2. Prior to the age of 17, was there a major upheaval between your parents (such as divorce, 
separation)?_________ If yes, how old were you?________ 
If yes, how traumatic was this? (where 7 = extremely traumatic)______ 
If yes, how much did you confide in others? (7 = a great deal)_______ 
3. Prior to the age of 17, did you have a traumatic sexual experience (raped, molested, 
etc.)?_______ If yes, how old were you?_______ 
If yes, how traumatic was this? (7 = extremely traumatic)_______ 
If yes, how much did you confide in others? (7 = a great deal)_______ 
4. Prior to the age of 17, were you the victim of violence (child abuse, mugged or assaulted -- 
other than sexual)?______ If yes, how old were you?______ 
If yes, how traumatic was this? (7 = extremely traumatic)_______ 
If yes, how much did you confide in others? (7 = a great deal)_______ 
5. Prior to the age of 17, were you extremely ill or injured?______ If yes, how old were 
you?________ 
If yes, how traumatic was this? (7 = extremely traumatic)_______ 
If yes, how much did you confide in others? (7 = a great deal)_______ 
6. Prior to the age of 17, did you experience any other major upheaval that you think may 
have 
shaped your life or personality significantly?_______ If yes, how old were you?_______ 
If yes, what was the event?_______________________________________ 
If yes, how traumatic was this? (7 = extremely traumatic)_______ 
If yes, how much did you confide in others? (7 = a great deal)_______ 
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Appendix	I:	Recent	Traumatic	Events	Scale	
For the following questions, again answer each item that is relevant and again be as honest as 
you 
can. Each question refers to any event that you may have experienced within the last 3 
years. 
1. Within the last 3 years, did you experience a death of a very close friend or family 
member? 
______ 
If yes, how traumatic was this? (1 = not at all traumatic, 7 = extremely traumatic)_______ 
If yes, how much did you confide in others about the experience at the time? (1 = not at all, 
7 = a great deal)______ 
2. Within the last 3 years, was there a major upheaval between you and your spouse (such as 
divorce, separation)?______ 
If yes, how traumatic was this?______ 
If yes, how much did you confide in others?_____ 
3. Within the last 3 years, did you have a traumatic sexual experience (raped, molested, 
etc.)?_____ 
If yes, how traumatic was this?_____ 
If yes, how much did you confide in others?_____ 
4. Within the last 3 years, were you the victim of violence (other than sexual)?______ 
If yes, how traumatic was this?_____ 
If yes, how much did you confide in others?______ 
5. Within the last 3 years, were you extremely ill or injured?_____ 
If yes, how traumatic was this?_____ 
If yes, how much did you confide in others?_____ 
6. Within the last 3 years, has there been a major change in the kind of work you do (e.g., a 
new 
job, promotion, demotion, lateral transfer)?_____ 
If yes, how traumatic was this?_____ 
If yes, how much did you confide in others?_____ 
7. Within the last 3 years, did you experience any other major upheaval that you think may 
have 
shaped your life or personality significantly?_____ 
If yes, what was the event?_______________________________________ 
If yes, how traumatic was this?_____ 
If yes, how much did you confide in others?_____ 
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Appendix	J:	PATIENT	INFORMATION	SHEET	(i)	
Study Title: Interoception of Sympathetic Nerve Activity in Dysautonomia (PhD study) 
Investigators: Andrew Owens, Dr Valeria Iodice, Professor Christopher Mathias, Professor 
Hugo Critchley, Dr David Low 
You are invited to participate in the above study, before you decide, it is important for you to 
understand why the research is being carried out and what is involved. Please take some time 
to read the following information carefully and feel free to discuss with others if you wish.  
Part 1 of this patient information sheet tells you the purpose of the study and what will happen 
if you take part. 
Part 2 gives you more detailed information about the conduct of the study 
Thank you very much for taking the time to read more about this study. 
 
Part 1. Purpose of the research. 
Background of the study: 
Theories of emotion suggest that emotions are a result of things we see, hear and feel, such 
as reactions to bodily sensations caused by things we experience. So, if something that makes 
our heart rate increase or causes us to sweat, this may well influence our emotions. The 
autonomic nervous system (ANS) controls a range of bodily responses, such as blood 
pressure (BP), heart rate (HR) and sweating. The word ‘autonomic’ is used because ANS 
function is unconsciously controlled. We are investigating if disorders of the ANS that affect 
blood pressure, heart rate and sweating, e.g., excessive uncontrollable sweating 
(hyperhidrosis), Postural Tachycardia Syndrome (PoTS) and fainting (syncope), also influence 
emotions, as patients may physical states similar to heightened emotions, like; 
Ø a racing heart caused by excitement or stress in PoTS 
Ø light-headedness or feeling overwhelmed during fainting 
Ø feeling hot or clammy in hyperhidrosis 
The link between autonomic dysfunction (dysautonomia) of these disorders and any emotional 
changes that may occur has not been thoroughly investigated, however. For example, does 
the severity of the autonomic dysfunction dictate the influence on any emotional changes, if 
any changes are present? 
 
Specific aims of this study: 
In this study, emotional and autonomic factors in dysautonomia patients will be compared to 
participants without dysautonomia.  
 
Why have you been chosen? 
You have been chosen because you have a form of dysautonomia.  
 
Do I have to take part? 
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Taking part in this research study is entirely voluntary. It is up to you to decide whether or not 
to take part. If you do decide to take part you will be given this information sheet to keep and 
be asked to sign a consent form. If you decide to take part you are still free to withdraw at any 
time and without giving a reason.  A decision to withdraw at any time, or a decision not to take 
part, will not affect your rights at all. 
 
Part 2 – what will happen if you take part 
How long will the study last? 
All procedures will last ~60 mins in total in 1 visit. The testing will take place at the Autonomic 
Unit, National Hospital for Neurology and Neurosurgery, London.  
 
Study procedures: 
First you will be asked to complete some questionnaires that are designed to assess your 
experiences and emotions, which should take no more than 20 minutes. You will then be asked 
to lie down on a bed for ten minutes while cuffs are wrapped around one of your arms and 
fingers to record your BP and sensors are placed on your chest and ankles to record your HR. 
Next, you will be asked to squeeze a pad, and then put your hand on something cold, whilst 
trying to count your own heartbeats for brief periods during these 2 (gripping, cold pack) 
exercises. You may have previously performed these exercises at our department as they 
provide a very good insight into your autonomic nervous system. 
 
The bed you are laying on will then be tilted to sixty degrees (head up tilt table test) and you 
will be asked to try and count along to your own heartbeat (experimental task) again for 
between 60-120 seconds during the 9 minute period of being tilted with your head up. You 
may have previously performed a tilt table test at our department as it provides a very good 
insight into your autonomic nervous system function. The bed will then be lowered back to its 
normal position, you will be disconnected from the BP and HR monitors and will be free to go 
home. Please feel free to ask the investigator any questions at the end of testing or after you 
have left via the contact details provided.   
 
What data will be collected? 
The data that will be collected is your BP and HR reactions to the exercises and your 
questionnaires. All data will be anonymised (e.g., it will not identify you). 
 
What are the possible risks of taking part? 
There are a minimal amount of risks to taking part in this study. Should you have any adverse 
reactions, the Autonomic Unit, as well as the Hospital, have a number of highly-trained experts 
and emergency paramedics for such situations. There is possible risk of fainting during the 
upright phase of the tilting. BP and HR will be measured continuously during this test (and all 
the others) and therefore will be frequently monitored and, if blood pressure does fall to low 
levels, action can be taken immediately by stopping the test and returning you to the lying 
down position, when BP will return to normal and you should feel much better almost 
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immediately. If any new information becomes available during your participation that suggests 
that it might be in your best interests to withdraw from the study, this decision will be made by 
the Principal Investigator, your doctor and yourself. In all cases, the reasons will be thoroughly 
explained to you. 
 
What are the benefits of taking part? 
There is no direct benefit to you for taking part, however, it is hoped that the findings from this 
research will help the understanding and treatment of dysautonomia.  
 
What if something goes wrong? 
University College London holds insurance policies which apply to this study.  If you 
experience serious and enduring harm or injury as a result of taking part in this study, you may 
be eligible to claim compensation without having to prove that University College is at fault.  
This does not affect your legal rights to seek compensation. If you are harmed due to 
someone’s negligence, then you may have grounds for a legal action.  Regardless of this, if 
you wish to complain, or have any concerns about any aspect of the way you have been 
treated during the course of this study then you should immediately inform the Investigator 
Andrew Owens (andrew.owens.13@ucl.ac.uk, tel: 020 3456 1383 or 020 3448 3413).  The 
normal National Health Service complaints mechanisms are also available to you.  If you are 
still not satisfied with the response, you may contact the University Joint Research Compliance 
Office. 
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be kept 
strictly confidential. An identification code will be ascribed to each participant and all data 
collected will be electronically compiled anonymously. Any information about you which leaves 
the Unit will have your name removed so that you cannot be recognised from it. Procedures 
for handling, processing, storage and destruction of data are compliant with the Data 
Protection Act 1998. We would like to inform your GP that you are taking part in this research, 
which you will be free to decide (or not) to provide your consent for us to do so. 
 
What will happen to the results of the research study? 
Results will be presented anonymously at scientific conferences and in published research 
articles, which will typically occur ~6 months after the final participant has completed the study. 
If you would like, the Chief Investigator can provide you with a copy of the published results. 
You will not be identified in any report/publication.  
 
Who is organising and funding the research? 
This research study is being organised through University College London. 
 
Contact for Further Information 
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Andrew Owens 
Autonomic Unit 
National Hospital for Neurology and Neurosurgery 
2nd Floor 
Queen Mary Wing 
Queen Square 
London WC1N 3BG 
 
Email: andrew.owens.13@ucl.ac.uk   Phone: 020 3456 1383 or 020 3448 3413 
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Appendix	K:	PATIENT	INFORMATION	SHEET	(ii)	
Study Title: Psychological symptoms and dysautonomia: antecedent or succedent 
complications? (PhD study) 
Investigators: Andrew Owens (PhD student), Dr Valeria Iodice, Professor Christopher Mathias, 
Professor Hugo Critchley, Dr David Low 
You are invited to participate in the above study, before you decide, it is important for you to 
understand why the research is being carried out and what is involved. Please take some time 
to read the following information carefully and feel free to discuss with others if you wish. This 
study has been reviewed and approved by the London – Harrow Research Ethics Committee.    
Part 1 of this patient information sheet tells you the purpose of the study and what will happen 
if you take part. 
Part 2 gives you more detailed information about the conduct of the study 
Thank you very much for taking the time to read more about this study. 
Part 1. Purpose of the research. 
Background of the study: 
Theories of emotion suggest that emotions are a result of things we see, hear and feel, such 
as reactions to bodily sensations caused by things we experience. So, if something that makes 
our heart rate increase or causes us to sweat, this may well influence our emotions. The 
autonomic nervous system (ANS) controls a range of bodily responses, such as blood 
pressure (BP), heart rate (HR) and sweating. The word ‘autonomic’ is used because ANS 
function is unconsciously controlled. We are investigating if disorders of the ANS that affect 
blood pressure, heart rate and sweating, e.g., excessive uncontrollable sweating 
(hyperhidrosis), Postural Tachycardia Syndrome (PoTS) and fainting (syncope), also influence 
emotions, as patients may physical states similar to heightened emotions, like; 
Ø a racing heart caused by excitement or stress in PoTS 
Ø light-headedness or feeling overwhelmed during fainting 
Ø feeling hot or clammy in hyperhidrosis 
The link between autonomic dysfunction (dysautonomia) of these disorders and any emotional 
changes that may occur has not been thoroughly investigated, however. For example, does 
the severity of the autonomic dysfunction dictate the influence on any emotional changes, if 
any changes are present? 
 
Specific aims of this study: 
In this study, the autonomic responses (BP and HR) to physical and psychological stimuli in 
dysautonomia patients who have difficulty in regulating their sweating and body temperature, 
heart rate (such as Postural Tachycardia Syndrome) and blood pressure (causing fainting),  
will be compared to volunteers without any symptoms. Awareness of bodily sensations, such 
as a racing heart, has been proposed to play an important part in the formation of emotions, 
such as feeling nervous or excited. This study aims to examine how dysautonomia patients, 
who have symptoms that can mimic emotional responses, such as sweating, fainting or a 
racing heart, respond to emotional stimuli, like pictures and music.  
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Why have you been chosen? 
You have been chosen because you have dysautonomia or because you do not have 
dysautonomia or any other autonomic conditions and your data will be used as ‘control data’ 
and used as a normative comparison for the data of the dysautonomia group.  
 
Do I have to take part? 
Taking part in this research study is entirely voluntary. It is up to you to decide whether or not 
to take part. If you do decide to take part you will be given this information sheet to keep and 
be asked to sign a consent form. If you decide to take part you are still free to withdraw at any 
time and without giving a reason.  A decision to withdraw at any time, or a decision not to take 
part, will not affect your rights at all. 
 
Part 2 – what will happen if you take part 
How long will the study last? 
About an hour. The testing will take place at the Autonomic Unit, National Hospital for 
Neurology and Neurosurgery, Queen Square, London.  
 
Study procedures: 
This study should take no more than 90 minutes and combines some tests that are part of your 
routine diagnosis (head up tilt) and visual and audio stimuli that may provoke an emotional 
response. First you will be asked to complete some questionnaires that are designed to assess 
your experiences of mood, this should take no more than 15 minutes. You will then be asked 
to lie down on a bed for ten minutes while a cuff is wrapped around one of your arms and 
fingers to measure blood pressure and sensors are placed on your collar bones, rib cage and 
ankles. These sensors are connected to an electrocardiogram (ECG) which records your heart 
function. You will be shown some pictures and played pieces of music that contain an 
assortment of pleasant, neutral and unpleasant stimuli and be asked to rate each image and 
piece of music. The images are shown for around 5 minutes and the music played for around 
12 minutes. The bed you are on will then be safely tilted to 60 degrees with your head up and 
you will be presented with a new set of pictures for around 5 minutes and music for around 12 
minutes that contain an assortment of pleasant, neutral and unpleasant stimuli and asked to 
rate each image and piece of music. The bed will then be lowered back to its normal position 
and the study will end.  
 
What data will be collected? 
All data is anonymised. The other data that is collected is your ratings and BP and HR reactions 
to the autonomic and emotional stimuli, as well as the questionnaire data.  
 
What are the possible risks of taking part? 
Minimal. Should you have any adverse reactions, a team of emergency paramedics operate 
at the hospital around the clock. The Autonomic Unit also has a number of highly-trained 
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experts on-hand. There is possible risk of fainting during the upright phase of the tilting 
procedure. BP and HR will be measured continuously during this test (and all the others) and 
therefore will be frequently monitored and, if blood pressure does fall to precipitously low 
levels, action can be taken immediately by stopping the test and returning you to the supine 
position, when BP will return to normal and you should feel much better almost immediately. 
 
If any new information becomes available during your participation that suggests that it might 
be in your best interests to withdraw from the study, this decision will be made by the Principal 
Investigator, your doctor and yourself. In all cases, the reasons will be thoroughly explained to 
you. 
 
What are the benefits of taking part? 
There is no direct benefit to you for taking part, however, it is hoped that the findings from this 
research will help the understanding and treatment of dysautonomia.  
 
What if something goes wrong? 
University College London holds insurance policies which apply to this study.  If you 
experience serious and enduring harm or injury as a result of taking part in this study, you may 
be eligible to claim compensation without having to prove that Imperial College is at fault.  This 
does not affect your legal rights to seek compensation. 
 If you are harmed due to someone’s negligence, then you may have grounds for a legal action.  
Regardless of this, if you wish to complain, or have any concerns about any aspect of the way 
you have been treated during the course of this study then you should immediately inform the 
Investigator Andrew Owens (andrew.owens.13@ucl.ac.uk, tel: 020 3456 1383 or 020 3448 
3413).  The normal National Health Service complaints mechanisms are also available to you.  
If you are still not satisfied with the response, you may contact the University College London 
Hospitals NHS Foundation Trust, Joint Research Office.   
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be kept 
strictly confidential. An identification code will be ascribed to each participant and all data 
collected will be electronically compiled anonymously. Any information about you which leaves 
the Unit will have your name removed so that you cannot be recognised from it. Procedures 
for handling, processing, storage and destruction of data are compliant with the Data 
Protection Act 1998. We would like to inform your GP that you are taking part in this research, 
which you will be free to decide (or not) to provide your consent for us to do so. 
 
 What will happen to the results of the research study? 
Results will be presented anonymously at scientific conferences and in published research 
articles, which will typically occur ~6 months after the final participant has completed the study. 
If you would like, the Principal Investigator can provide you with a copy of the published results. 
You will not be identified in any report/publication.  
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Who is organising and funding the research? 
This research study is being organised through University College London. 
 
Contact for Further Information 
Andrew Owens 
Autonomic Unit 
National Hospital for Neurology and Neurosurgery 
2nd Floor 
Queen Mary Wing 
Queen Square 
London WC1N 3BG 
 
Email: andrew.owens.13@ucl.ac.uk   Phone: 020 3456 1383 or 020 3448 3413 
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